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Summary
The unique structure o f the cornea is essential for this connective tissue to be transparent. 
Any disruption in the spatial arrangement or size o f collagen fibrils results in cornea 
becoming opaque. Thus, ultrastructure is closely linked to transparency. Proteoglycans in the 
corneal stroma are widely believed to influence its ultrastructure.
This thesis will focus on two situations in which proteoglycan changes are potentially linked 
to comeal structural change and transparency loss. In developing chick cornea, changes in 
stromal architecture, hydration and content o f extracellular matrix molecules such as 
proteoglycans accompanies the onset o f  transparency in the last week o f development. 
Conversely, in patients suffering from genetic malfunctions in the proteoglycan synthesis 
pathway, comeal structure is often changed and transparency lost. These model systems will 
be studied to shed light on possible roles o f proteoglycans for the control o f comeal fibril 
structure and thus transparency.
In the developing chick cornea and in macular cornea dystrophy (MCD) it was found that the 
progressive close packing o f collagen fibrils is not homogenous. Microbeam small angle X- 
ray diffraction revealed that in MCD collagen fibrils are more closely packed in the deep 
stromal layers, which was attributed to differential distribution o f proteoglycans. In the 
developing chick cornea, compaction o f collagen fibrils starts in the deep stromal layers, to 
be followed by the outer layers so that spacing becomes uniform across the comeal depth 
before hatch. These changes are most likely associated with preferential sulphation o f 
proteoglycans.
Transmission electron microscopy o f  a human cornea with excess chondroitin 
sulphate/dermatan sulphate glycosaminoglycan showed that changes in proteoglycan 
structure, content and sulphation lead to the formation o f abnormally large collagen fibrils. 
The lack o f sulphation o f keratan sulphate in MCD also led to abnormally large fibrils, which 
are present in the deep stromal layers. These findings suggest overlapping roles o f  the two 
proteoglycan populations in the comeal stroma with possible feedback mechanisms, too.
Taken together, the findings o f this thesis indicate the central role played by proteoglycan- 
collagen interactions in the development and maintenance o f properly formed comeal stroma.
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Chapter One
1 Introduction
This chapter presents a b rief description o f the ocular system with emphasis on 
corneal structure. To act as a basis for the research presented and discussed in this 
thesis, it provides information about proteoglycans, collagen structure and 
biosynthesis, as well as the interactions and functions o f these molecules. Brief 
introductions to chick eye development and human ocular disease affecting the 
structure o f the cornea are also included.
1.1 The eye
The eye is the organ o f  photoreception in the animal kingdom. The structure of 
vertebrate’s eyes, including human and bird eyes share fundamental similarities 
(Figure 1.1). In the eye, the incoming light has to pass through four transparent 
media: the cornea, aqueous humor, lens and vitreous humor before reaching the 
retina, where photoreceptors convert light energy into electric impulses. These 
impulses are sent via the optic nerve to the brain’s cortex, where a visual image 
emerges. Several extraneous structures and layers give the eye the strength to resist 
injuries, withstand intraocular pressure and help in accommodation. For example, the 
eye is suspended and moved in the orbit o f skull by six extra-ocular muscles attached 
to the white outer coat o f  the eye, called the sclera. The conjunctiva lines the eyelids 
and folds back to attach to the eye. The back eye’s nourishment is provided by a 
vascular layer called the choroid. The front o f the eye is nourished by the turnover o f 
aqueous humor produced by the ciliary body and tear film. Small ciliary body muscle 
are responsible for the movement o f the lens causing changes in accommodation, 
with the amount o f light entering the eye controlled by small ring muscle o f the iris 
which changes its aperture.
Inevitably some differences occur between avian and human eye, mainly due to 
avian adaptation to various habitats and avian nature in general. The main differences 
are presented in Table 1.1, which I created based on a selection o f anatomical books.
1
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A
Annulus ossicularis 
s d e ra e '
Ora serrata
Sclera-  
Choroidea
Fovea
centralis
Retina
Polus anterior Camera anterior bulbi
Cornea Pulvinus annularis lentis
Reticulum trabeculare
Corpus ciliare Sinus venosus sderae 
"Fibrae zonulares
Plicae ciliares
Equator
TEMPORAL
Pecten ocuii
N. opticus
Lamina carlilaginea 
sclerae
Equator
NASAL
Polus posterior
Figure 1.1 Schematic diagram o f a cross-section of (a) a human eye (after Mac and Joy, 2000) 
and (b) an avian eye (after Giintiirkun, 1998).
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Table 1.1 Differences between the human and avian eye.
H um an eye Avian eve
flattened
Shape sphere globose
tubular
Accommodation organ lens lenscornea
Nutrition provider
choroid 
aqueous humor 
tear film
pecten 
choroid 
aqueous humor
Number o f eyelids 2 3
Transmitted light visible UV-visible
The human eye is nearly spherical and is 25mm in diameter and 6.5ml in volume 
(Forrester et al., 2002). Avian eyes differ in shape and size but are always large in 
comparison to their body size. The equatorial diameter o f a 3-week-old White 
Leghorn chicken, for example, has been reported to be nearly 13mm (Prashar et al.,
2009). The retinal surface is increased in birds to enhance visual acuity and depth o f 
focus. Thanks to the presence o f ciliary muscles attach to bony scleral ossicles, 
changes in corneal curvature and thereby refractive power are possible in the avian 
eye (Beer, 1893; Schaffel et al., 1987; Glasser et al., 1994). In adult chick an 
accommodation o f 25 Dioptres can be induced, with 40% due to the corneal 
curvature and remaining 60% to the change in shape o f lens (Glasser et al., 1994). 
Another interesting feature in a bird’s eye is a pecten. The pecten is located directly 
over the optic disc near the retina and is completely made up o f blood vessels and 
extravascular pigmented stroma cells (Bellhom and Bellhom, 1975). The avian retina 
is completely avascularised and the presence o f this unusual nutritional device seems 
to compensate for this.
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1.2 Cornea
The most outer layer in the front o f  the eye has to combine an optical function with 
structural strength. For that reason, cornea has to be fully transparent to focus 
incoming light and be tough to counter trauma and infections from the outside 
environment. The cornea bulges from the sclera in the transition region called the 
limbus. This highly vascularised area is rich in stem cells that are responsible for an 
epithelial layer turnover (Davanger and Evensen, 1971) and wound healing (Huang 
and Tseng, 1991).
The human cornea is roughly spherical, although its diameter is slightly smaller in 
the vertical (9.0-11.0mm) than in the horizontal (10.6-11.7mm) direction, and it is 
thicker at the periphery (0.67mm) in comparison with the centre (0.52mm) (Tovee, 
2008). The chick cornea continues to grow after hatch and from 0.16mm thick at 
hatch it reaches 0.25mm in the young hen (Hay and Revel, 1969). Corneal curvature 
and axial length are maintained by pressure from the fluids inside the eye (Oyster,
1999).
Chick and human cornea differ in size, however, their basic structure manifests 
considerable similarity. In the normal physiological state the cornea has no blood 
vessels, but has tightly packed nerve endings on the surface (Rozsa and Beuerman, 
1982). The fully developed human and avian cornea consists o f five layers (Figure
Figure 1.2 Image of the section o f  the cornea divided into five layers.
(Modified from ://education.vetmed.vt.edu/curriculum/VM 8054/EYE/CRNSCLRA.HTM )
1.2 ).
Epithelium * •« 0 • •  • 
tilUlltiitti Bowman's
layer
Stroma
Endothelium
Descemet's
membrane
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The human epithelium is around 50pm thick, which is approximately 10% of the 
whole thickness of the cornea and it consist of different types of cells described in 
Table 1.2.
Table 1.2 Types of corneal epithelial layers based on selection of books.
Cells type Number of layers Characteristics
flattened
surface cells 2 squam ous
non-keratin ised
polygonal cells 2-3 w ing  shaped
basal cells 1 cuboid
The basal cells constantly proliferate and thus push existing epithelial cells upwards. 
With each division the most superficial layer o f surface cells is removed. Total 
epithelial turnover takes around 2 weeks (Cenedella and Fleschner, 1990). All 
epithelial cells are held together by desmosomes, and the epithelium is attached to 
the stroma by an attachment complex. The lamina densa is anchored to the 
Bowman’s layer by a meshwork of anchoring collagen VI and VII filaments and 
hemidesmosomes (Gipson et al., 1987).
The most anterior part o f the corneal stroma is Bowman’s layer. It takes up to 2% of 
the total corneal thickness and is 8- 14pm thick in humans and 4-5pm thick in the 
hen. This layer is an acellular meshwork o f disorganised collagen, consisting o f short 
and thin fibrils, and this is believed to make Bowman’s layer more resistant to strain.
The stroma constitutes approximately 90% of the corneal thickness. It is mainly 
composed o f water being about 75% hydrated (by weight) with the biological 
material comprising various collagens, glycoproteins, proteoglycans and keratocytes. 
Keratocytes are flattened corneal fibroblasts that occupy 9% (middle) to 17% 
(posterior) of the human stroma’s volume (Hahnel et al., 2000). Stromal collagen 
fibrils are organised into approximately 200 (Hogan et al., 1971) 2pm thick lamellae 
that lie parallel to the corneal surface in the central cornea (Komai and Ushiki, 1991). 
Within the lamellae run regularly arranged collagen fibrils of small uniform
5
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diameter. The strom a’s unique structure makes the cornea the only connective tissue 
which is transparent. The architecture o f the stroma and the theories o f transparency 
will be presented in Section 4.
Descemet’s membrane is produced by the endothelium to separate it from the 
stromal matrix. It constitutes less than 2% o f corneal thickness. It can be divided into 
zones: one o f which is granular and amorphous and the other, well organised and 
banded with nodes linked together with strands into hexagons (Jakus, 1956). This 
membrane is rich in fibronectin or laminin, and in collagen types IV, V, VI and VIII.
The corneal endothelium is a single layer o f hexagonal cells that form the posterior 
surface o f the cornea. These cells have a long life but low regenerative capacity. Cell 
density decreases with age in normal adult cornea at a rate o f 0.6% per year (Bourne 
et al., 1997). The remaining cells compensate for this loss by stretching and changing 
shape (Yee et al., 1985). The endothelium, via a system o f pumps, controls the 
maintenance o f the right corneal hydration, and thus transparency (Maurice, 1972). It 
controls the flow o f fluids and ions between the stroma and aqueous (Hodson and 
Miller, 1976; Bonanno, 2003).
1.3 Collagen
Collagen is the most abundant protein in the animal kingdom and a prevalent 
component o f  the corneal stromal extracellular matrix. It plays not only a structural 
role but is involved in cell attachment, differentiation, and also in 
immunopathological, developmental and physiological processes.
To date, 28 collagen types have been identified, o f which 18 can be found in human 
cornea and 11 take part in the process o f corneal development (Linsenmayer et al., 
1998; Ihanamaki et al., 2004; Gordon and Hahn, 2010).
1.3.1 Collagen structure and biosynthesis
There are two characteristics that all collagen molecules have in common, that is 
being composed o f three a-chains and having at least one domain in which these
6
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chains are arranged in a left-handed triple helix by being closely wrapped around one 
another (Figure 1.3).
Figure 1.3 Schematic o f a single collagen a -ch a in  and a triple helical conformation (after 
Alberts et al., 2002).
This conformation is stabilised by inter-chain hydrogen bonds. The peptide bonds 
linking adjacent amino acids are hidden in the interior o f the molecule. To fold a - 
chains into the proper helical conformation, glycine must be present as every third 
amino acid. The chains are therefore composed of a series of triplets Gly-X-Y, where 
X and Y can be any amino acid but are often proline and hydroxyproline, 
respectively (Ramshaw et al., 1998). Triple helical regions (Col domains) are flanked 
by non-collagenous domains, which are non-glycine-X-Y regions (NC domains or 
telopeptides). The significance o f the triplet with Gly to form the triple helix 
becomes obvious when mutation o f a single residue (replacing Gly with Ala) results 
in the formation o f  crystals rather than fibrils (Bella et al., 1994). The hydroxyproline 
in the position Y but not X, increases dramatically the thermal stability of triple 
helices (Berg and Prockop, 1973).
Collagen is firstly synthesised in the rough endoplasmic reticulum of stromal 
keratocytes (Ruggiero et al., 1996). Then procollagen molecules undergo a series of 
modifications and folding that involves activity of glycosyltransferases, isomerases 
and collagen-specific chaperone Hsp47 (Nagata, 1998). Procollagen molecules are 
transported then to the Golgi apparatus where molecules are stacked laterally and are 
secreted into the extracellular space (Figure 1.4).
7
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Figure 1.4 Representation o f collagen biosynthesis (after Alberts et al., 2002).
At this stage molecules are composed o f a central triple helical domain and non 
collagenous domains at N- and C- terminal ends. Both o f these domains are cleaved 
by propeptidase enzymes generating mature collagen molecules. However, only 
removing C-propeptides is required for the correct course of events where mature 
triple helical collagen molecules assemble into fibrils (Kadler et al., 1987). 
Fibrillogenesis is a self-assembly process, but in vivo, the presence of fibronectin, 
fibronectin-binding and collagen-binding integrins and collagen V or XI is required 
(Linsenmayer et al., 1993; Wenstrup et al., 2004; Kadler et al., 2008).
Fibril forming collagen has an axial D-periodicity o f 67nm and displays a staining 
pattern comprising a gap (dark) and an overlap (light) zone (Petruska and Hodge, 
1964). However, D-periodicity in different tissues can vary and has been reported to 
be 65nm in corneal collagen (Meek et al., 1981). This light and dark pattern is a 
reason for calling fibril forming collagen a banded fibrils. The positive staining 
pattern shows even more intense banding along the fibrillar axis. Bands within each 
D-periodicity have designated letters “a” to “e” (Figure 1.5) (Smith and Frame, 
1969).
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Figure 1.5 Schematic o f collagen molecules assembled into a fibril with overlap and gap zones 
visible (a). Fibrils negatively (b) and positively (c) stained with PTA show collagen binding sites 
(after Kadler et al., 1996).
The stability o f the collagen fibril comes from its coiled coil three-dimensional 
structure. A single collagen a-chain is a right-hand helix, which with two other a - 
chains form a left-hand triple helical structure. These triple helices are organised into 
microfibrils arranged in the way that they form another right-hand helix by being 
tilted -15° to the fibril long axis (Wess et al., 1998; Holmes et al., 2001). Microfibrils 
show a quasi-hexagonal cells packing (Orgel et al., 2000) and a separation of intact 
microfibrils is virtually impossible, because of an interaction between N- and C- 
termini o f collagen molecules, which creates covalent cross-links within and in 
between microfibrils (Orgel et al., 2000).
1.3.2 Types of collagen
It is now well established that most connective tissues are composed of several 
collagen types. Collagen o f a specific type can consist of homotrimeric molecules 
(e.g. type II, III) where all three a  chains are the same, or can be formed of
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heterotrimers with one different a -cha in  (e.g. type I) or all three a-chains different 
from one another (e.g. type IX).
Pure single-type collagen fibrils are unlikely to exist. Collagen type I in the cornea 
and collagen type II in cartilage are paired to create heterotypic fibrils with collagen 
type V and collagen type XI, respectively (Birk et al., 1986, Mendler et al., 1989). 
The role o f the two latter types is to control fibril diameter and longitudal growth 
(Birk et al., 1990; Linsenmayer et al., 1993; Blaschke et al., 2000; Birk, 2001).
Several classes o f collagenous molecules can be distinguished based on size, domain 
structure and supramolecular organisation. 27 collagen types are presented in Table 
1.3. The most recent collagen type XXVIII has been identified but cannot be clearly 
assign into any collagen subgroup (Veit et al., 2006).
Table 1.3 Vertebrate collagen classes (Shoulders and Raines, 2009).
Collagen class Collagen types
Fibrillar I, II, III, V, XI, XXIV, XXVII
FACIT IX, XII, XIV, XVI, XIX, XX, XXI, XXII, XXVI
Network IV, VI, VIII, X,
Anchoring fibrils VII
MACIT XIII, XVII, XXIII, XXV
MULTIPLEXIN XV, XVIII
Abbreviations:
FACIT -  fibril-associated collagen with interrupted triple helices 
MACIT -  membrane-associated collagen with interrupted triple helices 
MULTIPLEXIN -  multiple triple-helix domains and interruptions
1.3.2.1 F ibrillar collagen
The most abundant and broadly studied collagen class is fibrillar collagen. Structure, 
biosynthesis and fibrillogenesis o f this classic striated collagen are described in part
3.1 of this chapter as a representative model of collagen. In the cornea, which is the 
subject of all the research included in this thesis, type I, II, III and V can be found.
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Type I collagen has been isolated from many adult connective tissues, including the 
primary and secondary corneal stroma and Bowman’s layer. Its function is to give 
tissue tensile strength. Type II collagen is mainly found in cartilage (Miller and 
Matukas, 1969) and vitreous (Trelstad and Kang, 1974). In an avian developing 
cornea type II is present in the primary stroma, although it disappears by E20 and is 
visible in hen cornea only in Descemet’s membrane (Hendrix et al., 1982). The 
proportion of type III collagens is low in healthy cornea but increases during wound 
healing or inflammation (Mally et al., 1990). Detectable collagen III in mature tissue 
is associated with the stroma and epithelial substratum. Type V collagen is a part of a 
heterotypic fibril with collagen type I in mature corneal stroma (Fitch et al., 1984). 
Type V in the native form retains a large pepsin-sensitive NH2-terminal domain at 
the end of its a-chains, which regulates fibrillogenesis and fibril diameter 
(Linsenmayer et al., 1993; Andrikopoulos et al., 1995; Linsenmayer et al., 1998) and 
in Bowman’s layer its function may be the anchoring of basement membranes to the 
underlying stromal matrix (Adachi and Hayashi, 1986).
1.3.2.2 FACIT
Fibril associated collagens with interrupted triple helices (FACITs) are a class of 
molecules designed for interaction with fibrils and other matrix components. Each 
FACIT molecule contains multiple triple helical domains interrupted by non-triple 
helical domains (Figure 1.6). Some domains lie along the fibril surface and anchor 
the molecule to the underlying fibrillar collagens. Other domains protrude from the 
fibril to support interactions with adjacent fibrils or matrix components (Shaw and 
Olsen, 1991).
GAG- *
Collagen type IX
NC 2
COOH
COL
Collagen type II
Figure 1.6 Diagram of FACIT collagen type IX along a type II fibrillar collagen. COL-triple 
helical collagen domain, NC-non collagenous domain.
11
Introduction
Type IX collagen is associated with type II collagen molecules o f fibrils in the 
primary corneal stroma, the vitreous and cartilage (Fitch et al., 1988). Collagen type 
IX consists o f three Col domains and four NC domains (Figure 1.6) (van der Rest et 
al., 1985). One o f the NC domains may have a chondroitin sulphate side chain 
attached, which provides another potential functional group for interaction with 
matrix components (van der Rest and Mayne, 1988; Fitch et al., 1995). Type IX 
function in cornea is probably to stabilise the primary corneal matrix; hence this 
collagen type disappears after stromal swelling (Cai et al., 1994; Fitch et al., 1998).
Type XII and XIV are structurally similar and are associated with fibrils containing 
collagen type I (Gordon et al., 1990; Keene et al., 1991). In the developing avian 
cornea both types are temporally and spatially separated. Collagen type XIV is 
detectable throughout the stromal thickness in early development and during tissue 
compaction, while collagen type XII is deposited near Bowman’s layer and 
Descemet’s membrane regions where matrices interface with one another throughout 
development (Gordon et al., 1996; Akimoto et al., 2002). This may suggest that type 
XII collagen has a role in development o f stromal architecture and maintenance o f 
fibril organisation, while type XIV collagen may play a role in the regulation o f 
fibrillogenesis (Young et al., 2002).
1.3.2.3 Other collagens
In the cornea there are three types o f network-forming collagens: IV, VI and VIII. 
Type IV collagen makes a three-dimensional structure in basement membranes 
(Yurchenco and Ruben, 1988) and is present in the developing avian stroma as 
strings and plaques o f  basement-like material (Fitch et al., 1991). Another common 
collagen in the developing cornea is collagen type VI, which becomes detectable at 
the time o f fibroblasts invasion and stromal swelling (Linsenmayer et al., 1986) 
Collagen type VI is secreted by fibroblasts; however, its presence in subepithelial 
and subendothelial areas suggests that those layers may also participate. In the 
mature tissue, beaded filaments o f collagen VI run between layers, bundles and 
fibrils, and in the less dense matrix interact with striated fibrils o f collagen I 
(Bonaldo et al., 1990). Collagen type VIII (Sage et al., 1983) forms hexagonal 
lattices in Descem et’s membrane o f the cornea (Sawada et al., 1990). Collagen type
12
Introduction
VII is a part o f the anchoring filaments which form an attachment complex adhering 
the comeal epithelium to the anterior stroma (Burgeson et ah, 1990; Gipson, 1992). 
Recently it also has been shown merging into the banded collagen fibrils in dermis 
(Villone et ah, 2008), whereas type XVII is involved in a hemidesmosomal 
attachment complex (Li et ah, 1993; Gordon et ah, 1997).
The types of collagen detected in the cornea are shown in the Table 1.4 according to 
their position in the cornea, except collagen type XX. Although expression of this 
type o f collagen has been found in the layer of comeal epithelium, insufficient 
information is available to place this FACIT into any of categories below (Koch et 
ah, 2001).
Table 1.4 Distribution of the main collagen types in the corneal layers (Marshall et al., 1993; 
Linsenmayer et al., 1998; Michelacci, 2003).
i 11 III IV V VI VII VIII IX XII XIII XIV XVII XVIII
Anchoring complex X X X X
Bowman’s layer X X X X
Primary stroma X X X X X
Secondary stroma X X X X X X X
Descemet’s membrane X X X X
1.4 Collagen arrangem en t and corneal transparency
Collagen fibrils are arranged in the comeal stroma into lamellae stacked on one 
another and especially in the developmental stage, they are organised into orthogonal 
lattices. Most fibrils have a uniform diameter (25-35nm) and run nearly parallel to 
each other with regular spacing, forming bundles that coalesce into flat lamellae 
throughout development (Figure 1.7) (Trelstad and Coulombre, 1971; Birk and 
Trelstad, 1984; Meek and Leonard, 1993; Hirsch et ah, 1999).
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Figure 1.7 Scanning electron micrograph o f a stack o f lamellae in the corneal stroma showing 
collagen fibrils running parallel to each other within a lamella, but lamellae rotated compared 
to each other. Calibration bar = 10pm (after Radner et al., 1998).
In the central region o f the human cornea, there are approximately 240 stacked 
lamellae and this number increases to 500 at the limbus (Hamada et al., 1972; 
Bergmanson et al., 2005). Each lamella is rotated in the plane of the cornea at a 
certain degree (between 0 and 90°) compared to the adjacent lamella. In the anterior 
stroma, collagen lamellae are thin (0.2- 1.2pm), sometimes splitting into two or three 
sublayers that become interwoven. Sometimes lamellae split not only in the 
horizontal direction but also in the anterior to posterior direction (Radner et al., 
1998). In the posterior stroma, collagen lamellae tend to be parallel to the corneal 
surface and are thicker (0.2-2.5pm) than in the anterior stroma. In a thin layer near 
Descemet’s membrane collagen fibrils run in various directions and form a loose 
fibrillar network (Komai and Ushiki, 1991). In the plane of the cornea, collagen 
fibrils run in different directions, although it is possible to distinguish a preferential 
spatial organisation. In the central cornea fibrils are orientated in the inferior-superior 
and nasal-temporal directions, while near the limbus collagen run along the 
circumference (Meek et al., 1987; Boote et al., 2005) (Figure 1.8). The preferential 
orientation o f highly aligned collagen is restricted to the posterior stromal layers 
(Kamma-Lorger et al., 2010).
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nasal sclera
Figure 1.8 Preferential collagen orientation in the human cornea (after Boote et al., 2005).
Unlike all other collagen-rich tissues, the cornea is transparent and, as I will describe 
later, the characteristic fibrillar architecture o f the stroma is responsible for this. The 
stroma, apart from collagen fibrils, also includes keratocytes and other matrix 
components. Corneal fibroblasts in the normal healthy state produce corneal 
crystallins, which make them weak light scatterers by reducing refractive index 
inhomogenieties in the cytoplasm and make keratocytes more transparent (Jester et 
al., 1999; Jester, 2008). For that reason, in most o f the transparency theories, an 
important feature is the arrangement, centre-to-centre spacing, and size o f the 
collagen fibrils.
The lattice arrangement o f corneal collagen fibrils inspired the first explanation of 
corneal transparency by Maurice (1957). It proposed that the small size and uniform 
spacing leads to destructive interference between the light scattered by individual 
fibrils, thus limiting the intensity o f scattered light and resulted in only forward 
transmission o f light. Goldman et al. (1968) modified the lattice theory o f Maurice 
and included the fluctuation in the index of refraction within the media as a function 
o f distance. In general, it proposed that incident light scattering in the media is 
dependent on the wavelength o f light and the magnitude o f the refractive index 
fluctuations. When the distance between scattering structures is less than half the 
wavelength o f visible light (approximately 200nm), the medium is transparent. 
Another model was suggested by Smith (1969) in which he assumed that all corneal 
components have a uniform refractive index and light propagates through the tissue 
unscattered. This model proved to be unsound based on evidence including X-ray
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diffraction data, which confirmed the difference in the refractive indices between 
collagen fibrils and the rest o f extracellular matrix (Leonard and Meek, 1997).
The pioneering lattice theory o f Maurice (1957) has proved to be a basis for the 
current models o f corneal transparency, although the geometrically perfect regularity 
o f the lattice is not required for transparency (Goodfellow et al., 1978). Hart and 
Farrell (1969) showed that only short-range order in the fibril arrangement is 
necessary for the destructive interference o f scattered light, while Feuk (1970) 
developed a long-range order model based on small, random displacements from the 
ideal lattice. Twersky (1975) assumed a two-dimensional fibril arrangement and 
distribution based on the volume fraction occupied by fibrils, whilst Benedek (1971) 
focused on the fibril number density. Hart and Farrell (1969) presented as concept of 
a radial distribution function that helped Freund to develop a statistical method called 
the Direct Summation o f Fields to predict transmission by a short-range order 
distribution o f different-sized fibrils (Freund et al., 1986). Based on these studies it is 
believed that corneal transparency depends on incident light wavelength, density o f 
fibril packing, fibril diameter, refractive index o f collagen, interfibrillar matrix and 
their ratio, light scattering angle and thickness o f the cornea (Farrell and McCally,
2000). Some o f those can be influenced by components o f comeal extracellular 
matrix, mainly proteoglycans.
1.5 Proteoglycans
Proteoglycans (PGs) are molecules associated with the extracellular matrix in many 
tissues, and in cornea are composed o f a core protein with covalently attached 
glycosaminoglycan (GAG) chains. The exception is hyaluronan which is a GAG not 
linked to the protein. PGs can be divided into three main categories: small leucine- 
rich PGs, modular PGs and cell-surface PGs.
PGs are structural proteins; thus, they play a major role in signal transduction, 
adhesion, migration, and proliferation o f cells, fibril assembly, degradation and 
inflammation (Fullwood et al., 1996; Merline et al., 2009; Schaefer and Schaefer,
2010). PGs are so functionally diverse due to the numerous differences in size and 
structure o f protein between molecules. The size o f a core protein is in the range 20
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to 450kD. GAG chains, which are repeating disaccharides with sulphate esters, can 
be up to 70kD large and can be divided into three main types: chondroitin/dermatan 
sulphate (CS/DS), keratan sulphate (KS) and heparan sulphate.
1.5.1 Small leucine-rich proteoglycans
Corneal proteoglycans belong to the small leucine-rich proteoglycans (SLRP) family, 
which consist o f 5 subfamilies and is expanding (Figure 1.9). Members of SLRP PGs 
share some common characteristics. For example, the central domain of the core 
protein constitutes leucine-rich motifs repeats (LRR) flanked by two conserved 
cysteine-rich regions. In all SLRP PGs, the C-terminal cysteine motif forms a 
disulfide bond between Cys 284 and Cys 317 causing the extended LRR to fold 
creating the structure called an “ear repeat”. N-terminal contains a cluster of four 
cysteines capping motif and GAG chain attachment sites (Scott et al., 2004; McEwan 
et al., 2006).
i  Biglycan CS/DS
  Decorin CS/DS
  Asporin
  ECM2
Fibromodulin KS
Lumican KS
PRELP
Keratocan KS
Osteoadherin KS
Epiphycan CS/DS
Opticin
Osteoglycin/Mimecan KS
IV —  Chondroadherin 
  Nyctalopin
  Tsukushi
—  Podocan
—  Podocan-like protein 1
Figure 1.9 Small leucine-rich core proteins organised into 5 subfamilies (Scheaffer and lozzo, 
2008). Next to proteins, GAG chains that can be attached to the core to form PGs.
V
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In the healthy adult corneal stroma, four main PGs can be found: decorin (Li et al., 
1992), lumican (Blochberger et al., 1992b; Kao, 2006), keratocan (Corpuz et al., 
1996; Chakravarti, 2006) and mimecan (Funderburgh et al., 1997).
The core proteins o f all corneal PGs have a similar size o f 40-52kD (Blochberger et 
al., 1992b). Decorin has a single 55-60kD CS/DS chain, while lumican, keratocan 
and osteoglycin/mimecan have 2-3 KS chains o f 10-15kD each (Hassell et al., 1979; 
Midura and Hascall, 1989; Dunlevy et al., 1998).
1.5.2 Glycosaminoglycans
GAG chains are made o f repeating disaccharide regions containing acetylated amino 
sugar moieties (N-acetyl-galactosamine or N-acetyl-glucosamine) and uronic acid 
(D-glucoronic acid or L-iduronic acid). KS GAGs are based on repeating 
disaccharides [-4 N -acetyl-glucosam ine-pi,3-galactosepl]n (Neame and Kay, 2000).
D erm atan sulfate 
proteoglycan
S° 3CHjOH COO- S° 3c h 2OH CO O ' CH2OH CHjOH
:oo- coo-
NH
—
IduA GalNAc4S IduA GalNAc4S GluA GalNAc4S GluA Gal Gal Xyl Ser
Linkage region Core protein
Keratan sulfate 
proteoglycan
CHjOH CH20SO3- CH2OSO3' CH2OSO3- CHjOH CH2OH CHjOH
m +c  1 J - A c  T HN-Ac CH
Gal GlcNAc6S Gal6S GlcNAcSS Gal GlcNAc
CHjOH CHjOS0 3- CH2OSO3- CH jO SO j- CHjOH CHjOH
Fuc
HN-Ac HN-Ac
NH
-C-CH2-CH 
H II I O CO
HN-Ac HNAc NH 
Man GlcNAc GlcNAc Asp
HNAc
Linkage region Core protein
Figure 1.10 Simplified structures o f  corneal matrix glycosaminoglycans attached to the core 
protein via linkage region (after M ichelacci, 2003).
CS/DS GAG chains are O- attached to the serine in a Ser-Gly pair near the N- 
terminal o f core protein via tetrasaccharide glucuronic acid-galactose-galactose-
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xylose (Chopra et al., 1985) (Figure 1.10), while KS is N-linked to asparagine o f the 
core protein via a mannose-N-acetyl-glucosamine complex. The extended KS chain 
links to the 6-position o f  mannose while the 3-position branches into the short non- 
sulphated chain capped by sialic acid (Stein et al., 1982; Oeben et al., 1987). In 
cartilage, the KS chain is O-linked to serine or threonine (Funderburgh, 2000) and in 
brain Man-O-Ser linkages may exist (Krusius et al., 1986).
Under normal physiological conditions, GAG chains have a hydrophilic nature, are 
highly negatively charged and exhibit varying sulphation patterns. Sulphation o f KS 
occurs on C6 o f the N-acetylglucosamine and an additional sulphate may occur on 
C6 o f galactose (Scudder et al., 1986). Distribution o f sulphation along the KS chain 
has been characterised in detail for porcine KS. It shows that 4-6 N- 
acetylglucosamine disaccharide moieties nearest the protein are unsulphated, the next 
10-12 disaccharides are sulphated only on the glucosamine, and the additional 2-10 
disulphated disaccharides occur on non-reducing termini o f the chains (Oeben et al.,
1987). CS chains are less sulphated and have no more than one sulphate group per 
disaccharide. Sulphation may occur at C4, or less often at C6 o f N- 
acetylgalactosamine. In a human cornea, approximately 64% o f CS/DS disaccharides 
stay unsulphated (Plaas et al., 2001).
In the cornea, PGs are synthesised by stromal keratocytes (Midura et al., 1989; di 
Iorio et al., 2010). The core protein is synthesised in the rough endoplasmic 
reticulum and while it is transferred to the Golgi apparatus the linkage region is 
attached to Ser or Asp. In the Golgi apparatus, GAG chains are elongated by 
sequential addition o f  sugar residues to the non-reducing terminus o f the chain. 
Separate glycosyltransferases are active in CS/DS elongation for attachment o f 
glucuronic acid and for N-acetylgalactosamine. CS and DS GAGs are initially 
synthesised as CS GAG, and the activity o f  the enzyme C5-epimerase isomerise 
glucuronic acid into iduronic acid creating DS (Silbert et al., 1989; Little et al., 
2008). In KS chains, elongation different glycosyltransferases attach alternately 
galactose and N-acetylglucosamine to the growing chain (Calabro et al., 2000; 
Funderburgh, 2000).
19
Introduction
The GAG chain elongation process is coordinated with chain sulphation (Uchimura 
et al., 1998). Sulfotransferases add sulfoesters to 4- or 6-hydroxyl of the GalNAc 
residues in CS/DS. KS chains are sulphated by two sulfotransferases, one of which 
adds sulphate to GlcNAc. The other one is able to add sulphate to galactose of KS 
and to GalNAc o f CS/DS (Ruter and Kresse, 1984; Habuchi et al., 1996; Fucuta et 
al., 1997). The final synthesised structure o f corneal GAGs is presented in Table 1.5.
Table 1.5 General structure o f corneal GAGs.
D isa c ch a r id e  S u lp hation  position
Demiatan sulphate 
Chondroitin sulphate 
Keratan sulphate
L-iduronic acid + GalNAc 4
D-glucuronic acid + GalNAc 4 or 6
galactose + GlcNAc 6
1.5.3 Proteoglycans of the cornea.
Decorin and biglycan
Decorin and biglycan were first identified in bovine bone and cartilage (Rosenberg et 
al., 1985; Fisher et al., 1987). Both decorin and biglycan have a similar gene 
structure and have CS/DS GAG attachment sites at the N-terminal domain. The 
structure o f the GAG depends on the tissue in which decorin is expressed. CS chains 
exist in developing bone, DS in skin or tendon, and a mixture of CS/DS in cartilage 
and cornea. Decorin usually carries one GAG chain, while biglycan has two attached 
chains; however, a few exceptions can be found. In a chicken cartilage, decorin 
exists with two GAG chains (Blaschke et al., 1996), and in a mammalian cartilage, 
decorin protein without GAG substitutions has been identified (Sampaio et al., 
1988). It has also been suggested that biglycan with only one GAG chain exists in 
embryonic chick and human cornea (Funderburgh et al., 1998). Another reported 
dissimilarity in the structure o f decorin in adult hen and in bovine cornea is that the 
GAG chain may contain KS as well as DS (Blochberger et al., 1992a).
Decorin is one o f the most abundant PGs in ocular tissue, while biglycan has only 
been detected in the normal corneal epithelium of, and in very small quantities in the
20
Introduction
stroma o f mostly older corneal tissues (Bianco et al., 1990; Funderburgh et al., 
1998). Stromal deposition o f  biglycan is more common diseases such as keratoconus 
and bullous keratopathy and in corneal scarring (Cintron et al., 1990; Funderburgh et 
al., 1998).
The presence or lack o f decorin influences collagen fibril assembly, diameter and 
mechanical strength (Danielson et al., 1997; Corsi et al., 2002). It has been reported 
that decorin inhibits fibrillogenesis o f collagen I and II in tendon and cartilage 
(Vogel et al., 1984). In the process o f collagen assembly, an increase in the amount 
o f decorin increases the density o f  the collagen fibril network (Iwasaki et al., 2008).
Decorin knock-out mice demonstrate a wide range o f collagen fibril diameters 
accompanied by skin fragility but not corneal clouding (Danielson et al., 1997). 
Later, it was discovered that during the absence o f decorin, expression and 
deposition o f biglycan increases, resulting in nearly normal fibrillogenesis. Double- 
deficient mice (decorin and biglycan null mice) show dysfunctional fibrillogenesis 
during the development o f the cornea causing changes in the structure and 
organisation, with abnormal fibrils mainly in the posterior stroma. This shows that 
decorin has a role in regulating stromal fibril assembly and lateral fibril growth that 
can be fine-tunned by biglycan during early development (Zhang et al., 2009). In 
case o f decorin-deficiency, biglycan is up-regulated, but not the reverse (Birk et al., 
2006).
Decorin GAG chains also play an important role in maintaining normal corneal 
structure. The presence o f p-D xyloside during development affects the process o f 
attaching the PG linkage region to the core protein, which results in production o f 
decorin without GAG chains. Corneas treated in this way show disruptions in 
collagen fibril packing and lamellar disorganisation, but with no collagen fibril 
diameter alterations (Hahn and Birk, 1992). However, a reducing effect o f decorin 
GAG chains on collagen fibril diameter, in the vitro study, been reported (Vogel and 
Trotter, 1987; Ruhland et al., 2007). In the developing chick cornea, mRNA of 
decorin is expressed from E9 and increases until E l8 (Dunlevy et al., 2000).
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Lumican
Lumican expression is highest, but not exclusively so, in the cornea because it has 
been found in other tissues and organs, such as kidneys and lungs (Schaefer et al., 
2000, Ying et al., 1997). Bovine lumican carries one KS chain (Funderburgh et al., 
1991). However, in mature chick cornea, lumican protein has five potential KS 
attachment sites (Blochberger et al., 1992a); thus, only three o f those 
oligosaccharides are substituted with KS chains (Midura and Hascall, 1989; Dunlevy 
et al., 1998). Corneal lumican is ordinarily expressed by keratocytes, but during the 
early stages o f wound healing it is expressed by the corneal epithelium (Saika et al., 
2000). Lumican-null mice manifest opaque corneas and skin fragility. In the 
posterior cornea abnormally thick collagen fibrils are formed probably by fibril 
fusion, and this suggests that lumican may be needed to limit fibrils lateral growth 
(Chakravarti et al., 2000). In the developing chick cornea, a switch from a 
glycoprotein to a sulphated proteoglycan form o f lumican is detected between E l2 
and E l5, which is synchronised with the onset o f corneal transparency (Comuet et 
al., 1994). Expression o f lumican is coupled with expression o f keratocan and, in 
corneas o f lumican deficient mice, keratocan expression decreases, which is a sign o f 
a regulatory function o f lumican on the transcription o f keratocan (Carlson et al., 
2005).
Keratocan and mimecan
Keratocan is expressed early in development and is present across the entire 
thickness o f the stroma (Liu et al., 1998). Only in the cornea does keratocan contain 
large sulphated KS chains. In other tissues keratocan is primarily non-suphated 
(Corpuz et al., 1996). Expression o f keratocan mRNA in chick development is found 
to be at similar levels to lumican at E9 but decreases as the cornea becomes 
transparent (Dunlevy et al., 2000). Keratocan-null mice manifest a less severe 
phenotype from lumican-null mice. The cornea is clear and yet thinner, and has 
abnormal collagen fibril diameter and spacing compared with the wild type (Meek et 
al., 2003b; Kao and Liu, 2003).
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Osteoglycin, later renamed mimecan, initially was isolated from bovine bone, and 
then from the cornea (Funderburgh et al., 1997). Mimecan mRNA is expressed 
during chick corneal development at low levels and is undetectable in adult hen 
corneas (Dunlevy et al., 2000). M imecan core protein carries KS GAGs in human, 
bovine and developing chick cornea but not in the murine cornea (Funderburgh et al., 
1997), which explains why mimecan-null mice do not manifest loss in comeal 
transparency or a decrease in thickness (Tasheva et al., 2002).
1.5.4 Proteoglycans collagen interaction
Proteoglycans are associated with comeal collagen, specifically at the a and c (KS 
PG) and d and e (DS PG) bands visible on positive fibril staining (Scott and Orford, 
1981; Scott and Haigh, 1985; M eek et al., 1986; Scott and Haigh, 1988a). In the 
absence o f any o f  the PGs, the binding sites o f these PGs stay unoccupied (Scott,
1988). The core protein is non-covalently attached to the collagen fibril with GAG 
chains reaching outwards from the fibril into the interfibrillar space, regulating 
collagen spacing where, it has been proposed, they form duplexes with each other 
(Scott, 1991a; Rada et al., 1993). It has been also indicated that CS/DS filaments are 
able to form periodic interactions with collagen fibrils even without a protein core 
(Raspanti et al., 2008).
To explain how PG core protein interacts with much bigger collagen fibrils, an 
insight into the protein structure is required. The structure o f the core protein o f all 
SLRP exhibits similarities due to the leucine repeats. The most studied structure is 
that o f the decorin core protein. The first decorin model was based upon the crystal 
structure o f  the porcine ribonuclease inhibitor (Weber et al., 1996). LRR region is 
composed o f  altering short p-strands and a-helices which run parallel to the common 
axis and form an arched structure with P-sheets linking concave surface o f  the 
molecule and the a-helices positioned at the convex face (Kobe and Deisenhofer, 
1993; 1995). It was originally proposed that the inner concave surface is o f  a size and 
shape able to accommodate only one collagen triple helix, 3nm in length (Weber et 
al., 1996). It is at this surface through which decorin has been proposed to dimerise 
(Scott et al., 2004). More recent study shows that one molecule o f decorin core 
protein interacts with four to six collagen molecules, and a large number o f  hydrogen
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bonds and electrostatic interactions with d and ei bands of collagen can determinate 
binding specificity and protein conformation (Figure 1.11) (Orgel et al., 2009).
Figure 1.11 Decorin core protein interacting with the collagen fibril surface via hydrogen bonds 
between amino acid residues. A and B represents PG binding at the e band in common and wide 
conformation respectively, and C and D represents a decorin dimer binding at the d band in 
common and wide conformation (after Orgel et al., 2009).
The most recent three-dimensional electron tomography o f bovine and murine 
corneal stroma (Lewis et al., 2010; Parfitt et al., 2010) led to the idea o f a new model 
o f collagen-PG interactions. It is apparent that stained PG filaments can extend 
between two or more collagen fibrils. However, PG filaments are not long enough to 
span this distance (Scott, 1992), and it was suggested that GAG chains from separate 
PGs may join together. Pre-incubation o f corneal tissue with specific GAG- 
degrading enzymes has shown that that CS/DS chains in the cornea are longer and 
can create bridges among several collagen fibrils, whereas KS chains connect 
adjacent fibrils. Proteoglycans are likely to optimise the spacing by contracting and 
expanding space between individual collagen fibrils. It is postulated that less 
sulphated proteoglycans pull in fibrils to restrict and stabilise interfibrillar spacing, 
and highly sulphated proteoglycans are capable o f attracting an influx o f water and
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push out fibrils. This model postulates that proteoglycans control interfibrillar 
spacing through thermal motion and osmotic pressure.
1.6 Chick eye developm ent
The eye o f the chick develops early and quickly reaches a relatively large size in 
comparison to the rest o f the body. Additionally, an easy access to the embryos 
means birds are often chosen for eye research. Detailed study o f the chick comeal 
development was described by Hay and Revel (1969), and based primarily on this 
research chick comeal development events are summarised and presented in Table
1.6 and figure 1.12. Hamburger and Hamilton (1951) divided chicken development 
into 46 stages, where stage 46 is hatching (Hamburger and Hamilton, 1992). These 
stages are used along with embryonic days to describe the main events in comeal 
development.
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Figure 1.12 Diagrams representing the first 7 days o f chicken corneal development when the 
cornea is created and the major changes occur (after Hay and Revel, 1969).
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Corneal development can be divided into four main stages:
1st Q  events leading to formation o f the primary stroma
2nd Q  development o f primary stroma
3rd O  development o f  secondary stroma
4th £  dehydration and compaction o f  the stroma
Table 1.6 Chick corneal development.
Day / 
stage
Stromal
thickness
Event
14
2.5 16
18
3  18
3.5 22
4 23
4.5 24
5 25
5 26
5.5 27
6  28
10 pm
60 pm 
110pm
6.5 29
Optic vesicle forms a cup shaped structure 
Overlying ectoderm forms lens placode 
Lens vesicle detaches from the ectoderm
Ectoderm differentiates into a 2 cell thick comeal epithelium 
Basal cells o f  epithelium increase in height
Comeal epithelium synthesise fibrous and acellular matrix between 
itself and the basal surface o f  the anterior lens epithelium called the 
primary stroma
Long isoform o f  collagen IX is expressed (Fitch et al., 1995; Svoboda 
et al., 1988)
Corneal endothelium arises from vascular mesenchyme and is placed 
near the lip o f the optic cup
Endothelium migrates between primary stroma and lens to form 
Brille (epithelium + stroma + endothelium)
Short isoforms o f  collagen IX expressed (Fitch et al., 1995)
Stroma invaded by secondary mesenchymal cells (Linsenmayer et 
al., 1998)
Disappearance o f  fibril-associated IX collagen which let lamellae 
separate during later swelling (Cai et al., 1994, Fitch et al., 1995) 
Mesenchymal cells differentiate into fibroblasts (Garrett and Conrad, 
1979)
Collagen XII and XIV synthesised by epithelial cells (Gordon et al., 
1996)
Collagen XII expressed in the long form (Akimoto et al., 2002) 
Secretion o f  hyaluronate by epithelium or endothelium (Conrad, 
1970; Toole and Trelstad, 1971)
Secretion o f  hybrid collagen I/V fibrils (Brik et al., 1986)
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7 30 140pm Fibroblasts penetrate lamellae o f the stroma, although not the part 
adjacent to epithelium
8 34 170pm Formation o f  vitreous humor, thus presence o f intraocular pressure 
and first signs o f  comeal curvature (Coulombre and Coulombre,
9 35 1958b)
10 36 190-220 Endothelium forms Descemet’s membrane
pm Anterior-most 1pm thick layer o f stroma not invaded by fibroblasts
11 37 Collagen type XIV mRNA expression reaches high level (Young et 
al., 2002)
• l a p s 200pm Anterior stroma becomes Bowman’s layer (Fitch et al., 1994)
13 39 Stroma undergoes a dehydration
14 40 150pm PGs synthesis increases (Nakazawa et al., 1995)
15 41 Collagen XIV expression decreases to disappear by El 8 (Young et
16 42 al., 2002)
17 43
18 44 160pm Tissue becomes fully transparent (Coulombre and Coulombre, 1958a)
250pm Cornea keeps growing
1.7 H um an corneal disorders
To study the biologic function o f PGs in cornea, the genetically altered organisms 
can be created and we can study tissue structure and function when PG alterations 
occur. In addition, one can study the human condition by investigating the corneal 
stroma in selected diseases caused by genetic malfunctions. The most useful for my 
research are disorders in which the phenotype manifests change in corneal 
transparency and in which the biosynthetic pathway o f the PGs is altered.
1.7.1 Dystrophies
A corneal dystrophy is defined as a heterogenous group o f bilateral genetically 
determined non-inflammatory diseases that are restricted to the cornea and which are 
not manifested systemically (Klintworth, 2009).
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Dystrophies can be divided into three groups based upon the anatomical location of 
the changes. Anterior corneal dystrophies affect the corneal epithelium, basement 
membrane and Bowman layer, stromal corneal dystrophies affect the corneal stroma, 
and posterior corneal dystrophies affect Descemet’s membrane and the corneal 
endothelium (Table 1.7). M ost dystrophies follow a Mendelian inheritance pattern, 
autosomal dominant, autosomal recessive and X-linked recessive (Klintworth, 2009).
Table 1.7 Corneal dystrophies (after Klinthworth, 2009).
Superficial com eal 
dystrophies
M eesmann’s dystrophy
Reis-Bucklers’ corneal dystrophy
Thiel-Behnke dystrophy
Gelatinous drop-like comeal dystrophy
Lisch epithelial comeal dystrophy
Epithelial recurrent erosion dystrophy
Subepithelial mucinous comeal dystrophy
.
Corneal stromal 
dystrophies
M a c u la r  co r n e a l d y str o p h y  (M C D )
Granular corneal dystrophy
Lattice comeal dystrophy
Fleck’s dystrophy
Schnyder s corneal dystrophy
Posterior amorphous corneal dystrophy
C o n g e n ita l s tro m a l co rn ea l d ystrop h y(C S C D )
Posterior dystrophies
Fuchs’ dystrophy
Posterior polymorphous dystrophy
Congenital endothelial dystrophy
X-linked endothelial dystrophy
In the scope o f this thesis it is the structure o f the stroma which is of interest, thus I 
have chosen to study selected cases o f  stromal dystrophies. In chapter 6, MCD and 
CSCD will be presented in detail. Both dystrophies cause loss o f corneal 
transparency and are characterised by structural changes within the stroma. They are 
chosen because their underlying genetic defect influences PGs. MCD is caused by 
the production o f KS GAGs with altered sulphation pattern (Klintworth et al., 1986)
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while CSCD characterises production o f decorin with truncated core protein 
(Bredrup et al., 2005).
1.7.2 M ucopolisaccharidoses
The mucopolisaccharidoses (MPSs) are a group o f disorders caused by inherited 
defects in lysosomal enzymes, resulting in widespread intra- and extra-cellular 
accumulation o f glycosaminoglycans. Lack or reduced activity of enzymes 
responsible for catabolism o f GAG chains results in systemic storage o f GAGs in 
lysosomes, including ocular tissues.
MPSs are divided according to the enzyme defect and systemic manifestations and 
the groups are presented in Table 1.8.
Table 1.8 The mucopolisaccharidoses with indicated enzym e malfunction and type o f GAG 
accumulated in the lysosomes (Ashworth et al., 2006).
MPS Type Enzym e deficiency GAG
MPS I (Hurler, Scheie, 
Hurler/Scheie)
a-L-Iduronidase DS, HS
MPS II (Hunter) Iduronate-2-sulfatase DS, HS
Heparan sulfamidase (A) HS
N-Acetyl-a-D-glucosaminidase (B) HS
MPS III (Sanfilippo) Acetyo-Co A : ag l ucosam i n idase HS
N-acetyltransferase (C) HS
N-Acetylglucosamine-6-sulfatase (D) HS
MPS IV (Morquio) N-Acetylgalactosamine-6-sulfatase KS
MPS VI (Maroteaux-Lamy) N-acetylgalactosamine-4-sulfatase DS
MPS VII (Sly) p-D-Glucuronidase DS, HS, CS
MPS IX (Natowicz) Hyaluronidase CS
MPSs as systemic diseases cause more severe changes in human phenotype. An 
ocular defect is only one o f many abnormalities. In this thesis, MPS VII will be 
presented with the emphasis on the collagen fibrils in the stroma.
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1.8. Aims and objectives
The aim o f this thesis is to develop further our understanding o f structure-function 
relationships in the cornea.
There is an emphasis on proteoglycans influencing structural alterations in collagen 
architecture by its altered composition or molecular structure. Two model systems 
will be investigated: development and disease. Embryonic chick corneas in which the 
PG content is alters with time will be studied along with human corneas with 
diseases involving genetic mutations in PG pathways.
Chapter Three
Aim:
To test the hypothesis that a developing cornea transmits light to varying degrees and 
that this is due to changes in the structure.
Objective:
Quantify the light transmission through the cornea at different stages o f development 
at different wavelengths.
Chapter Four
Aim:
To test the hypothesis that collagen spacing changes with depth and laterality during 
corneal development.
Objective:
Use microbeam X-Ray diffraction to investigate the collagen centre-to-centre 
spacing across the cornea (periphery-centre-periphery) and across the corneal depth 
(epithelium-endothelium).
Chapter Five
Aim:
To test the hypothesis that localisation o f proteoglycans (CS/DS) changes within the 
depth o f the corneal stroma during development.
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Objective:
Detect native CS/DS PGs in the stroma o f developing chick by immunolabeling and 
enzymaticly digest CS/DS PGs to visually distinguish the population o f CS/DS PGs 
from KS PGs on the electron micrograph.
Chapter Six
Aim:
To test the hypothesis that changes in proteoglycan structure is associated with 
structural abnormalities in human corneal disease.
Objective:
Bring together the techniques used to investigate the chick model to study structural 
changes in collagen size and arrangem ent in MCD, CSCD and MPSVII.
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Chapter Two
2 General methods
In this chapter the principles o f  the methods used in the thesis will be presented. Four 
main techniques were used as research tools: small-angle X-ray fibre diffraction, 
electron microscopy, spectrophotometry and immunofluorescence microscopy. More 
detailed description o f  the methods, including the protocols, is an integral part of 
each result chapter.
2.1 X-ray diffraction
All small angle X-ray diffraction studies included in this thesis were conducted at the 
Spring8 synchrotron in Hyogo, Japan (Figure 2.1). This facility is a 3rd generation 
synchrotron opened in 1997 and it provides the most powerful synchrotron radiation 
currently available. Storage ring circumference is 1436m and the generated energy 
reaches 8 GeV.
A synchrotron is a type o f  particle accelerator generating a high-intensity light, 
which is an electro-magnetic wave emitted from an electron travelling at almost the 
speed o f light when its path is bent by a magnet creating a uniform magnetic field. 
There are two types o f  a light source at SPring8: an insertion devise and bending 
magnets. There are two insertion devices: an undulator and a wiggler. The beam size 
and angular spread o f  synchrotron radiation from the undulator is much lower than 
that from the bending magnets and wiggler. In my experiment the insertion device 
was the undulator. Synchrotron radiation is characterised by features like brightness, 
high directionality and variable polarisation.
Along the circumference o f  the storage ring, there are 53 experimental hutches. Each 
o f the beam line is used for a different purpose. My small angle X-ray diffraction 
study was performed on a 40XU High Flux beam line. This beam line is being used 
for:
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- time-resolved diffraction and scattering experiments
- X-ray speckle experiments 
Microbeam x-ray diffraction experiments 
X-ray fluorescence analysis.
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Figure 2.1 A) The SPring8 synchrotron and a schematic representation of the facility B) Inside 
the 40XU beam-line, and a holder with attached microscope.
The beam line 40XU is equipped with x-ray shutters, a fast CCD camera, an X-ray 
image intensifier, YAG laser and a vacuum path for small angle X-ray scattering.
2.1.1 Principals of m ethod
When a focused beam o f monochromatic X-rays passes through biological tissue, the 
majority o f rays pass straight through without an interaction. However, some rays are 
absorbed by the tissue itself, whilst the remainder of X-rays are scattered at various 
angles by the components o f the sample. For my experiments the incident beam is
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blocked by a lead backstop placed behind the sample, and the scattered rays form a 
diffraction pattern on a detector. Because X-rays are scattered through large and 
small angles, it is important to locate the detector an adequate distance away from the 
sample to record the desired part o f the X-ray pattern. In the case of a small 
scattering angle, the low-angle pattern is recorded with a detector separated by 
several metres from the sample, while the wide-angle pattern for experiments on the 
cornea is detected at a distance o f  tens o f centimetres.
Scatter raised from the sample is a function o f the electron distribution in the sample. 
If collagen fibrils are held vertically in an X-ray beam, X-rays scattered parallel to 
the fibril axis give rise to what is called a meridional pattern. An equatorial pattern is 
produced by the X-rays being scattered at right angles to the fibril axis (Figure 2.2). 
Meridional reflections arise from the D-periodicity along the axis o f the collagen 
fibrils, whereas the equatorial reflection is a result o f lateral order o f the collagen 
fibril packing within the lamellae.
Figure 2.2 Schematic diagram  o f an X-ray beam being scattered from an array of cylindrical 
fibrils. The scattered beam gives rise to meridional and equatorial reflections.
In the cornea, if  the X-rays pass through the whole thickness of the cornea from front 
to back several hundred lamellae are traversed, with collagen running in all 
directions within the plane perpendicular to the optical axis. The beam is scattered
meridional x-ray 
reflection
lead
beam stopincident x-ray 
beam
equatorial x-ray 
reflection
collagen fibrils
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form each lamellae in a different direction and as a result the meridional pattern 
appears as a series o f concentric circles o f intensity.
Depending on the degree o f  order in the structure that is a subject for an X-ray 
experiment; different levels o f  interference between the scattered rays will take 
place. The higher the degree o f  order, the sharper the interference maxima will be. 
Completely disorganised structures will give rise to diffused scattering, called 
background scatter.
Though meridional and equatorial patterns o f the cornea are superimposed, they still 
can be distinguished from each other. The equatorial reflection is broader than the 
meridional, and their positions in the pattern also differ.
Important information like position o f  the collagen centre-to-centre spacing and 
collagen fibril radius can be estimated from equatorial small angle patterns. This is 
possible because X-rays are scattered from both an array o f collagen fibrils and a 
single cylinder, simultaneously (Goodfellow et al., 1978).
2.1.2 Data collection and analysis of patterns
For the experiments described here corneal specimens, either full-thickness or cut 
into thin strips, and tightly wrapped in cling film to limit dehydration are placed in 
the path o f the beam and the shutters are opened to expose the sample to the X-rays. 
The scattering pattern is then recorded on a detector and images obtained in the 
synchrotron are further analysed.
Before the start o f each experiment, a pattern o f rat tail tendon is obtained. The D- 
periodicity o f  the collagen fibrils in this tissue is known and equals 67nm 
(Goodfellow et al., 1978) therefore the pattern is used for the calibration which is 
described in detail later in the text. Collected data stored as images can be further 
analysed elsewhere using Unix based software (Fit2d) and statistics packages 
(Microsoft Excel, Statistica).
35
General methods
My studies focus mainly on a collagen interfibrillar spacing o f the samples, however 
if it is necessary, the fibril diameter can be calculated. The way to obtain fibril 
centre-to-centre spacing is shown below.
From the recorded images showing the diffraction pattern, a vertical transect (20 
pixel in width is found to be suitable) is taken throughout the centre (Figure 2.3) to 
produce a profile o f X-ray intensity (I) against radial position (R).
Figure 2.3 Transect taken through the centre o f a diffraction pattern obtained from human 
cornea.
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Figure 2.4 Projection o f the transect image as a graph of intensity against pixel position.
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To increase the signal and minimise the noise the symmetrical pattern (Figure 2.4) is 
folded along the centre point to generate the plot R versus IR with a clearly visible 
first order equatorial peak in the X-ray intensity profile (Figure 2.5). I is multiplied 
by R to minimise the error o f taking a linear scan across a circular X-ray pattern.
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Figure 2.5 An intensity profile o f the diffraction pattern with a visible first order equatorial 
peak used for calculation o f  the collagen interfibrillar spacing.
To remove scattering arising from other stromal matrix components different from 
collagen fibrils, a background curve is fitted and subtracted from the plot (Figure 
2 .6).
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Figure 2.6 An intensity profile o f the diffraction pattern with background scatter removed 
(green).
37
General methods
The intensity distribution is calculated from the equation:
I ( K)  = F 2(K)G(K)  + B
Where,
- K  is a scattering vector [2Tt/d or (47r/A)sin0] and represents the phase difference 
between the arrays o f collagen fibril
-I(K )  is the integrated intensity distribution,
- F(K) is the fibril transform which represents an intensity for a single collagen fibril,
- F 2(K) is the normalised scattered intensity for that single fibril,
- G(K) is the interference function, which describes the packing o f fibrils and 
depends upon K and relative position o f  cylinders,
- B  is a background scatter from less ordered components o f the stroma
The information about the centre-to-centre collagen fibril spacing is contained in the 
interference function.
G( K) =  I ( K ) - B / F 2( K)
For a crystalline lattice, G(K)=0, except sharp peaks when K=2rc/d. Then the position 
o f the Bragg peak is a function I(K)-B and is an equivalent o f the Bragg equation.
nX =  2 d  sin 6
Where,
- n is an order o f equatorial peak
- A is the wavelength
- d  is the Bragg spacing
- 0  is half the scattering angle
In rat tail tendon, collagen fibrils are running nearly parallel to the tendon axis and 
give rise to the well defined diffraction pattern that can be used for calibration. For 
the rat tail tendon the scattering angle 20 could be easily calculated from Bragg’s
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equation because spacing arising from the 67nm D-periodic repeat was obtained by 
the X-ray beam o f a wavelength equal 1.18A. This scattering angle was then used to 
calculate the centre-to-centre collagen fibril Bragg spacing of the samples.
Figure 2.7 Schematic representation of the diffraction angle, 0, for rat tail tendon (blue) and a 
cornea 0j (pink) and their interrelationship, r and rj represent the radial distance of a peak 
from the centre of the pattern, a is a distance from the sample to the detector.
From figure 2.7 it is deduced that sin 6  =  £ and sin 6^ =  ~r~. Because the
U
scattering angle is low and the distance from the sample to the detector is long we 
make the small-angle assumption that a = b = b i.
Therefore, sin 0 =  -  and sin = —.
a a
From Bragg’s law:
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Rat tail tendon:
Specimen:
d ± =
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The interfibrillar Bragg spacing in this thesis was calculated from the equation:
Where:
d j -  is the interfibrillar Bragg spacing o f  the specimen 
r -  is the radial position o f the 1st order meridional pick o f rat tail tendon 
rj -  is the radial position o f the 1st order equatorial pick o f the specimen
Interfibrillar Bragg spacing is a theoretical value for a crystal-like distribution o f the 
fibrils. Worthington and Inouye made an assumption that collagen fibrils in the 
cornea are packed into a two-dimensional liquid-like arrangement and, therefore, the 
Bragg spacing should be multiplied by 1.12 to obtain closer-to-real collagen 
interfibrillar value (W orthington and Inouye, 1985).
In this thesis, for the comparative study o f the developing chick cornea centre-to- 
centre fibril spacing values are presented as an interfibrillar Bragg spacing. However, 
in the MCD cornea study values are corrected by the 1.12 factor for better 
comparison with the literature.
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2.2 Transm ission electron  microscopy
In transmission electron microscopy, electrons are projected through a thin section of 
a resin-embedded sample creating a two-dimensional image on the fluorescent 
screen. The bright area represents regions where more electrons are transmitted 
through the specimen. In the area where electrons are deflected from the original 
path, dark shadows appear.
The first transmission electron microscope was developed in Germany by Max Knoll 
and Ernst Ruska in 1932. The parameters o f the microscope changed over time but 
the principle o f operation stayed the same.
high voltage source 
electron gun 
condenser lens 
objective lens 
electron beam
i
turbo pump 
_  (high vacuum)
“I
fluorescent screen 
plate camera
Figure 2.8 Schematic of a transmission electron microscope.
An electron beam o f uniform current density is emitted in the electron gun. A 
tungsten wire filament is superheated by an electric current and a beam of electrons 
is emitted and accelerated down the column by an anode.
Lenses in the electron microscope are magnetic coils tuned to focus and direct the 
passing electron beam. Electrons are converged onto the specimen by the condenser
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lenses, and the image is magnified and then focused on a screen at the bottom o f the 
column by a set o f  objective and projector lenses. Along the microscope column are 
apertures which are holes designed to limit the size o f the electron beam. To 
minimise an interaction between the electron beam and the air molecules, the inside 
o f the column is kept at a high vacuum.
Electrons strongly interfere with atoms and for that reason specimen sections inserted 
into the electron microscope have to be very thin (5-100nm). To achieve such thin 
sections, specimens have to be specially processed.
2.2.1 Tissue preparation
Fixation and primary staining
Fixation preserves the structure o f  the tissue with as little alteration from the living 
state as possible. It is necessary to preserve the structure during the complex and 
damaging process o f embedding, sectioning and exposure to the electron beam. 
Osmium tetroxide was historically used as the first fixation agent but the commonly 
used protocol nowdays was developed by Sabatini in 1963, and this uses a 
glutaraldehyde-osmium tetroxide mix (Bozzola and Russell, 1992; Hayat et al.,
1989). Osmium tetroxide (atomic num ber 76) works additionally as a general stain, 
reacting with cell membranes and cellular components. However, if  more specific 
staining is required osmium tetroxide is omitted. In this thesis a protocol for GAG 
staining uses glutaraldehyde with a cationic dye - cuprolinic blue in the fixation stage 
(Scott, 1980; Scott and Orford, 1981).
Washing
Washing is used to remove any excess o f glutaraldehyde that remains in the tissue. 
As a wash we use a buffer in which the fixative was made. The buffer prevents the 
production o f artefacts by controlling pH. Additionally, osmolarity can be adjusted 
by sodium or magnesium chloride.
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Dehydration
Dehydration replaces the water in cells with a fluid that acts as a solvent for the 
hydrophobic embedding medium. Ordinarily a gradient o f ethanol solutions (from 
the lowest to highest concentration) is used.
Infiltration with transitional solvents
After replacing water with ethanol, another solvent with high affinity to the liquid 
plastic medium is introduced to ensure a good infiltration o f tissue. The standard 
solvent is propylene oxide.
Infiltration with resin
In this stage the transition fluid is gradually replaced by liquid plastic monomer. In 
this thesis Araldite resin was a monomer. To make it active, a hardener and 
accelerator were added.
Embedding and curing
Specimens infiltrated with pure resin are transferred into silicone moulds and placed 
into an oven heated up to 60°C for minimum 24h. In this time, resin components 
polymerise to form solid blocks.
Cutting
Blocks are trimmed and shaped to obtain a trapezoid surface in the area o f our 
interest in the specimen. Sections ~90nm thick are cut on an ultramicrotome using a 
glass knife and collected on the water in the form o f a gold ribbons. Sections are 
fished out onto copper grids.
Staining to enhance contrast
Dark and bright areas on the electron micrograph arise from the differences in the 
density o f the specimen. Stain is additionally applied on the section to add greater 
density to the structure we are interested in. The higher atomic number o f the stain, 
the darker shadows appear; therefore, commonly used stains are heavy metal ions.
Phosphotugstic acid (PTA) is an anionic positive stain. The electron density arises 
from the tungsten atoms which each have an atomic number o f 74. An aqueous
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solution o f PTA shows an affinity for polysaccharides and carbohydrate moiety o f 
glycoproteins and it is used for enhancing contrast while examining PGs in the 
cornea. Uranyl acetate (UA) is a general unspecific stain used in most procedures in 
electron microscopy. It can act as a positive and a negative stain. Uranium is the 
heaviest metal used as a stain in electron microscopy with an atomic number 92. 
Uranyl ions react with phosphate and amino groups and stain nucleic acids and 
certain proteins. At high concentration, such as those used in the experiments 
described in this thesis, this stain shows an affinity to positively charged groups. 
Lead citrate is a positive stain used for the cell examination. Lead, o f atomic number 
82, binds to negatively charged components like hydroxyl groups and osmium- 
reacted areas.
A corneal specimen that has undergone all the preparation stages outlined above is 
ready for examination with the electron microscope. Specific protocols are provided 
in the relevant chapters.
2.3 Spectrophotometry
Spectrophotometry is a method that detects the intensity o f light transmitted through 
a sample, or absorbed by the sample, as a function o f wavelength. A single beam 
monochromatic spectrophotometer measures the relative light intensity o f the beam 
before and after the cuvette with the sample is inserted. To calibrate a single beam 
spectrophotometer, a blank probe is inserted first and the reading is set as a 100% 
transmission (absorption = 0). Generally in spectrophotometry any electromagnetic 
radiation spectrum can be used for measurements. I am using a wavelength range in 
the visible spectrum (400-700nm) because transmission in my study is intended to 
give an indication o f comeal transparency for visible light.
A transmission spectmm is obtained by successively changing the wavelength o f 
monochromatic light passing through the sample (by lOnm in the experiments 
described in chapter 3) and recording the change o f light transmitted.
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c
I
Figure 2.9 Representation o f the Lam bert-Beer law for transmission o f a beam of light through 
a cuvette with a sample. I0 is incident light intensity, I is transmitted light intensity, 1 is the 
distance the light travelled through the sam ple, c is the concentration o f absorbing sample and 
6 is the molar absorbtivity.
The basis for the spectrophotometry measurements is a law stating that there is a 
logarithmic dependence between the transmission o f light through a substance and 
the product o f the absorption coefficient o f  the substance, a ,  and the distance the 
light travels through the material I (Lam bert’s law). The absorption coefficient, a, 
can be written as a product o f  the molar absorptivity, £, o f the absorber, and the 
concentration, c, o f absorbing species (Beer’s law) (Figure 2.9).
T = — =  1 (T “ ! =  1 0 “ £ic
A =  elc =
T - i s  the transmission (transmittance)
Io -  is the intensity o f an incident light 
/ -  is the intensity o f a transm itted light 
a -  is the absorption coefficient
I -  is the distance the light travels through the material (cuvette thickness) 
c -  is the concentration o f  the absorbing sample 
e -  is the molar absorptivity 
A  -  is the absorbance
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2.4 Im m unofluorescence m icroscopy
Immunofluorescence microscopy is a technique that uses a fluorescent dye-coupled 
antibody to locate and visualise a target molecule in single cells or in tissue sections. 
This technique is based on the ability o f  antibodies to bind stably and specifically to 
their antigen while all unbound antibodies can be easily removed from the tissue.
Antibodies are a class o f immunoglobulins -  proteins used by the immune system to 
identify and fight foreign molecules. All types o f antibodies share the same basic Y 
shape structure. They are made o f  two heavy chains and two light chains (Figure 
2.10). The different types o f heavy chain define the immunoglobulin class. In my 
study I used only one type o f antibody, IgG, which contain y heavy chains and this is 
the most abundant immunoglobulin. At the tip o f the each protein is located a highly 
variable region which allows specific binding to a different target -  the antigen.
a n tig e n  b ind ing  s i te s
v a ria b le  reg ion
h e a v y  c h a in
Figure 2.10 Schematic antibody containing heavy and light chains and visible constant and 
variable regions. At the end o f the variable regions antigen binding sites are positioned.
To obtain an antibody which is directed against a desirable molecule, the antigen is 
injected into a small mammal such as a mouse or rabbit. To produce large quantities 
however, goats, sheep or horses may be immunised. In the blood of the animal, a 
natural mixture o f antibodies known as polyclonal antibodies can be found. They all 
recognise the same molecule (antigen) but are produced by different B-cells and may 
bind to different parts (epitopes) o f the antigen. To obtain a monoclonal antibody that 
will recognise a particular epitope, B-cells are removed from the animal’s spleen and 
are fused with tumor cells. The tissue cultures grow quickly and produce large 
quantities o f monoclonal antibodies.
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Immunofluorescence employs two sets o f antibodies: a primary antibody that 
identifies the antigen o f interest and a secondary antibody which is fluorophore- 
conjugated and recognises the primary antibody (Figure 2.11).
fluorescence
energy
secondary antibody  
conjugated with fluorophore
prim ary antibody
M  antigens
Figure 2.11 Schematic interaction between an epitope o f the antigen plus primary and 
secondary antibodies during labelling a specim en for im m unofluorescence microscopy.
To visualise the location o f the immunostained molecules, a dye attached to the 
antibody is excited by light o f  a specific wavelength. This radiation causes electrons 
in the fluorophore to become exited to a higher energy level. One o f the ways to 
return to a basic state o f  energy is to release energy via fluorescence. The emitted 
light has a lower energy (longer wavelength) compared to the excitation light and the 
two types o f light have to be separated by an emission filter. That makes the emitted 
light visible to a human eye. U nder the microscope, a fluorescing area is displayed as 
a collection o f bright spots which stand out against a dark background.
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Chapter Three 
3 Light transmission through developing chick cornea
The cornea is a tissue that undergoes dramatic structural changes during 
development. From being fragile and opaque it transforms into a strong and 
transparent structure. To be fully functional, the mature tissue must be able to 
transmit incident light in the visible part o f  spectrum. It is interesting that the 
structurally complex tissue, which consists o f five different layers, hundreds of 
lamellae in the stroma plus keratocytes, is transparent and is the only example 
amongst all connective tissues.
Several mathematical theories has been created to explain this phenomenon (Hart 
and Farrell, 1969; Feuk, 1970; Benedek, 1971; Maurice, 1975; Twersky 1975; 
Freund et al., 1986) and they all concentrate on stromal architecture and the light 
scattered from the collagen fibrils. According to the theory o f a direct summation of 
fields suggested by Freund (1986), transparency depends on the:
- order o f a fibrillar arrangement
- fibril diameter
- fibril number density
- balance between the refractive index o f the hydrated fibrils and the 
extrafibrillar matrix
- corneal thickness
One o f the other reasons for the loss o f  light transmission is absorption. Although, 
the majority o f corneal com ponents absorb light in the ultraviolet, this is below the 
visible wavelength, which means it would not affect the corneal transparency 
(Lerman, 1984) (Figure 3.1). The only chromophore present in the cornea is a 
cytochrom c in reduced and oxidised form, absorbing light at 400-420nm and at 520- 
600nm (Butt and Keilin, 1962).
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Figure 3.1 Part of the spectrum o f visible light in the wavelength range, 400-700nm, with 
absorption spectra for various corneal com ponents marked by pink rectangulars.
Developing chick cornea is a good model for studying transparency because all light 
scatter-dependent factors change during embryogenesis. The last study of 
transparency in visible light in chicks was conducted in the late 1950s. It showed a 
rise in the light transmission from about 40% before developmental day 14 to 95% 
the day before hatching (Coulombre and Coulombre, 1958a). Since then, there have 
been other light transmission studies o f human, rabbit and bovine cornea (Algvere et 
al., 1993; Kostyuk et al., 2002; Doutch et al., 2008), but no chick developmental 
studies. I present here a detailed wavelength dependency study o f a developing chick 
cornea in the 400-700nm wavelength spectrum.
3.1 Methods
All animals involved in this study were used in accordance with the Association for 
Research in Vision and Ophthalmology statement for the Use o f Animals in 
Ophthalmic and Vision Research.
White leghorn fertilised eggs were obtained from Henry Stewart Commercial 
Hatchery. Eggs were placed in the incubator with regulated humidity (Octagon 100, 
Stanford, England) every day for six days to produce chicks at the developmental 
stage 12 to 18 on the same day. Each chick was sacrificed immediately before the 
spectroscopy measurements were taken to minimise the time between the death of 
the animal and transmission reading. This was done to avoid dehydration and post­
mortem changes within the tissue. Corneas were dissected with laboratory scissors
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and placed on the inside wall o f a plastic cuvette containing silicone oil (Figure 3.2). 
Silicone oil was chosen because its refractive index equals the refractive index o f the 
cornea and thus eliminates additional scatter o f light passing through different 
mediums.
chick cornea
Figure 3.2 Spectrophotometer cuvette filled with silicone oil with a suspended chick cornea, 
~4mm in diameter.
The cuvette with the cornea positioned on the centre o f the inside wall was placed in 
a spectrophotometer (Pye Unicam SP8-100 UV/VIS, Cambridge, UK). The 
spectrophotometer was firstly calibrated against a blank probe, which was a cuvette 
containing silicone oil (Dow Coming 200/5cS, BDH Laboratory Supplies, Poole, 
UK). The position o f the 1mm x 1mm beam in the centre o f the cornea was found 
and a series o f transmission readings were taken at wavelengths in the range 400 -  
700nm in intervals o f lOnm.
3.2 Results
Transmission measurements were taken from the centres o f chick corneas at E l2 
(n=12), E13 (nl2), E14 (n=12), E15 (n=12), E16 (n=8), E17 (n=12) and E18 (n=12). 
Changes o f transmittance as a function o f development showed similar patterns at all 
recorded wavelengths. At the first three recorded stages (E l2 -E l4) transmission is on 
a similar level, then from E l 5 increases significantly (Figure 3.3 and Figure 3.4). 
This supports previous white light measurements which indicate that the main onset 
o f transparency take place from E14 onwards.
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Figure 3.3 Three-dimensional graph o f light transmission as a function of development and 
wavelength.
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Figure 3.4 Light transmission as a function o f development at different wavelengths (400- 
700nm).
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Transmission measured in lOnm intervals reveals some absorbance, especially at E l7 
in the ranges 460-5lOnm and 560-610 nm (Fig.3.5). At all stages o f development 
transmission is lower at short wavelengths (19-62%), gradually increasing towards 
longer wavelengths (34-81%). The cornea becomes more transparent with 
development and this is evidenced by the highest values of transmission at E l 8. The 
highest recorded transmission reached 81.5% (SD=2.9) at 700nm wavelength for 
E l8 (Figure 3.3 and Figure 3.5).
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Figure 3.5 Light transmission as a function o f wavelength for corneas o f developmental stage 
E12-E18.
Although the greatest percentage o f light transmission occurs for a wavelength o f 
700nm, 500nm is commonly used for corneal analysis. 500nm avoids the impact o f 
absorption which occurs with lower wavelengths and a sufficient amount o f the light 
is scattered from the components of the tissue to compare different developmental 
stages. 500nm is therefore the optimal wavelength to compare developmental stages 
in the cornea. For the wavelength 500nm only 26% light is transmitted at E l2 and 
then increase to 73% at E l 8 (Figure 3.6).
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Figure 3.6 Light transmission at 500nm wavelength as a function of development,.
3.3 Discussion
My data quantify light transmission through the centre of the developing chick 
cornea as an indication o f the level o f  transparency. Transmission of light travelling 
through the tissue can be disrupted by reflection at the tissue surface, absorption or 
scattering. I minimised a loss o f  transmission by reflection at the surface by 
immersing the corneas in the silicone oil, which has a refractive index o f 1.397. It 
has been calculated elsewhere that the loss o f transmitted light when isolated corneas 
are held in silicone oil is only 0.006% and can be omitted (Kostyuk et al., 2002). The 
majority of corneal components absorb light in wavelengths shorter that violet light 
and light transmission, thus transparency, in visible light is not affected (Lerman, 
1984). The only pigment absorption in the visible light spectrum was recorded at 
wavelengths characteristic for the reduced and oxidised cytochrom c localised in the 
mitochondria o f cells. This caused low readings of transmission for corneas at all 
developing stages at 400-420nm and 520-600nm. The strongest absorption is visible 
at E l7. At this stage there is also an additional absorption visible at 460-490nm, 
although it cannot be explained what causes it.
It can be assumed then that a main reason of the transmission loss in my experiment 
is light scattering. During corneal development the tissue becomes more transparent, 
which means that light scattering decreases. Scattering in developing tissue, cells 
aside, is reduced by fibrils being arranged in a more order fashion, thinning o f the 
cornea, a decrease in the fibril number density, and probably changes in the
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refractive index between hydrated fibrils and the extracellular matrix (Hart and 
Farrell, 1969; Freund et al., 1986; Meek et al., 2003a). A refractive index imbalance 
between the fibrils and extracellular matrix must have an impact on the scattering of 
light, and we know that the amount and type o f proteoglycans in the stromal matrix 
changes significantly during development (Anseth, 1961; Zhang et al., 2005). 
According to Benedek a large amount o f light is scattered by so called “lakes” in the 
corneal stroma and that is a reason for swollen corneas to be opaque (Benedek, 
1971). The same lakes are present in the stroma o f developing chicks and only with 
time do the number o f lakes decrease significantly, reducing scatter o f light and 
making the cornea more transparent (Figure 3.7).
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Figure 3.7 Transmission electron 
micrographs o f developing chick cornea 
(E12-E18). The number o f lakes (i.e. 
collagen-free spaces) decreases with 
development leaving a stroma which is 
more compact. Calibration bar = 1pm 
and applies to all panels.
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In the developing chick cornea Coulombre and Coulombre (1958a) report 39% 
transmission o f incident light at E l2. At E l8 this was 80% and the maximum is 
reached a day before hatching at E20 and equals 95%. This white-light transmission 
data is in line with our measurement for the 700nm wavelength measurements in 
which transmission increases from 35% at E12 to 81% at E l8. Light transmission at 
500nm is lower than at 700nm reaching only 73% at E l8.
Previous light transmission studies have reported nearly 90% transmission in human 
cornea (Doutch et al., 2008) and over 90% in rabbit cornea (Algvere et al., 1993) and 
bovine cornea (Kostyuk et al., 2002), although the measurements were taken under 
different conditions than in the present experiment. Bovine and human corneas were 
stripped o f their epithelium and endothelium layers, thus measurements apply only to 
the corneal stroma. Additionally, transmission in rabbit cornea was measured in vivo, 
and the other corneas had pressure applied to simulate intraocular pressure o f an 
eyeball. Chick corneas are too small and too fragile to attempt measurements under 
pressure. Previously it was reported that a lack o f pressure results in a decrease o f 
light transmission at around 4% in a large animal with a thicker cornea (Kostyuk et 
al., 2002). In the case o f  very thin chick corneas a transmission loss is expected to be 
much less and not that significant.
Farrell described the wavelength dependence in normal cornea to be an inverse- 
cubic, and a pathological swollen cornea to show an inverse-square dependence 
(Farrell et al., 1973). In the developing chick cornea at E l8, wavelength dependency 
is an inverse-square that fits the model o f a swollen cornea. It could be caused by still 
high water content o f  a cornea and not full maturation o f a tissue.
To summarise, light transmission through the chick cornea increases with 
development, especially after E l4. Transmission values in the longer wavelengths 
(near red) are higher than in the shorter wavelengths (near violet) because blue light 
scatters more than the red light. Additionally, at 400-420nm, transmission is lower 
because o f  an absorption o f light by cytochrome c. The biggest impact on 
transparency is the scatter o f light caused by the presence o f lakes in the stroma, 
changes in interspacing and in fibril arrangement, changes o f thickness and 
imbalance o f  refractive indices between collagen fibrils and extrafibrillar substance.
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Chapter Four 
4 Spatial and temporal alterations in collagen architecture in 
developing chick cornea
The cornea requires the development o f  strength and transparency at the same time 
and undergoes a series o f events during the period o f development to obtain the 
required structure (Hay and Revel, 1969). To reach full transparency, collagen fibrils 
must be arranged in a well organised manner (Maurice, 1957; Benedek, 1971). 
Fibrils o f a uniform diameter and regularly spaced, are arranged into lamellae. 
Within the lamella, fibrils are running parallel to each other, but adjacent lamellae 
are tilted by a few degrees within the plane o f  the cornea. All the changes o f the 
comeal ultrastructure are important to obtain and to keep functionality o f the tissue.
During tissue development, compaction o f  the lamellae occurs in the comeal stroma 
and the spacing between the collagen fibrils decreases (Quantock et al., 1998). In the 
developing chicken cornea, the stroma reaches maximal thickness by E10 and then 
undergoes a process o f compaction between E l4 and E l8 (Quantock et al., 2003). 
Compaction is caused mainly by a water loss which leads to a concentration o f the 
matrix components. The content o f proteoglycans within the stromal extracellular 
matrix also changes and all events happen simultaneously with the tissue becoming 
more transparent.
At E l 8 o f development, the cornea reaches nearly 90% o f transparency o f the mature 
cornea (Coulombre and Coulombre, 1958a). Previous studies show that centre-to- 
centre interfibrillar spacing decreases while the cornea develops (Quantock et al., 
1998; Quantock et al., 2003). The measurements were obtained by synchrotron X-ray 
diffraction throughout the whole depth o f the cornea in the central region. Thus 
values are the average throughout all lamellae. To investigate if  there is any 
difference in the collagen fibril interspacing between central and periphery o f the 
cornea and if  there is any difference according to the depth o f the cornea, an X-ray 
diffraction ultrastmcture study was conducted using a 25pm-diameter beam.
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4.1 Methods
All animals involved in this study were used in accordance with the Association for 
Research in Vision and Ophthalmology statement for the Use o f Animals in 
Ophthalmic and Vision Research.
4.1.1 Specimens
Corneas were obtained from white leghorn chicks (Henry Steward Commercial 
Hatchery) on developing day 14 (E l4) to 18 (E l8) in daily intervals. Tissue was 
dissected round the limbus with scissors after which corneas were immediately fixed 
in eppendorf tubes in 4%  paraformaldehyde in a 0.1M Sorens phosphate buffer. 
After 24 hours, corneas were moved to 0.5% paraformaldehyde in a 0.1M Sorens 
phosphate buffer for transport to the Spring8 synchrotron in Japan. All work was 
conducted in accordance with the ARVO Resolution for the Use o f Animals in 
Ophthalmic and Vision Research.
4.1.2 Synchrotron X-ray diffraction
X-ray diffraction study was performed at the SPring8 synchrotron in Hyogo, Japan, 
on the 40XU beam line with a millisecond exposure times. Corneas from E l4 to E l8, 
previously fixed, were wrapped in clingfilm to prevent hydration loss and mounted 
on a holder that was placed in the path o f the X-ray beam.
First, a scan was performed on the whole cornea positioned such that the surface o f 
the cornea was perpendicular to the direction o f the beam (Figure 4.1 A). This front­
on scan was conducted on one cornea o f each developmental day. The scan started 
above the tissue, ran through the diameter o f the cornea with the 25pm beam moving 
in 50pm steps and finished below the tissue.
The second type o f scan was performed on a thin strip o f cornea around 400pm thick 
that was cut free-hand with a laboratory blade from the central area o f the cornea and 
orientated in the holder in such a way that the edge o f the corneal strip was facing the
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beam. The scan was run throughout the depth o f the cornea starting above the 
epithelium down to endothelium with the 25pm beam in 25pm steps thus sampling 
the whole o f the stromal depth. The available optical system allowed the choice o f 
the position o f the scan in the area o f the strip where no visible tilting occurred 
(Figure 4. IB).
Figure 4.1 Front-on (A) and edgeways (B) scan o f the chick cornea indicating path o f the beam 
and direction o f raster scan. Calibration bar = 2mm (A) and 100pm (B).
The obtained patterns (1024 x 1024 pixels) were analyzed using Unix based software 
(Sun Microsystems, M ountain View, CA) and statistical software (Statistica7) as 
previously described (Meek and Quantock, 2001).
Based on the position o f  the first order equatorial reflection and calibrated against the 
67nm D-periodicity o f  collagen fibrils in wet rat tail tendon, fibril centre to centre 
spacing was calculated across the corneal button and across the depth o f the cornea 
for the developmental period E l 4-E l 8.
4.2 Results
4.2.1 U ltra s tru c tu ra l fibril changes from  corneal centre to periphery  with 
developm ent
X-ray diffraction patterns o f  scans through the front o f the cornea from E14 to E l 8 
were analysed. The results o f over 350 patterns analysed show that with 
development, mean centre-to-centre fibril spacing steadily decreases. Due to the 
orientation o f the tissue towards the X-ray beam, the values o f the fibril interspacing 
registered show an average o f the collagen in all lamellae within the stroma. From
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the data presented in Figure 4.2a and 4.2b it can be seen that the compaction of 
collagen fibrils between E l4 and E l8 reaches 25% in the central and peripheral 
regions.
Compaction o f the fibrils with development occurs across a whole corneal diameter, 
but additionally there is a noticeable reduction in the fibrillar interspacing in the 
central region o f each cornea. This is especially notable in the earlier stages of the 
development (Figure 4.2b). At E14 the reduction between the peripheral and central 
250pm o f the cornea is 18% and at E l 5 and E16 it is 15%. In the later developmental 
stages the difference between collagen fibril interspacing in the centre and periphery 
o f the cornea is lower and reaches 7% by E l 8.
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Figure 4.2a Collagen fibril spacing as a function o f development and radial position in the front 
on scan.
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Figure 4.2b Collagen Fibril spacing as a function o f radial position in the front-on scan.
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4.2.2 Depth-profiled ultrastructural fibril changes with development
Experiments were then performed with corneal strips orientated edge wise towards 
the X-ray beam and 51 patterns were recorded from chick corneas at developmental 
stage E l 4-E l 8. Contrary to the first part o f the experiment, the value of the collagen 
interspacing is not an average o f the whole thickness of the cornea, but represents the 
value o f each o f  the 25 pm thick stromal layers recorded, while scanning from the 
epithelium to the endothelium (Figure 4 .IB).
This experiment was performed twice at the SPring8 synchrotron with the full E l4 - 
El 8 developmental period studied in each case.
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Figure 4.3 Data from experiment #1: Fibril interspacing as a function of stromal depth in the 
developing chick cornea. 0 indicates starting point o f the scan at the anterior surface of the 
stroma.
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4.2.2.1 Depth-profiled data set #1
On analysis, it was clear that the data set taken across the corneal strip at E l4 was 
highly unusual. Many more diffraction patterns were obtained than expected because 
the stroma is usually closer to 150pm thick at this stage o f development (Hay and 
Revel, 1969) not over 400pm thick as my data appear to show. The most likely 
explanation for this is that the specimen was wrongly oriented in the specimen holder 
so that X-ray patterns were actually taken front-on across the thin strip (which is 
estimated to be about 0.4 mm thick). Thus, the E14 data presented here for 
completeness are considered compromised and not valid.
Collagen fibril interspacing differs within the depth o f the cornea, and changes with 
developmental stage. On E l 5 interfibrillar spacing is slightly smaller in the posterior 
stroma and later during development. Even more extensive compaction in the deep 
regions o f the stroma is visible in E l6 and E l7. Between E l7 and E l8 the most 
significant reduction in the collagen spacing occurs in the anterior stroma (around 
lOnm).
Because E14 data were corrupt and to test for repeatability the whole experiment was 
conducted again with a new batch o f corneas.
The original protocol was followed in every step without any changes and the repeat 
was conducted in the same radiation source - SPring8 synchrotron. Another 51 
diffraction patterns arisen from regularly arranged collagen in the corneal stroma 
were analyzed in the E l 4-E l 8 chick corneas.
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Figure 4.4 Data from experim ent #2: Fibril interspacing as a function o f stromal depth in the 
developing chick cornea. 0 indicates starting point o f the scan at the anterior surface o f the 
stroma.
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4.2.2.2 Depth-profiled data set #2
The X-ray scan is started above the anterior surface o f the cornea (Figure 4 .IB) and 
ended below the posterior surface. If  there is no tissue is in the path o f the X-ray 
beam there is no diffraction pattern, but when tissue is present, the pattern occurs. 
Thus, the number o f diffraction patterns in 25pm steps gives us an indication o f the 
thickness o f the stroma’s strip being analysed. Data from the experiment #2 (Figure 
4.4), similarly to the data from the experiment #1 (Figure 4.3), shows variations in 
the collagen fibril spacing within the stromal depth and across development. 
However, the data from E l4 are still questionable. A cornea is unlikely to be over 
300pm thick at this stage o f development and I suspect that the tissue has been 
distorted during the placement in the holder. A less mature tissue has the higher 
water content, which makes it less rigid and more susceptible to tilting. 
Unfortunately, I have to exclude E l4 from the data set #2 from further analysis.
From the trend o f  the collagen interspacing in developmental day E l 5-El 8, we can 
perceive that at E l 5, collagen centre-to-centre spacing decreases toward the 
endothelium. W ith an overall compaction o f the tissue, collagen interspacing at E16 
remains significantly smaller in the posterior part. From E l7 a more rapid decrease 
o f fibril spacing occurs in the anterior stroma in comparison with the posterior 
stroma. At E l 8 collagen fibril spacing seems to be smaller close to the epithelium 
than in the deeper layers.
To summarise, the results o f both data sets indicate that at E l5 the interfibrillar 
spacing in the anterior and middle part o f the comeal stroma is higher than close to 
the endothelium. At E l 6 the posterior part o f the cornea seems to compact more 
significantly, as is showed by the lower collagen fibril centre-to-centre spacing. As a 
next step, during the course o f two days, compaction o f the near epithelial layers is 
more pronounced. At E l 8 the differences in values o f interspacing within the depth 
do not vary much, although the spacing cannot be described as uniform.
Collagen fibril centre-to-centre spacing decreases between E l5 and E l8 altogether 
more in the region close to the epithelium than close to the endothelium (Table 4.1).
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When taken the nearest 75 pm to epithelium and 75 pm to endothelium, data set #1 
and data set #2 show bigger collagen interspacing reduction near epithelium by lnm 
and 2.5nm accordingly.
Table 4.1 Table of collagen interspacing in the developing cornea (E15-E18) in the 75pm closest 
to the epithelium and the endothelium for data set #1 and #2.
S ta g e  o f
D ata  set #1 D ata  set #2
d ev e lo p m en t 75pm closest to 75pm closest to 75 pm closest to 75 pm closest to
the epithelium the endothelium the epithelium the endothelium
E15 53.0 nm 5 1.5 nm 65.7 nm 64.5 nm
E16 54.0 nm 49.3 nm 70.4 nm 66.2 nm
E17 49.4 nm 40.7 nm 63.8 nm 65.2 nm
E18 40.9 nm 40.4 nm 62.1 nm 63.4 nm
Both data sets seems to show the same trend for the collagen fibril spacing in the 
depth o f the developing stroma, however the absolute values differ. Any possible 
mistakes during data analysing has been excluded and I am not sure, why the 
absolute values difference occurred.
4.3 Discussion
Compaction o f the developing stroma and reduction of the collagen centre-to-centre 
spacing within the lamellae leads to the onset of the transparency in the cornea. 
Assembly o f the collagen fibrils, thinning o f the tissue and the changes in the 
composition o f  the extracellular matrix were broadly studied by previous workers 
(Hay and Revel, 1969; Conrad, 1970; Trelstad and Coulombre, 1971; Quantock et 
al., 1998; Meek and Quantock, 2001). In my experiment I am concentrating on the 
later stages o f the development (after E l 4) when more settled changes occur.
All structural changes that happen across the cornea from centre to periphery and 
throughout its depth were o f  interest. The study shows that the collagen fibril 
spacing, while taken as an average across the whole depth o f the stroma, increases 
while measured away from the prepupillary region and it applies to each stage
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between E14 and E l8. A similar study was performed on the human cornea (Boote et 
ah, 2003) which showed the mean fibril spacing in the central cornea was 5-7% 
lower than that in the peripheral cornea. My aim was to investigate in an animal 
model o f development whether or not central versus peripheral differences in 
collagen spacing are present during tissue morphogenesis. What was interesting was 
a chance to study if  the structure o f the developing cornea resembles the mature 
tissue at each stage between E l4 and E l8. My data shows that, on average, the 
fibrillar spacing decreases across the whole extent o f the cornea, but the difference 
between central and peripheral region in each stage is not constant. While tissue 
develops, the difference in collagen interspacing between central and peripheral 
region is 17% at E l4 and only 7% at E l8. This could be a result o f changes in the 
collagen alignment. Mature normal chicken cornea has got collagen fibrils aligning 
circumferentially in the peripheral cornea and limbus that is lost in the chickens 
affected by rethinopathy globe enlarge (rge) mutation (Boote et al., 2008). This 
mutation causes the cornea to flatten and collagen fibril spacing to increase rapidly 
towards the corneal periphery comparison to the unaffected tissue (Boote et al., 
2009). At E14 and E l 5, tissue is not fully structurally established and collagen fibrils 
in the periphery have probably not reached the final alignment. In support o f this, up 
to E l6, when dissecting cornea, it is still possible to separate the cornea by peeling 
off with a tweezers. In the later stages, scalpels or scissors have to be used. The 
structural development in the limbal area, mainly circumferentially alignment of 
collagen, causes the decrease o f collagen fibril spacing and emerging o f corneal 
curvature. This could be a reason why the collagen fibril spacing does not compact at 
the same rate in the centre and in the periphery o f the cornea.
The result o f the in-depth micro scan showed that at E l5, the corneal stroma is 
slightly more compact close to the endothelium. E l6 brings further, even more 
noticeable, collagen interspacing reduction in the posterior stroma. At E l7 
compaction slows in the posterior stroma but fibril spacing near the epithelial region 
starts to rapidly decrease.
In the developing chick’s eye, the compaction that starts at E l4 in the posterior 
stroma has been previously reported (Trelstad and Coulombre, 1971) and that is in 
line with my findings where the collagen fibril spacing decreases towards the
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posterior at E l5 and E l 6. Unfortunately, data o f E l4 from both sets o f scans has to 
be excluded, because the thickness o f the cornea is too great to be real. A tilting of 
the tissue, hence the increase o f the thickness is suspected.
Connon’s study on the developing chick cornea reported a decrease o f the 
interfibrillar spacing both in the anterior and the posterior between E l6 and E l8. It 
also shows that fibril arrangem ent in the stroma becomes homogenous around day 18 
(Connon et al., 2004). I cannot fully relate my finding to the published data, as more 
repeats o f the depth scans are needed to obtain a reliable and clear pattern o f collagen 
compaction during the chick development.
From the form er experim ent I can clearly say that a link exists between the tissue 
swelling or com pacting and the content o f the extracellular matrix. Study o f the 
water gradient and proteoglycan content in the bovine and rabbit cornea showed that 
the posterior stroma is more hydrated and in this part the concentration o f the keratan 
sulphate proteoglycan is greater than in the anterior part (Castoro et al., 1988; 
Bettelheim and Goetz, 1976). It happens because the two types o f proteoglycan seem 
to have a different w ater affinity. CS/DS PGs have bigger affinity power than KS 
PGs that is why the latter release water easier and accumulates water easier 
(Bettelheim and Ehrlich, 1963; Plessy and Bettelheim, 1975).
Early experiments on localisation o f KS PGs in chick developing cornea showed 
accumulation o f  KS first in the posterior stroma and then uniform throughout the 
stroma (Funderburgh et al., 1986; Takahashi et al, 1999). Although, the latest most 
comprehensive im munohistochemical study revealed KS PGs to appear in the 
opposite m anner to previous findings and opposite to the bovine and rabbit cornea. It 
shows, that by E l4, KS PGs are mainly accumulated in the anterior part o f the 
cornea, especially highly sulphated KS and then the distribution becomes more 
uniformly spread across the stroma by day 18 (Young et al., 2007b; Gealy et al., 
2007). That would suggest that the anterior part o f the stroma has higher water 
content in early stages o f  development. That is in line with my findings that the 
greater com paction in total occurs in the outer layer o f the stroma.
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While KS is spreading from the anterior to the posterior, CS/DS is first accumulated 
in the posterior part near day 12-14 o f development and then spreads towards the 
epithelium, which is based on my observations further presented in Chapter Five. 
Each study presents two different kinds o f PGs, with different affinity to the water, 
that are localised at the opposite sides o f corneal stroma and then spread uniformly 
across the corneal depth and is simultaneous with closer uniform interfibrillar 
spacing by the developing tissue.
The corneal structure is mainly shaped by the dehydration triggered by the activation 
o f the endothelial pumps. However, equally important is the sulphation o f the GAG 
chains present in the corneal stroma and changes in the ratio and the location o f the 
PGs. All o f the above changes happen during development and most likely contribute 
towards the differences in the collagen spacing within the depth o f the stroma.
It is known that while cornea becomes more dehydrated, it accumulates more 
sulphated KS (Hart, 1976; Com uet et al., 1994). In the human cornea, in the central 
region there are 24% more acidic glycosaminoglycans, mostly KS, than in the 
periphery (Brocherding et al., 1975). This may contribute to the higher values of 
collagen fibril interspacing in the periphery o f the cornea. In developing chicks, KS 
becomes more sulphated with development (Liles et al., 2010). Sulphation o f the 
CS/DS also changes. Chondroitin-6-sulphate decreases while chondroitin-4-sulphate 
increases near day 14 o f development (Zhang et al., 2005). There is no information 
how the PGs are distributed in the stroma so we cannot incorporate these changes 
into our model o f  depth related collagen interfibrillar changes.
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Chapter Five 
5 Spatial and temporal alterations in proteoglycan content in 
developing chick cornea
During the process o f development, changes in the level o f biosynthesis o f GAG 
chains occur along with changes in the sulphation patterns. Additionally, 
proteoglycans are not uniformly distributed across the corneal stroma. Localisation 
o f sulphated KS has been broadly studied (Funderburgh et al., 1986; Takahashi et al., 
1999; Young et al., 2007b; Gealy et al., 2007), but there are no reports about 
localisation o f  CS/DS. Here I use the monoclonal antibodies raised against native 
proteoglycans carrying CS chains to visualise spatial distribution o f CS in the stroma.
In the extracellular matrix o f the developing chick stroma, two groups of 
proteoglycans are present. One has keratan sulphate GAG chains attached to the core 
protein o f which there are three types: keratocan (Corpuz et al., 1996; Liu et al., 
1998), lumican (Blochberger et al., 1992b) and mimecan (Funderburgh et al., 1997). 
The other proteoglycans carry chondroitin/dermatan GAG chains and they are 
decorin (Li et al., 1992) and biglycan (Bianco et al., 1990).
For a better differentiation between the two groups o f proteoglycans, for the second 
part o f experiment, I removed one population using an enzyme called chondroitinase 
ABC. This enzyme cleaves mainly next to 4- sulphated disaccharides from the non­
reducing terminal o f  CS chains (Hardingham et al., 1993) but taking into 
consideration that in developing chick cornea the majority o f sulphated CS are 4 -  
sulphated (Hart, 1976; Nakazawa et al., 1995; Zhang et al., 2005), it makes this 
enzyme suitable for the experiment. After enzyme digestion we can investigate the 
developing stroma under transmission electron microscope to search for 
compositional and spatial differences between KS and CS/DS.
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5.1 Methods
All animals involved in this study were used in accordance with the Association for 
Research in Vision and Ophthalmology statement for the Use o f Animals in 
Ophthalmic and Vision Research.
5.1.1 Immunofluorescence microscopy
16 fertilised white leghorn chicken eggs were collected from a commercial hatchery 
(Hy-line UK, W arwickshire) and placed in the incubator to develop. At day 12, 14, 
16 and 18 o f  development, embryonic corneas were dissected (n=8 for each stage). 
Corneas were then embedded in Tissue Tek (O.C.T. compound, Sakura Finetek) on 
cork disks, snap-frozen by dipping in liquid nitrogen-cooling isopentane and then 
stored at -80°C until use.
Sectioning was carried out on a cryostat at -20°C and tissue sections 8pm thick were 
obtained and collected on glass slides (RaLamb, UK). Sections were allowed to thaw 
and circumscribed with the “Immegde pen” that prevents cross contamination o f the 
antibody by leaving water repellent rings around individual sections on the slide. On 
each section 200pl 0 .01M phosphate-buffered saline (PBS) without Tween 20 was 
applied and left for 10 min to rehydrate samples and then removed.
Non-specific binding was eliminated by coating slides with a blocking agent -  1% 
bovine serum albumin (BSA) for 30 min using 1 5 0 jli1 per section at room 
temperature. Blocking serum was washed out with PBS. Primary antibodies (Ab) 
6C3, 4C3 and 7D4 o f  working dilution 1:100 and at a volume o f 200pm per circle 
were applied. As a negative control, slides with no primary Ab and with naive mouse 
immunoglobuline (mlgG) used at a dilution o f 1:200 instead o f  CS/DS mouse 
antibody (mAb) were prepared. Slides with primary Ab were incubated for 2 hours in 
a humid box at room temperature and then washed.
A goat anti-mouse IgG FITC conjugate antibody diluted 1:400 was used as a 
secondary antibody. 150pl o f  secondary antibody solution per section was applied 
and incubated for an hour in the dark at room temperature before washing in PBS.
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Comeal sections were mounted in a drop of Vectashield (mounting medium for 
fluorescence with DAPI, H-1200) under glass coverslips and examined using a Leica 
TCS SP2 fluorescence microscope (Leica, Vienna, Austria). DAPI excites at 360nm 
and emits at 460nm when bound to DNA. This allows visualisation not only of the 
location o f  secondary antibodies but nuclei o f cells in the comeal slice. Images were 
taken using an Olympus AX470 camera (Olympus, UK)
5.1.2 Electron microscopy
21 corneas from white leghorn chickens (Henry Stewart & Co. Ltd., Louth, 
Lincolnshire, UK) at developmental stages E l2 to E l 8, along with biopsies o f chick 
skin from E l 8 as a positive control were dissected with scissors, handled carefully to 
avoid stmctural deformation and prepared for electron microscopy.
One batch o f  E l2 to E l 8 corneas was quartered and fixed overnight in 2.5% 
glutaraldehyde in 25 mM  sodium acetate buffer with 0.05% cuprolinic blue (0.1 M 
MgCL, pH 5.7) to stain the sulphated PGs (Scott, 1980).
Another series was fixed for 10 minutes in 4% paraformaldehyde in Tris/sodium 
acetate buffer (pH 7.2) to make the tissue more resistant to swelling during a period 
o f incubation with enzyme. These corneas were then washed twice in chondroitinase 
buffer, which is the buffer used to reconstitute the chondroitinase ABC (50 mM Tris, 
pH 8, 60 mM  sodium acetate and 0.02% BSA) and cut into quarters. Comeal pieces 
were then incubated for 4 hours at 37°C in chondroitinase buffer containing 2.5 U/ml 
chondroitinase ABC (from Proteus vulgaris; Sigma-Aldrich) to remove the 
chondroitin- and dermatan-sulfate GAG chains from the tissue. Commercially 
prepared protease inhibitor cocktail for general use (Sigma-Aldrich) was added to the 
chondroitinase buffer (1% o f  total volume) to inhibit endogenous PG degradation.
The third, control, series o f E l2 to E l 8 comeal quarters was similarly processed but 
the chonroitinase buffer contained only protease inhibitor cocktail and no 
chondroitinase ABC. This was done to investigate if  the incubation period had any 
negative impact on the PG content. After incubation, samples from the second and 
third series were washed in chondroitinase buffer (without enzyme), before fixation 
and staining overnight in 2.5% glutaraldehyde in 25 mM sodium acetate buffer with
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0.05% cuprolinic blue (0.1 M MgCU, pH 5.7) in an identical manner to which non­
digested tissue had been treated.
Skin biopsies were treated simultaneously with all three series o f cornea quarters to 
represent a control for chondroitinase ABC activity. All tissues were then rinsed in 
25mM sodium acetate buffer (pH 5.7) and contrast enhanced with 0.5% sodium 
tungstate. The tissue was then dehydrated in 0.5% sodium tungstate in 50% ethanol 
which was followed by 70% ethanol, 90% ethanol, 100% ethanol and finished with 
propylene oxide before embedding in Araldite resin. Individual pieces o f tissue were 
placed in moulds in more Araldite resin and cured in the oven in 60°C for 2 days. 
Ultrathin sections (approx 90nm thick) were cut on glass knives on an Ultracut E 
microtome (Reichert-Jung, Vienna, Austria), collected on copper grids (300 square 
mesh, Agar), and stained with 1% aqueous phosphotungstic acid and saturated 
aqueous uranyl acetate before examination by transmission electron microscopy 
(JEM-1010; JEOL, Tokyo, Japan) equipped with an 11-megapixel CCD camera 
(Orius SC 1000 CCD camera; Gatan Ltd., UK, Cambridge, UK).
5.2 Results
5.2.1 Immunofluorescence microscopy
Immunofluorescence microscopy o f  the developing cornea shows an accumulation o f 
CS/DS during the later stages o f incubation. Staining with the monoclonal antibody 
7D4 revealed chains o f chondroitin/dermatan sulphate through the corneal stroma 
(Figure 5.1). Images o f  the negative control confirmed lack o f non-specific binding 
o f the secondary antibody. Staining with the two other monoclonal antibodies 6C3 
and 4C3 displayed the same pattern. Neither o f the antibodies used is fully 
characterised and for the analysis only one out o f three sets o f staining was chosen to 
be presented.
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Control Figure 5.1 Im munofluorescence staining 
with antibody 7D4, for chondroitin  
sulphate glycosam inoglycan chains in the 
chick cornea at E12 and E18 and the 
negative control for secondary antibody’s 
nonspecific binding. Nuclei o f cells are 
stained blue, while CS/DS is green. 
Calibration bar = 35pm  M agnification  
x20.
At day 12 o f developm ent, CS/DS has clearly accumulated in the posterior region of 
the stroma with a clear unstained region in the anterior part o f the stroma. During the 
next stages (E l4 and E l 6), chondroitin/dermatan sulphate chains are present as well 
in the anterior part. Interestingly, only on day 16 o f development does 
im munofluorescence staining appear to be homogenous. At the final stage (E l8), 
CS/DS are visible throughout the whole thickness o f the tissue with easy to 
distinguish layers o f  higher intensity near the epithelium and the endothelium.
Corneal matrix com paction and dehydration by day 15 cause sections to become 
thinner from this stage onwards (Siegler and Quantock, 2002). This allows a full 
thickness image on E l 8 to be obtained at x20 magnification in comparison to E l2.
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5.2.2 TEM
The stroma o f developing chick corneas in daily intervals E l2 -  E l8 was studied 
using electron microscopy. Cuprolinic blue stain made sulpahated GAG chains in 
both KS and CS/DS PGs visible. To distinguish KS PGs from CS/DS PGs an 
enzymatic digestion using chondroitinase ABC was performed. In the tissue stained 
with cuprolinic blue PGs are visible as long and thick GAG chains running along 
collagen fibrils as well as in between adjacent fibrils. They are most prominent in the 
earlier stages o f development -  up to E l5 (Figure 5.2a-d). However, smaller GAG 
chains are also present in the developing matrix.
Enzymatic digestion process requires a few hours incubation and it has to be 
established if  this causes any proteoglycan content changes. One o f the causes could 
be a PGs leaching out into the bathing fluid. As a control, corneas E l 2-El 8 were 
incubated in the buffer used to reconstitute an enzyme, for the same period o f time as 
tissue ongoing enzymatic digestion, and then stained with cuprolinic blue. When 
compared with untreated corneas, there are no visible, significant differences in 
proteoglycan content at any studied stage o f development. There are still two 
different types o f  proteoglycans noticeable. It is likely that the brief pre-fixation 
helped prevent this loss o f  PGs.
To test chondroitinase ABC activity, skin biopsies from the skin o f chick (E l 8) were 
treated in the same way corneas were treated. Skin was chosen as a control because 
its extracellular matrix contains one type o f proteoglycans: decorin. After enzyme 
digestion there are only bare collagen fibrils visible with no PGs left in the tissue 
(Figure 5.2h). It shows that following the protocol we are able to remove all 
chondroitin/dermatan sulphate from the tissue.
In chick corneas in the E l 2-El 8 timeframe which underwent the enzymatic digestion 
we can no longer observe long and thick GAG chains (Figure 5.2a-g). That indicates 
that the large filaments often linking adjacent collagen fibrils are CS/DS 
proteoglycans. Remaining small enzyme resistant filaments on the surface o f fibrils 
are KS proteoglycans in developing chick cornea. Comparing chondroitinase ABC 
digested corneas E l 2-El 8 shows that amount o f visible KS PGs increases in the mid 
section o f the extracellular matrix o f the stroma while tissue develops (Figure 5.3).
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a) E12 b) E13
1 0 0 n m
Figure 5.2a-b Collagen fibrils in the mid corneal stroma at E12 and E13 with visible GAG 
chains of proteoglycans. The 3rd row shows tissue with CS/DS removed by chondroitinase ABC 
and no large filam ents are evident. M icrographs taken at x20k magnification.
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Figure 5.2c-d Collagen fibrils in the mid corneal stroma at E14 and E15 with visible GAG  
chains o f proteoglycans. The 3 r(l row shows tissue with CS/DS removed by chondroitinase ABC  
and no large filam ents are evident. M icrographs taken at x20k magnification.
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e) E16 f)E17
1 0 0 n m
Figure 5.2e-f C ollagen fibrils in the mid corneal strom a at E16 and E17 with visible GAG chains 
of proteoglycans. The 3 r(l row  show s tissue with CS/DS rem oved by chondroitinase ABC. No 
large filam ents are evident, but m ore sm all collagen  associated PG filam ents are seen. These are 
o f the KS variety. M icrographs taken at x20k m agnification.
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Figure 5.2g-h C ollagen fibrils in the m id corneal strom a at E l 8 and skin with visible GAG  
chains of proteoglycans. The 3 rd row  show s tissue with CS/DS rem oved by chondroitinase ABC. 
No large filam ents are evident in the cornea, but m ore sm all collagen associated PG filam ents 
are seen. These are o f the KS variety. No PGs are visible in the skin control confirm ing good 
enzym e activity. M icrographs taken at x20k m agnification for the cornea and at xlOk for the 
skin.
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Figure 5.3 Accum ulation of keratan 
sulphate proteoglycans in the developing 
chick cornea at E12-E18. Tissue treated 
with chondroitinase ABC to remove 
chondroitin/derm atan sulphate PGs 
Calibration bar = lOOnm applies to all 
m icrograps.
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5.3 Discussion
In the developing chick cornea proteoglycans are first synthesised after invasion of 
the primary stroma by fibroblasts. Those synthesised on E5 are mainly CS/DS PGs, 
and then on E7 an increase in synthesis o f  KS PGs occurs (Hart, 1975; Nakazawa et 
al., 1995; Takahashi et al., 1999). W ith development the total amount of 
glycosaminoglycans per dry w eight o f  cornea increases (Anseth, 1961), but it is not a 
uniform process. Synthesis o f  KS PGs increases until E l4 when it peaks and then 
starts to decline until E l 8 (N akazaw a et al., 1995; Zhang et al., 2005). The 
biosynthesis o f CS/DS PGs is highest in the early stages o f development, decreases 
until E l 8, and is lower still in adult chickens (Nakazawa et al., 1995; Zhang et al., 
2005). However, not only does the biosynthesis and ratio o f  PGs change with 
development, but also its spatial accum ulation in the stroma.
Results o f  the im munofluorescence study suggest that the accumulation o f CS/DS 
throughout the corneal strom a proceeds in a posterior to anterior manner. In the early 
stages o f  development CS/DC appears on the posterior side o f  the stroma and around 
E14 spreads out in an anterior direction. That is in opposite to the accumulation o f 
high-sulphated KS (Young et al., 2007b). Unfortunately, the types o f  antibody that 
were used in experim ent do not provide us w ith information about how accumulation 
o f CS/DS refers to its sulphation. A ntibodies 7D4, 4C3 and 6C3 were raised against 
native chick bone m arrow  proteoglycans and recognise CS chains, however, the 
epitopes have not been fully characterised (Sorrel et al., 1990). It is known that 
native CS epitopes for these antibodies are more structurally complex than the 0-, 4-, 
6-sulfated disaccharide repeats o f  CS chains and are distributed within the linear 
framework o f chains (Sorrel et al., 1993). Additionally, the presence and location o f 
the epitopes may vary w ith source, developm ental stage and pathological status o f 
the tissue (Caterson et al., 1990). For that reason, the presented data show only 
overall CS/DS PG distribution w ithin the depth o f  the cornea without providing any 
information about the GAG chains sulphation.
There are no studies on the location o f  CS/DS according to its sulphation pattern in 
chick cornea, but in the case o f  mice, a presence o f chondroitin chains rich in 4- 
sulphated disaccharides in com eal PGs was revealed (Young et al., 2005). However,
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previous studies on other connective tissues have shown that the ratio o f 6:4 
sulphated CS PGs increases w ith age (Lauder et al., 2001) and epitopes for antibody 
that recognise 6-sulphated disaccharides may be present at a later stage.
Chondroitinase ABC digestion and transm ission electron microscopy o f the 
developing chick corneas has been perform ed to distinguish between two types of 
proteoglycans in the stroma. On m icrographs there are usually two types o f filament 
visible. In one group PGs are small and associated with collagen fibrils surface. 
Another one are larger and lie along collagen fibrils or extend out into the 
extracellular matrix, connecting with adjacent fibrils (Connon et al., 2003). In this 
study all PGs with large filam ents were removed from the tissue during enzymatic 
digestion in all stages o f  developm ent, indicating that they are CS/DS PGs.
Additionally, it can be noticed that GAG chains o f  CS/DS PGs are longer and thicker 
in the early stages o f  developm ent -  until E l 5. This might be due to the sulphation 
changes, although I can only speculate. The ratio o f 4 - sulphated to 6 -  sulphated 
CS/DS increases in chick developm ent and reaches a maximum at E l4 (Hart, 1976; 
Zhang et al., 2005). Thus, the majority o f  the visible CS/DS are probably 4 -  
sulphated CS/DS because chondroitin 6 -  sulphate is synthesised only in the very 
early and very late developm ental stages (Nakazawa et al., 1995). These large 
filaments, approxim ate 65nm  long but being even lOOnm long, found in the chick 
cornea resemble filam ents in the mouse cornea, which are describe as 4 -  sulphated 
CS/DS. However, m urine filam ents are m uch longer and are able to connect more 
than 2 collagen fibrils (Y oung et al., 2005).
The number o f  small filam ents o f  KS on the surface o f  collagen fibrils which remain 
after digestion with chondroitinase ABC increases between E l2 and E l 8. This is 
probably the result o f  PGs accum ulation and increase in KS chains sulphation which 
happens during developm ent (Nakazaw a et al., 1995). Especially highly sulphated 
KS GAG epitopes are detectable in the last week o f  chick development (Liles et al., 
2010), which is our studied period. The character o f  used cationic dye supports an 
increase in KS detection w ith increase o f  sulphation, because cuprolinic blue 
complexes with negative charges o f  sulphated GAG chains (Scott, 1972). However, 
the accumulation o f  KS PGs presented in this study is only a qualitative, not a
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quantitative representation, o f  the process. To quantify the amount o f PG within the 
stroma based on the electron micrographs, all three areas o f the stromal depth 
(anterior, mid, posterior) have to be represented. I showed only PGs in the middle 
stroma. This may not be representative o f  the entire depth o f the stroma.
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Chapter Six
6 Collagen architecture in human pathologies with proteoglycan 
defects
This chapter presents studies o f  three diseased human corneas with different genetic 
mutations in PG pathways, 1) M acular com eal dystrophy in which sulphation o f KS 
GAGs is disrupted (Hassell et al., 1980), 2) Sly syndrome where GAG chains are 
accumulated due to the inability o f  the organism to catalyse them (Sly et al., 1973), 
and 3) Congenital Stromal Com eal Dystrophy (CSCD) in which a tmncated decorin 
core protein is produced (Berdrup et al., 2005). All o f these abnormalities lead to the 
opacification o f  the cornea. The structural changes in size and spacing o f  collagen 
fibrils in the comeal strom a will be described.
6.1 Macular corneal dystrophy
Macular comeal dystrophy (M CD; M IM  217800) is an autosomal recessive disease 
characterised by progressive com eal cloudiness and focal opacities caused by an 
anomaly in the production o f  KS GAG (Klintworth and Vogel et al., 1964; 
Klintworth and Smith, 1983; Hassell et al., 1980; N akazawa et al., 1984; M idura et 
al., 1990; Plaas et al., 2001).
Three main im munophenotypes o f  M CD can be distinguished (type I, type IA and 
type II) based on the reactivity o f  com eal tissue and/or serum to a monoclonal 
antibody (5D4) which recognises high-sulphated KS (Caterson et al., 1983; Mehmet 
et al., 1986). Sulphated KS, which is present in the cornea and serum o f non-affected 
individuals, is absent from the serum and cornea in the majority o f MCD patients, 
and these are categorised as M CD type I (Thonar et al., 1986; Klintworth et al., 
1986). Initially, all M CD patients were believed to have defective, unsulphated KS- 
GAG systemically, but in the late 1980s it was discovered that some patients had 
immunodetectable KS in their serum and cornea (designated MCD type II), even 
though the different M CD types are clinically indistinguishable (Yang et al., 1988; 
Edward et al., 1988). Further studies have identified MCD type IA, in which there is
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no detectable KS in sera o f  affected individuals, but a 5D4-positive signal in 
keratocytes (K lintworth et al., 1997).
As mentioned in earlier chapters KS, in the cornea is an important matrix molecule, 
which forms PG by binding to one o f  three core proteins, lumican, keratocan or 
mimecan (Blochberger et al., 1992b; Corpuz et al., 1996; Funderburgh et al., 1997). 
KS PGs bind to collagen fibrils via their core proteins at defined locations along the 
fibril axis (Scott and Haigh, 1985; M eek et al., 1986) with the hydrophilic, sulphated 
GAG chains occupying the extrafibrillar space where they help control the swelling 
properties o f  the strom a and the structural arrangement o f  the collagen fibrils 
(Bettelheim and Plessy, 1975; Bettelheim  and Goetz, 1976; Castoro et al., 1988; 
Borcherding et al., 1975). The cornea affected by MCD is thinner than normal 
(Ehlers and Bramsen, 1978; D onnenfeld et al., 1986) and, unlike in other conditions 
such as keratoconus where a slippage o f  lamellae is suspected to be responsible for 
the reduction in central corneal thickness (Fullw ood et al., 1992; M eek et al., 2005), 
the collagen fibrils in M CD are m ore closely spaced than normal (M eek et al., 1989; 
Quantock et al., 1990).
All previous measurem ents o f  collagen fibril spacing by small-angle X-ray 
diffraction represent an average value throughout the whole thickness o f the stroma. 
KS, however, is not evenly distributed throughout the cornea (Scott and Haigh, 
1988c; Scott and Bosworth, 1990), so to investigate whether or not the PG alterations 
manifested in M CD are associated with location-specific changes in stromal 
extracellular matrix architecture we conducted a series o f  microbeam synchrotron X- 
ray diffraction experim ents at a spatial resolution o f  25 pm  to ascertain the depth- 
dependent nature o f  collagen fibril spacing in MCD.
6.1.1 Case report and methods
The research described in this chapter was carried out in collaboration with 
colleagues in Kyoto Prefectural University o f  Medicine, and was approved by the 
Committee for Ethical Issues on Hum an Research o f  Kyoto Prefectural University o f 
Medicine and followed the tenets o f  the Declaration o f  Helsinki.
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The patient was a 50-yr-old female with bilateral MCD type I, who 11 years earlier 
had undergone penetrating keratoplasty in her right eye. As with the right cornea, the 
left cornea was affected by a diffuse ground-glass-like stromal opacity, and 
numerous irregularly-shaped white patches which were confined mainly to the deep 
part o f the stroma (Figure 6.1).
Figure 6.1 Clinical appearance o f  the M CD cornea exam ined in this thesis. Diffuse ground-glass­
like strom al opacities w ere observed on slit-lam p exam ination (A), with irregular patches visible 
in the cornea by the scleral scattering technique (B).
The edges o f the opacities were dull and indistinct. A penetrating keratoplasty was 
performed in the patient’s left eye in September 2007, after which the excised button 
(7mm-diameter) was immediately wrapped in Clingfilm to prevent dehydration, and 
stored at -80°C for 7 days prior to transportation on dry ice from the hospital in 
Kyoto to the SPring-8 synchrotron facility in Hyogo Prefecture, Japan, where small- 
angle X-ray scattering techniques were used to investigate the internal fine structure 
o f the comeal strom a in its hydrated state as described in methods (Meek and 
Quantock, 2001).
A human eye-bank cornea deemed unsuitable for grafting because o f a low 
endothelial cell count was similarly examined. Under a binocular microscope, two 
thin strips were cut across the centres o f  the MCD and eye bank corneas using a 
surgical blade, w ith the edge o f  a glass microscope slide serving as a guide for the 
dissection. This was done with the epithelial side up, and the cut strips were 
estimated to be in the region o f  400pm  thick.
Two thin strips o f  tissue were dissected across the central cornea. One strip was 
analysed with the X-ray beam directed through the comeal strip from front to back,
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whilst the second strip was oriented so that the beam passed through the corneal strip 
edgeways (Figure 6.2).
Figure 6.2 The tissue holder with two mounted strips o f cornea. The one at the top is mounted 
facing the x-ray beam edge w ise w hile the bottom corneal strip is mounted face-on. 
The right hand schem atic shows corneal strips with the approxim ate direction o f the 
collagen fibrils indicated.
Depth-profiled data were collected from the centre o f the cut-strip (i.e. at a location 
corresponding to the corneal centre) and at a position in the mid-periphery, 
approximately 3mm from the corneal centre. On the high flux beamline 40XU, a 
series o f small-angle X-ray diffraction patterns was obtained with a 25jam beam ( X = 
1.18A) in 25|im  steps using sub-second exposure times as described previously 
(Quantock et al., 2007). A series o f  small angle diffraction patterns were recorded on 
the detector (4 inch II (V7739P/ION) + C4880-50) situated 3.13m behind the 
specimen. Patterns were analyzed to provide values for the mean collagen 
interfibrillar spacing, calibrated to the meridional reflection arising from the 67-nm 
axial repeat o f  collagen in rat tail tendon and adjusted by a 1.12 calibration factor to 
take into account the mode o f  packing o f  collagen fibrils in cornea (W orthington and 
Inouye, 1985), as was done in previous studies o f  MCD (Meek et al., 1989; 
Quantock et al., 1990).
After X-ray exposure, small full-thickness pieces o f MCD cornea were prepared by 
conventional fixation in 2.5%  buffered glutaraldehyde, followed by post-fixation for 
1-hr each in 1% aqueous osm ium  tetroxide and 0.5% aqueous uranyl acetate. Tissue 
was then dehydrated through an ascending series o f ethanol concentrations, 
immersed in propylene oxide, and embedded in Araldite CY212 epoxy resin. 
Ultrathin sections were cut w ith a diamond knife on a Leica UC6 ultramicrotome,
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picked up on uncoated copper grids, contrasted with satu rated  uranyl acetate and 
Reynold’s lead citrate, and imaged on a Philips/FEI 208 e lec tron  microscope.
On the basis o f  the obtained electronmicrographs, histogram s o f fibril diameter were 
prepared using ImageJ software. The scale for m easurem ents was set using the pixel 
size o f the scale bar. The threshold was changed to obtain th e  best contrast between 
the collagen fibril and the background. Then each ind iv idual collagen fibril was 
measured by drawing a straight line across the shortest d iam ete r o f fibril to eliminate 
an error which might have occurred from a possible tilt o f  th e  fibril.
6.1.2 Results
Comparison o f  raw diffraction patterns shows a decrease in  the collagen centre-to- 
centre fibril spacing in the M CD cornea. The equatorial reflection ring in the eye 
bank human cornea and in the M CD cornea had different rad ii (Figure 6.3). In the 
small angle X-ray diffraction, a bigger equatorial re flec tion  ring indicates smaller 
fibril interspacing. The 1st and 3rd meridional reflections which were within the 
collection area o f the detector were unchanged, ind icating  that the axial order o f 
collagen molecules or D-period is the same in both the e y e  bank cornea and the 
MCD cornea.
Eye MCD
bank
1st order
meridional
reflection
Equatorial
reflection
3rd order
meridional
reflection
Figure 6.3 Small angle X-ray diffraction pattern o f a human eye b a n k  cornea (left) and MCD  
cornea (right) with visible meridional and equatorial reflections.
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Collagen interfibrillar spacing, measured at 27 positions, 25pm apart, in the central 
region o f the eye bank cornea and in 21 positions in the MCD cornea with the beam 
directed at right angles to the corneal surface and passed through the whole thickness 
o f the tissue gave mean values o f 52.0nm (SD ± 0.3nm) and 40.7nm (SD ± 0.7nm), 
respectively (Figure 6.4). Previous measurements by synchrotron X-ray diffraction of 
collagen fibril spacing in MCD indicated a reduction o f 22% compared to the fibril 
spacing in a post-mortem human cornea, with the values representing an average 
throughout the whole thickness o f the stroma (Quantock et al., 1990). A similar 
proportional reduction is seen in the current analysis.
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Figure 6.4 C entre-to-centre collagen fibril spacing measured across the strip o f human eye 
bank cornea (pink) and M CD cornea (blue) in the central region. Error bars show accuracy of  
the reading: the longer the bar the less accurate the reading.
What is not known, however, is whether or not this reduced fibril spacing in MCD 
varies with stromal depth. To rectify this, measurements o f collagen interfibrillar 
spacing were obtained in sequential steps o f 25pm across the MCD and eye bank 
corneas from anterior to posterior. Eye bank data confirmed previous depth-profiled 
X-ray diffraction studies (Quantock et al., 2007) and showed that collagen fibrils 
were more widely spaced in the posterior stroma (by approximately 25%) as 
compared to the mid-depth or anterior stroma (Figure 6.5). The opposite was true,
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however, for the MCD cornea, with collagen fibril spacing clearly lower in the 
posterior stroma (Figure 6.5).
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Figure 6.5 C entre-to-centre collagen fibril spacing measured across a human eye bank cornea 
and MCD cornea from epithelium  to endothelium . Depth-profiled information from the centre 
(blue) and m id-peripheral (green) cornea shows a clear decrease in the collagen fibril spacing in 
the deeper stroma. D epth-profiled information from the eye bank cornea showed decrease in the 
collagen fibril spacing in the outer strom a (purple). Error bars show accuracy o f the reading: 
the longer the bar the less accurate the reading.
This was the case in the mid-periphery too, although values are higher than in the 
corneal centre as tends to be the case in human cornea (Boote et al., 2003). At the 
centre o f  the M CD cornea, collagen spacing is 5.4% less in the posterior 100pm of 
stroma compared to the anterior 100pm (p<0.01). At the mid-periphery, the posterior 
100pm o f the MCD stroma shows a collagen spacing which was 10.0% less than that 
in the anterior 100pm (p<0.01). Thus, the profile o f collagen fibril spacing as a 
function o f stromal depth in a MCD cornea (lower fibril spacing in the deep stroma) 
is unlike that for a human cornea from the eye bank (lower fibril spacing in the 
anterior stroma).
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m m
Confirmation o f more prevalent stromal alterations in the posterior cornea in MCD 
came from electron microscopic examination of the cornea. This disclosed that the 
collagen fibrils appear structurally normal in the anterior cornea, but that the deep 
stroma possesses focal pockets o f  abnormally large diameter collagen fibrils (Figure 
6 .6).
Figure 6.6 Transverse-section electron m icroscopic images o f collagen fibrils in the anterior (A) 
and posterior (B) strom a in M CD. Focal pockets o f collagen fibrils o f abnormally large diameter 
are present in the posterior strom a. M agnification 32k.Calibration bar=300nm.
To exclude the possibility that unusual collagen fibrils are only an individual 
characteristic, electron m icroscopy was again carried out on the corneal biopsy of 
another Japanese patient suffering from MCD. I received the MCD corneal piece in 
January 2010. After fixation and staining in 2.5% buffered glutaraldehyde and 0.05% 
cuprolinic blue, tissue was em bedded in Araldite CY212 epoxy resin. Ultrathin 
sections (90nm thick) were cut with a glass knife, collected on copper grids (300 
square mesh, Agar scientific), and stained with 1% aqueous phosphotungstic acid 
and saturated aqueous uranyl acetate before examination by transmission electron 
microscopy (JEM-1010; JEOL, Tokyo, Japan) equipped with an 11-megapixel CCD 
camera (Orius SC 1000 CCD camera; Gatan Ltd., UK, Cambridge, UK). Pockets with 
enlarged collagen fibrils were found in the posterior stroma (Figure 6.7).
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Figure 6.7 Transverse-section electron m icroscopic images o f collagen fibrils in the posterior 
stroma in a second patient with M CD. Visibly enlarged collagen fibrils are in evidence (arrows). 
Calibration bar =150nm.
Fibrils (n=802) in the eye bank cornea examined displayed a normal distribution of 
fibril diameters which ranged from 20.0nm-35.6nm (Figure 6.8B), and was centred 
on 26.4nm (SD±2.6nm), similar to published values o f 26.0nm (SD±2.4nm) 
(Quantock et al., 1993a). M easurement o f fibrils (n=800) in areas which contained 
the congregations o f  large-diameter fibrils gave a range o f 20nm to 63nm, with a 
distribution which was not normal (one-sample Kolmogorov-Smimov Test p<0.001) 
and skewed towards higher diameters (Figure 6.8).
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Figure 6.8 Histograms showing the range of collagen fibril diameters in regions of MCD stroma 
which contain abnorm ally large diameter fibrils (A) and in the normal human cornea (B).
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Large-diameter collagen fibrils have been documented previously in MCD where 
they range in size between 20nm and 60nm (Quantock et al., 1993; Quantock et al.,
1997). However, it was not indicated at what stromal depth they existed. In the MCD 
cornea studied here, it was clear that abnormally large collagen fibrils were restricted 
to the deep stroma.
6.1.3 Discussion
M utations found in a gene, CHST6, which encodes the N-acetylglucosamine 6 -0  
sulphotransferase cause an abnormality in the biosynthetic pathway o f KS that occurs 
in MCD (Akama et al., 2000). The KS GAG chain comprises a repeating series of 
disaccharides, in w hich each is composed o f  galactose and A-acetylglucosamine. 
This inactive sulphotransferase, in normal conditions, transfers sulphate onto the 6-O 
positions o f  GlcNAc and Gal (Akama et al., 2001; Fukuta et al., 1997), thus a 
mutation in CHST6 adversely affects the production o f a mature, sulphated KS 
GAG. Since the initial discovery o f the causative gene for MCD, molecular genetic 
studies have reported mutations in CHST6 in MCD patients worldwide (Liu et al., 
2000; El-Ashry et al., 2002; Niel et al., 2003; Iida-Hasegawa et al., 2003; Warren et 
al., 2003; Abbruzzese et al., 2004; Aldave and Sonmez, 2004; El-Ashry et al., 2005; 
Liu et al., 2005; Liu et al., 2006; Klintworth et al., 2006; Liskova et al., 2008; 
Sultana et al., 2009; Dang et al., 2009; El-Ashry et al., 2010).
KS PGs are believed to influence the ultrastructural arrangement o f collagen fibrils 
in the cornea. Fibril diam eter can be controlled by the proportion o f type V collagen 
molecules in the hybrid type IN  fibril, with higher proportions o f collagen type V 
leading to narrower fibrils (Birk et al., 1990). Evidence exists, too, for a role for KS 
PGs and CS/DS PGs in the regulation o f fibril diameter in vitro. Both, lumican and 
decorin regulate collagen fibrillogenesis, although, interestingly, they do so with, as 
well as without, the GAG side chain (Rada et al., 1993). This suggests that the 
regulatory ability might lie with the core protein, and studies o f the corneas o f 
lumican-null mice show that collagen fibrils are sometimes abnormally large 
(Chakravarti et al., 2000). The presence o f  unusually large collagen fibrils in the 
corneas o f  MCD patients is indicative o f  a role for the GAG side chain o f KS in the 
regulation o f fibril diameter. Collagen intermolecular spacing appears to be
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unchanged within fibrils in MCD corneas (Quantock et al., 1992), I can therefore 
probably assign the larger fibril diameters to the aggregation o f more molecules into 
fibrils, and even perhaps the merging o f existing fibrils, rather than the existence of 
more widely spaced collagen molecules within fibrils. Studies on the corneas of 
gene-targeted mice with a mutation o f Chst5, a murine equivalent o f CHST6 in 
humans, have reported a thin stroma and closer-than-normal collagen fibril spacing, 
but not pockets o f  abnormally large collagen fibrils in the corneal stroma (Hayashida 
et al., 2006). I reanalysed tissue blocks from Hayashida’s published study (2006) and 
after extensive searching did not find any evidence o f large diameter collagen fibrils 
in the stroma. The mouse cornea, however, contains KS GAG chains that are less 
sulphated than those in human cornea (Young et al., 2005), so perhaps the lack o f KS 
sulphotransferase activity in the Chst5-null mouse has less o f an impact on collagen 
fibril diameter because o f  the lower need for sulphated KS GAG in the cornea o f this 
species.
The low levels o f  sulphated KS GAG in the mouse cornea have been attributed to the 
thinness o f the cornea, into which oxygen readily diffuses to all layers o f the stroma 
(Scott and Bosworth, 1990). It was postulated by Scott and colleagues however, that 
proportionally higher levels o f  sulphated KS GAG found in the deeper layers o f the 
thicker corneas o f  larger animals is a direct consequence o f the restricted oxygen 
supply, and that KS GAG acts as a “stand-in” for CS/DS GAG in conditions o f 
oxygen lack (Scott and Haigh, 1988b; Scott, 1991a; Scott, 1994). This concept has 
support in other tissues such as articular cartilage, in which a similarly increased 
prevalence o f  KS GAG is seen in thicker cartilages with a greater abundance in 
deeper layers (Stockwell and Scott, 1965; Stockwell, 1991). KS GAG is not found in 
sulphated form in the stroma in MCD I (Thonar et al., 1986; Klintworth et al., 1986; 
Yang et al., 1988; Edward et al., 1988; Klintworth et al., 1997). Rather, it is present 
in unsulphated or low-sulphated form (Lewis et al., 2000; Young et al., 2007a; Saito 
et al., 2008). The current finding that structural matrix changes (i.e. reduced collagen 
fibril spacing and large-diam eter fibrils) are more prevalent in the deep stroma in 
MCD I might reflect the heightened importance o f sulphated KS PGs in this part of 
the tissue in the human cornea.
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6.2 Congenital stromal corneal dystrophy
Congenital stromal corneal dystrophy (CSCD; MIM 610048) is an autosomal 
dominant disorder causing cloudiness o f the cornea, and like other dystrophies, 
affects only the cornea without any association with secondary or systemic disease 
(Klintworth, 2009). CSCD is a very rare disease found only in three families of 
Norway, French and Belgium origin (Odland, 1968; Berdrup et al., 2005, Turpin et 
al., 1939; W itschel et al., 1978; Van Ginderdeuren et al., 2002). The disorder is 
caused by frame shift m utation in the DCN gene (c. 967delT or c. 941delC) localised 
on chromosome 12q22 that leads to truncation o f the C-terminal o f decorin protein 
(Bredrup et al., 2005; Rodahl et al., 2006). On clinical examination small flaky or 
feathery opacities are visible throughout the stroma from birth after when the opacity 
progresses. There are only four congenital dystrophies and CSCD is the only one 
with affected stroma. The other three are: congenital hereditary endothelial 
dystrophy, polym orphous dystrophy and posterior amorphous comeal dystrophy and 
they manifest defects in endothelial functions. In CSCD, opacities are probably 
visible in the electron microscope as layers o f amorphous material between the 
lamellae. I used an enzyme digestion to establish the character o f accumulated 
material.
6.2.1 Case report and methods
Comeal button biopsies were obtained from the Norwegian patient who underwent a 
penetrating keratoplasty. Immediately after dissection, the comeal button was frozen 
and stored in liquid nitrogen until use. One CSCD comeal piece and one sclera piece 
were pre-fixed in 4%  parformaldehyde in Tris/sodium acetate buffer (pH 7.2) to 
prevent swelling during period o f  incubation with an enzyme. Then the tissue was 
incubated in 2.5 U/ml chondroitinase ABC from Proteus vulgaris for 4 hours at 37°C 
to remove the chondroitin GAG chains. CSCD comeal biopsies and normal human 
scleral biopsies, with and without enzyme treatment, were fixed overnight in 2.5% 
glutaraldehyde in 25mM  sodium acetate buffer, pH 5.7, containing 0.1M magnesium 
chloride and 0.05% cuprolinic blue to stain sulphated GAG chains. The tissue was 
then dehydrated and embedded in Araldite resin. Sections were cut on a glass knife
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and picked upon copper grids were stained with 1% phosphotungsitc acid and 
saturated uranyl acetate solution. Scleral biopsies as a control for the enzyme activity 
and CSCD comeal biopsies were examined by transmission electron microscopy 
(JEM -1010; JEOL, Tokyo, Japan) equipped with an 11-megapixel CCD camera 
(Orius SC 1000 CCD camera; Gatan Ltd., UK, Cambridge, UK).
6.2.2 Results
Scleral extracellular matrix contains mainly aggrecan, biglycan and dermatan that 
carry chondroitin and/or dermatan sulphate chain (Young, 1985; Rada et al., 1997). 
This makes the sclera a good model for testing the activity o f chondroitinase ABC, 
an enzyme w hich cleaves CS and DS chains. In this study nearly 100% o f visible 
cuprolinic blue stained GAG chains were removed by chondroitinase ABC (Figure 
6.9); this confirms high enzyme activity and justifies the use o f this particular 
protocol for enzymatic removal o f CS/DS.
Figure 6.9 Transm ission electron micrographs o f the human sclera before (left) and after (right) 
chondroitinase ABC digestion. Arrows show cuprolinic blue stained GAG chains visible before 
enzyme digestion, and a lack o f  them after digestion which confirms chodroitinase ABC to be 
active as used in my digestion protocol. M agnification x20k, calibration bar =100nm and applies 
to both pictures.
CSCD matrix ultrastructure examined under the transmission electron microscope 
was severely disorganised, with break zones in-between and within lamellae. In the 
gap zones there are clearly visible filaments stained with cuprolinic blue, pointing to 
the presence o f sulphated GAG chains (Figure 6.10).
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Figure 6.10 Transm ission electron microscope o f CSCD cornea. In the break in between the 
lam ellae there are visible GAG filaments. Calibration bar=300nm.
After an enzymatic digestion with chondroitinase ABC, the small filaments in- 
between lamellae are no longer visible (Figure 6.11) suggesting that visible material 
in the gap area is a high sulphated CS/DS structure, presumably linked to abnormal 
decorin. Disruption in the structure o f the stroma is clearly noticeable.
Figure 6.11 Electron m icroscope micrographs o f the CSCD cornea treated with chondroitinase 
ABC to remove CS and DS GAG chains. Disrupted structure o f the stroma is visible but there 
are no visible filam ents in the gap area between lamellae.
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6.2.3 Discussion
Decorin is a small extracellular matrix proteoglycan with a single CS/DS GAG chain 
attached to a serine residue near the N terminus (Chopra et al., 1985). A core protein 
o f decorin contains 12 leucine-rich-repeates flanked by cysteine rich capping 
domains whose role is to stabilise the protein (McEwan et al., 2006). This area would 
not be affected by the C-terminal decorin truncation found in CSCD. However, at the 
C-terminal region there is a unique capping m otif called the “ear repeat” . Extended 
leucine-rich region folds and disulfide bonds are established between Cys 284 and 
Cys 317 (Scott et al., 2004). Deletion o f 33-C terminal amino acids in decorin core 
protein in CSCD is likely to disrupt this disulfide bond between cysteins which 
changes the protein structure. In my study I showed that filaments visible in electron 
micrographs in the break between lamellae are CS/DS GAG chains, which suggest 
the presence o f  decorin in this area. Truncated decorin caused by a mutation present 
in CSCD has an ear repeat m otif which is disrupted, and this is most likely to be 
responsible for the susceptibility o f this protein to aggregation. In the affected 
cornea, it is likely that decorin accumulates in the space between lamellae and even 
creates aggregates o f  protein which contributes to the disrupted structure and opacity 
o f the cornea.
6.3 Sly syndrome -  mucopolysaccharidosis VII
M ucopolysaccharidosis VII (MIM253220) was first described by Sly in 1973. It is an 
autosomal recesive disorder caused by the malfunction o f (3-glucuronidase enzyme 
leading to storage o f  heparan, dermatan and chondroitin sulphate in lysosomes (Sly 
et al., 1973). The disorder is manifested by slow and abnormal postnatal growth, 
mental problem s and learning difficulties, deafness, upper airway obstruction, 
corneal clouding, and heart problems (Lorincz, 1978). Comeal opacification that 
resembles ground glass is a characteristic feature for MPS type I, IV and VI (Gosh 
and M cCulloch, 1974; Haskins et al. 1980 and 1984; Chan et al., 1982; Klintworth, 
1994; Spencer, 1996) but occurs in MPSVII only in the patient with more severe 
forms o f  the disease (Sugar, 1997; Bergwerk et al., 2000).
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To date, various M PSs have been found or have been implemented into animal 
m odels o f  the disease. There are canine (Haskins et al., 1984; Ray et al., 1998; 
Silverstein Dombrowski, 2004), feline (Gitzelmann et al., 1994; Fyfe et al., 1999) 
and the m ost com mon murine models (Birkenmeier et al., 1989; Kyle et al., 1990; 
Sands and Birkenmeier, 1993; Gwynn et al., 1998; Sly et al., 2001, Vogler et al., 
2001; Tomatsu et al., 2003) available for studies o f  MPS and for testing possible 
cures. Bone marrow  transplant and enzyme replacement therapies are often used 
(Sands et al., 1993, 1994 and 1997a; Vogler et al., 1999 and 2005) and the most 
recent and most prom ising gene therapy is being also tested (Sands et al., 1997b; 
Kamata et al., 2001 and 2003; Grubb et al., 2010).
High magnification structural corneal studies have been carried on the tissue o f 
Scheie’s (MPS I-S), H urler (MPS I-H), Morquios (MPS IV) and Sanfilippo (MPS 
III) syndrome (Tabone et al., 1978; Zabel et al., 1989; Quantock et al., 1993a; 
Rummelt et al., 1992; H uang et al., 1996; Rawe et al., 1997; Alroy et al., 1999) but 
never Sly syndrome. Here, I undertook the first transmission electron microscope 
examination o f high m agnification corneal stroma o f human MPS VII and present 
fibril diameter m easurem ents from different depths o f the stroma.
6.3.1 Case report and methods
A 12 years old boy suffering from MPS VII underwent penetrating keratoplasty in 
hospital in Prague to graft his opaque cornea. Tissue was then immediately fixed in 
2% paraformaldehyde and 2.5%  glutaraldehyde 1:1 mix, followed by post-fixation 
for 1 hour each in 1% aqueous osmium tetroxide and 0.5% aqueous uranyl acetate. 
Tissue was then dehydrated through an ascending series o f  ethanol, immersed in 
propylene oxide, and em bedded in Araldite CY212 epoxy resin. Ultrathin sections 
were cut with a diam ond knife on a Leica UC6 ultramicrotome, picked up on 
uncoated copper grids, contrasted with saturated uranyl acetate and Reynold’s lead 
citrate, and imaged on transm ission electron microscope (JEM-1010; JEOL, Tokyo, 
Japan) equipped with an 11-megapixel CCD camera (Orius SC 1000 CCD camera; 
Gatan Ltd., UK, Cambridge, UK)
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Fibril diameter was measured using ImgageJ software. Pixel length was calibrated 
against the scale bar on the micrograph. Each fibril was individually measured across 
the shortest diameter o f  the fibril to eliminate the possibility o f measuring an oblique 
fibril’s surface.
6.3.2 Results
Parallel work within my group showed that the CB stained Sly syndrome cornea 
manifests the most significant change in morphology by the presence o f keratocytes 
with enlarged vacuoles filled with PGs and abnormally large PG filaments between 
the collagen fibrils in the stroma (Figure 6.12).
Figure 6.12 Transm ission electron micrograph o f a keratocyte in the Sly syndrome cornea with 
visibly enlarged vacuoles filled with PG (A) and enlarged filaments o f PG amongst collagen  
fibrils (B). Image courtesy o f  Dr Rob Young.
I prepared osmium tetroxide stained conreal biopsy, to search for differences in size 
and arrangement o f  the collagen fibrils. Cross-sectional, high-magnification 
micrographs were inspected and collagen fibrils seemed to be regularly packed, 
although fibrils are not o f a uniform diameter. Small and large collagen fibrils are 
visible across the corneal stroma, and abnornal diameter fibrils are localised mostly 
in the mid and posterior part o f the stroma. In the normal cornea, fibril diameter has 
previously been measured in the range 19.7nm to 33.4nm (Quantock et al., 1993a). 
Measurements o f  the collagen fibrils in Sly syndrome cornea at different depths 
show a broader range o f  collagen fibrils in comparison with the normal cornea. Fibril 
diameter in the anterior stroma (n=681) is measured between 13.6nm and 32.2nm, in 
a mid stroma (n=1026) between 12.7nm and 41.6nm, and in the posterior stroma
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(n=1136) between 16.6nm and 38.8nm (Figure 6.13). A one-sample Kolmogorov- 
Smim ov test shows that none o f the fibril diameter distributions are normal at all 
stromal depths (anterior p<0.03, mid p<0.01, posterior p<0.01). In the anterior 
stroma a spectrum o f  collagen fibril diameters is not as broad as in the mid and 
posterior stroma, but is still significantly different from the normal cornea.
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Figure 6.13 Transm ission electron m icrographs o f  the outer, mid and deep corneal stroma in Sly 
syndrom e with different sized collagen fibrils visible. Histograms represent fibril diameter 
m easurem ents (n=2843) in all three parts o f  the stroma. Calibration bars=100nm.
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6.3.3 Discussion
Sly syndrome, as with the other MPSs, is a serious systemic disease and the ocular 
disease is only one o f  a multitude o f symptoms. However, it does provide us with a 
good model to study transparency and the role o f proteoglycans. Fully functional 
P-glucuronidase enzyme degrades gycosaminoglycans (heparan, decorin, 
chondroitin) by removing p-glucoronosyl residues at the non reducing end of 
oligosaccharides (Levvy, 1953; Tomino et al., 1975). To date, 49 unique mutations 
have been found in GUS (Tomatsu 2009) which is a gene coding p-glucuronidase 
(GUS, EC 3.2.1.31, GUSB) located on chromosome arm 7 (Speleman et al., 1996). 
This mutation causes disease both in human and animal models.
This corneal ultrastructural study showed the presence o f collagen fibrils o f variable 
diameter throughout the stroma, but the arrangement o f the fibrils seems to be close 
to normal. M ore severe changes are noticeable in the mid and posterior part o f the 
cornea. M easured fibril diameter is in the range 12.7nm -  41.6nm which means, that 
there are smaller and larger fibrils in comparison to the normal human cornea, which 
have a mean value o f  collagen fibril diameter o f 26.4nm (SD±2.6nm). Fibril 
diam eter’s values are similar to the ones reported in the MPS I-H (Hurler syndrome) 
where the fibril diameters range from 12.5nm to 50.1nm (Huang et al., 1996). 
Interestingly, in MPS I-S (Scheie’s syndrome) and in MPS IV (Morquio syndrome) 
only fibrils o f  a larger diameter than normal have been reported, being 19.9nm to 
52.0nm (Quantock et al., 1993a) and 30-42nm (Rawe et al., 1997), respectively. The 
presence o f  collagen fibrils with reduced diameter in Sly syndrome might be caused 
by the accum ulation o f  decorin core protein in the stroma. Inhibition o f  collagen 
fibril growth by decorin has been reported (Vogel et al., 1984; Brown and Vogel, 
1989; Rada et al., 1993). Enlarged collagen fibril diameter resembles fibrils found in 
corneas o f  KS knock-out mice (Chakravarti et al., 2000). I can only speculate that an 
abundance o f  accumulated CS and DS may suppress the biosynthesis o f KS. After 
all, suppression o f sulphated KS in MCD I occurs in parallel with oversuphation o f 
CS/DS (M eek et al., 1989; Nakazawa et al., 1984; Plass et al., 2001), possibly via 
some yet to be defined feedback mechanism. A lack o f KS leads to the production o f 
thick fibrils (Birk et al., 1981). Maybe there is a suppression mechanism in the
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cornea. A compensation mechanism is already known when lack o f decorin triggers 
an increased synthesis o f biglycan (Zhang et al., 2009). That said, in MPS IV, where 
KS is accumulated, large diameter fibrils are reported (Rawe et al., 1997). Or, maybe 
malfunction in the PG ’s turnover means that even newly biosynthesised, fully 
functional proteoglycan cannot regulate fibrils sizes. More investigation is needed, 
however, to fully elucidate the molecular mechanisms and functional relationships.
The main cause o f the corneal opacities in MPS remains GAG chain accumulation in 
the vacuoles o f  keratocytes (Mollard et al., 1996). Migration o f the keratocytes with 
deposits o f GAGs can even cause the reoccurrence o f the cloudiness in the 
transplanted corneal graft (Schwartz et al., 1985; Aguirre et al., 1992). However, 
there are many structural changes o f the cornea reported in various 
mucopolisaccharidosis, including increased mean collagen fibril diameter, altered 
fibril spacing and irregular packing (Alroy et al., 1999; Huang et al., 1996; Quantock 
et al., 1993a; Rawe et al., 1997; Rummelt et al., 1992; Tabone et al., 1978; Zabel et 
al., 1989). It has been also reported that MPS II, MPS IIIA and MPS IIIB corneas are 
not cloudy even when corneal epithelium, keratocytes and endothelial cells contain 
storage material (Topping et al., 1971; Del Monte et al., 1983; Lavery et al., 1983; 
Alroy et al., 1992). Another evidence for the importance o f the ultrastructure is the 
fact that in adenovirus mediated gene therapy, which removes storage in lysosomes, 
lamellae disruption shows improvement only if  treatment is in neonatal period, not in 
adulthood (Kamata et al., 2001).
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Chapter Seven 
7 Concluding remarks
The aim o f this thesis has been to analyse the structure o f the corneal stroma during 
development and in disease and to investigate how the change in the structure, 
mainly in relation to the changes in proteoglycans structure and localisation, affects 
the transparency o f the tissue.
7.1 Chapter Three
The aim was to test the hypothesis that a developing cornea transmits light to varying 
degrees and that this is due to changes in the structure.
I quantified the level o f transparency in late stages o f chick development (E l2 -E l 8) 
by measuring the spectrum o f light transmitted through the centre o f  the cornea. In 
the first light transmission study, Coulombre and Coulombre reported 39% 
transmission o f incident white light at E l2 increasing to 95% at E20 (Coulombre and 
Coulombre, 1958a). My data concur with these measurements using a 700nm 
wavelength, where transmission increases from 35% at E l2 to 81% at E l8. At 
shorter wavelengths the light transmission is lower. For example, at 500nm 
wavelength, transm ission reaches only 73% at E l 8 which is caused by higher 
scattering in the blue light. Significant increase in the light transmission irrespective 
o f the wavelength occurs after E l 4.
The wavelength-transmission dependency at E l 8 exhibits an inverse-square 
relationship that matches the model o f a swollen human cornea (Farrell et al., 1973). 
Cytochrom c is responsible for the loss o f transmission at some wavelengths. 
However, the biggest impact on transparency arises from presence o f breaks in the 
integrity o f the stroma (Benedek, 1971), from changes in fibril interspacing and 
arrangement and from imbalance o f  refractive indices between collagen fibrils and 
extrafibrillar substance (Hart and Farrell, 1969; Freund et al., 1986; Meek et al., 
2003b). Variation in light transmission is considered to be the result o f structural
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changes and is presented in the panel o f electron micrographs in Figure 3.7. To trace 
in detail those changes, an in-depth study o f collagen fibril arrangement, as well as 
content and location o f  proteoglycans during chick corneal development, were 
undertaken and are described in Chapters Four and Five.
An im portant lim itation o f  the technique used to quantify transmission is that the 
m easurem ents w ere taken from dissected tissue. The lack o f  intraocular pressure 
could have caused structural changes in the lamellae organisation which could have 
affected the transm ission. For that reason, a new method o f measurement should be 
developed. A nother factor that could have affected the final result is that the 
refractive index ratio betw een the collagen fibrils and the extracellular matrix for 
each o f  the developm ental stages is not known.
7.2 Chapter 4
The aim w as to test the hypothesis that collagen spacing changes with depth and 
laterally during com eal developm ent.
I presented spatial and tem poral alterations in the collagen fibril arrangement in the 
chick strom a during the second stage o f  compaction (E l 5-El 8) using small angle X- 
ray diffraction. A ssem bly o f  the collagen fibrils, thinning o f  the cornea and changes 
in collagen fibril spacing w ithin the lamellae have been extensively studied in the 
past (Hay and Revel, 1969; Conrad, 1970; Trelstad and Coulombre, 1971; Quantock 
et al., 1998; M eek and Quantock, 2001). However, I am the first to present the 
com prehensive study o f  structural changes during chick development that includes 
the collagen interfibrillar spacing across the cornea from centre to periphery, taken 
across the w hole depth o f  the stroma.
The study show ed that the collagen fibril spacing, while taken as an average across 
the w hole depth o f  the stroma, decreases across the whole extent o f the cornea 
between E14 and E l 8. However, the difference between the central and peripheral 
region in each stage is not constant. In the centre o f  the cornea, in each 
developm ental day, collagen fibril spacing is smaller than in the periphery. This 
difference decreases w ith development and is 17% at E14 and only 7% at E l8. The
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possible cause o f  this change is the development o f corneal curvature which causes a 
decrease o f  collagen fibril spacing in the limbal area. This is exhibited as a smaller 
difference between the central and peripheral collagen interspacing.
The result o f  the in-depth micro scan showed that at E l 5 the comeal stroma is 
slightly m ore com pact in the near endothelial part. E l6 brings further collagen 
interspacing reduction in the posterior stroma. At E l7 compaction slows in the 
posterior strom a but fibril spacing close to the epithelium starts rapidly decreasing. 
This variation in collagen fibril spacing with depth is thought to be a result o f a non- 
uniform distribution o f  proteoglycans in the stromal matrix. The two repeats o f the 
in-depth scan confirm ed the heterogeneous nature o f  collagen spacing and changes 
occurring w ithin the depth during development. However, to an extent, the results are 
ambiguous. A trend can be seen in the differences in compaction; however, more 
repeats are needed before a final conclusion can be drawn.
7.3 Chapter Five
The aim was to test the hypothesis that localisation o f proteoglycans (CS/DS) 
changes within the depth o f  the com eal stroma during development and that the 
appearance o f  the m ain two types o f  PGs differs.
It is known that KS PG s are m ainly accumulated in the anterior part o f the cornea 
(especially highly sulphated KS) and that the distribution becomes more uniformly 
spread across the strom a by day 18 (Young et al., 2007b; Gealy et al., 2007). While 
KS is spreading from  the anterior to the posterior manner, CS/DS is first 
accumulated in the posterior part near day 12-14 o f  development and then spreads 
towards the epithelium . This was described in Chapter Five during the 
im munofluorescence m icroscopy experiment. These investigations o f two different 
kinds o f  PGs localised at the opposite sides o f  the comeal stroma, and then spreading 
uniformly across the corneal depth, show that it happens simultaneously with change 
in the interfibrillar spacing o f  the stroma.
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The transm ission electron microscopy experiment described in Chapter Five 
concentrated mainly on the temporal changes in the type o f PGs present in the 
developing stroma and on the structural changes between those two groups. From 
micrographs, there are usually two types o f filament visible. In one group, the PGs 
are small and associated with the collagen fibril surface. In the other group, larger 
(approxim ately 65-100nm ) filaments extend along collagen fibrils or out into the 
matrix, connecting w ith adjacent fibrils.
In this experim ent, quarters o f the cornea (E l2 -E l8) were incubated with 
chondroitinase ABC. This procedure removed all PGs with large filaments in all 
stages o f  developm ent, indicating that they are CS/DS PGs. The number o f small 
filaments o f  KS on the surface o f  collagen fibrils which remain after enzymatic 
digestion increased between E l2 and E l 8. This is probably the result o f PGs 
accumulation (Anseth, 1961) and increase in KS chains sulphation during 
development (N akazaw a et al., 1995; Liles et al., 2010). Sulphation o f the CS/DS 
also changes with developm ent (Zhang et al., 2005) indicating that sulphation may 
play a role in the fine tuning o f  the stromal structure and therefore the transparency 
of the cornea. Unfortunately, the nature o f the antibodies used for 
im munohistochemistry does not distinguish between different sulphation patterns. To 
fully understand the changes in CS/DS distribution, a different type o f antibodies has 
to be used and the m ethod o f  quantification o f the PG in the various layers o f cornea 
has to be studied.
7.4 Chapter 6
The aim was to test the hypothesis that changes in the proteoglycan structure is 
associated w ith structural abnormalities in human diseases.
A useful model o f  w hat happens in the absence o f sulphation in KS PGs is macular 
corneal dystrophy (described in Chapter Six). A mutation in a gene, CHST6, results 
in the absence o f  sulfotransferase responsible for the production o f  mature sulphated 
KS-GAGs (A kam a et al., 2000). This is the only difference between the healthy 
individual and the one suffering from MCD. It leads to structural changes in the
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corneal stroma, m ainly thinning (Ehlers and Bramsen, 1978), a decrease in collagen 
fibril spacing (M eek et al., 1989; Quantock et al., 1990), and finally a loss of 
transparency. I showed the presence o f unusually large collagen fibrils in the 
posterior stroma o f  corneas o f  two MCD patients. This can indicate a role for the 
GAG side chain o f  KS in the regulation o f fibril. Additionally, an in-depth small 
angle X-ray diffraction experim ent showed non-uniform collagen fibril spacing 
across MCD I cornea. The decrease in a fibril interspacing was more prevalent in the 
deep stroma which, taking into consideration the presence o f large fibrils, suggests 
the heightened im portance o f  sulphated KS in this part o f human cornea.
Another human dystrophy with a PG defect that manifests in loss o f a transparency, 
presented in Chapter Six, is congenital stromal corneal dystrophy. In this disorder, a 
C-terminal o f a core protein o f  decorin is truncated which changes a protein structure 
and most likely causes susceptibility o f decorin protein to aggregation. In this study, 
I showed, by exposing a tissue’s biopsy to an activity o f chondroitinase ABC, that 
filaments which are visible in electron micrographs in the break between lamellae are 
the CS/DS GAG chains. After the treatment, all filaments disappeared suggesting the 
presence o f decorin in this area, which most likely contributes to the disrupted 
structure and opacification o f  the cornea.
A final example o f  the cornea, in which structural changes arise from malfunction in 
PGs turnover, is Sly syndrome. This systemic disease fails to synthesise an enzyme 
responsible for catalysis o f  heparan, decorin and chondroitin GAG chains. I showed 
that collagen fibrils o f  variable diameter are present throughout the stroma. Fibril 
diameter ranged betw een 12.7nm-41.6nm with significantly smaller than normal 
fibrils present in the anterior stroma. However, most abnormal fibrils occurred in the 
mid and posterior part o f  the stroma. I can only speculate that accumulation of 
CS/DS may inhibit collagen fibril diameter. Sly syndrome is a very rare disease and 
the present study introduces the abnormal structure o f the fibrils in the stroma and is 
only the foundation to understand the role o f PGs.
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7.5 Wider implications and further work
The research presented in this thesis helps to further the understanding o f corneal 
development and structure. The knowledge o f the function o f proteoglycans in 
determining the structure o f  the cornea is pivotal for an attempt to create a fully 
functional artificial cornea. Such advances give hope to many patients awaiting 
corneal transplant to improve their vision.
More investigation is needed to fully understand the role o f PGs, and CS/DS in 
particular, in the cornea. M ore research is needed to develop antibodies that 
recognise different epitops and sulphation motifs in the chick tissue. To quantify the 
amount o f  PG in different part o f  the stroma, three dimensional models o f collagen- 
PG interactions need to be build. Only then, there is a possibility to distinguish with 
certainty between small KS filaments and larger CS/DS filaments. A method has to 
be developed to separate the particular layers o f the cornea in order that 
quantification m ethods, such as ELISA, could be applied .In addition, to improve the 
transparency m easurem ents, it would be useful to find a way to separate and then to 
estimate the im pact factor o f  each o f the contributors for transmission loss.
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D ifferential R elative Sulfation o f Keratan Sulfate 
G lycosam inoglycan in  the Chick Cornea during 
Em bryonic D evelopm ent
Melody Liles,1 Barbara P. Palka,1 Anthony Harris2 Briedgeen Kerr,2 Clare Hughes,2 
Robert D. Young, 1 Keith M. Meek,1 Bruce Caterson 2 and Andrew J. Quantock1
P u r p o s e . T o  investigate structural remodeling of the develop­
ing corneal stroma concomitant with changing sulfation pat­
terns of keratan sulfate (KS) glycosaminoglycan (GAG) 
epitopes during embryogenesis and the onset of corneal trans­
parency.
M e t h o d s . Developing chick corneas were obtained from em­
bryonic day (E)12 to E18 of incubation. Extracellular matrix 
composition and collagen fibril spacing were evaluated by 
synchrotron x-ray diffraction, hydroxyproline assay, ELISA 
(with antibodies against lesser and more highly sulfated KS), 
and transmission electron microscopy with specific proteogly­
can staining.
R e s u l t s . A  significant relative increase in highly sulfated KS 
epitope labeling occurred with respect to hydroxyproline con­
tent in the final week of chick development, as mean collagen 
interfibrillar distance decreased. Small KS PG filaments in­
creased in frequency with development and were predomi­
nantly fibril associated.
C o n c l u s io n s .  The accumulation of highly sulfated KS during the 
El 2 to E18 timeframe could serve to fine tune local matrix hydra­
tion and collagen fibril spacing during comeal growth, as gross 
dehydration and compaction of the stroma progress through the 
action of the nascent endothelial pump. (Invest Ophthalmol Vis 
Sci. 2010;51:1365-1372) D01:10.1l67/iovs.09-4004
The cornea is a connective tissue with remarkable transpar­ency that forms the primary refractive surface of the eye; 
yet, how this property arises in development remains little 
understood. The most widely studied model of corneal devel­
opment is that of the embryonic chicken.1,2 In this tissue, 
uniformly thin collagen fibrils are laid down by stromal fibro­
blasts in a secondary stroma and consolidate as a series of 
orthogonal fibril bundles that later form into lamellae.3 At
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embryonic day (E)14, the chick cornea transmits only approx­
imately 40% of white light, but then begins to increase in 
transparency so that, at E19, transmission is more than 95%, 
similar to the adult condition.4 The transparency increase after 
E14 is accompanied by significant dehydration of the cornea, 
flattening of keratocytes, and compaction of stromal collagen 
fibrils into a spatially ordered array.5,6 This restructuring of the 
stroma is key for the acquisition of comeal transparency.7,8
Small leucine-rich proteoglycans (PGs) interact with colla­
gen fibrils in the comeal stroma and are thought to help 
control fibril size and spatial organization.9 PGs are composed 
of a core protein covalently bound to sulfated glycosaminogly­
can (GAG) side chains. The major GAG in the cornea is keratan 
sulfate (KS), and three types of PG bear these side chains: 
lumican,10 keratocan,11 and mimecan (or osteoglycin).12 By 
El8, in the chick stroma KS PGs bear two to three GAG chains 
of approximately 15 kDa each,13 and the PGs lumican and 
keratocan have three of five potential linkage sites variably 
substituted with KS GAGs.14 Collagen-PG interactions are 
thought to occur via the PG core protein, with sulfated GAG 
chains extending into the interfibrillar space, where they con­
fer stromal water-binding and sorptive tendencies that help 
define the hydrophilicity and swelling properties, and thus the 
ultrastructure, of the stromal matrix.15
Comeal PGs, especially those carrying KS chains, fulfill an 
important role in the establishment of a properly formed 
stroma during corneal embryogenesis.16 The importance of 
these molecules is illustrated by the fact that the corruption of 
sulfate motifs on KS is associated with structural matrix alter­
ations in the corneas of humans with the inherited disease 
macular comeal dystrophy17,18 and in the corneas of mice with 
gene-targeted deletions in lumican19,20 or Chst5, a KS sulfo- 
transferase enzyme.21 Some investigators have reported the 
accumulation of KS GAGs and KS PGs during embryonic de­
velopment.22"25 Molecular studies have shown that levels of 
mRNA for keratocan, first expressed at E6,26 exhibit a steady 
decline from E9 to E18, whereas, over the same time period, 
lumican mRNA levels remain several-fold higher.27 Moreover, 
an approximate threefold increase in lumican core protein 
occurs between E7 and E9,28 with a two- to threefold increase 
in mRNA for /3-1,4-galactosyltransferase, an enzyme involved in 
sulfated KS synthesis, reported between E8 and El3.29 Bio­
chemical analyses have also shown that KS is synthesized by 
the chick cornea between E5 and E7, but that it only becomes 
highly sulfated by E l4,30 with another study indicating a 
switch in the production of unsulfated to sulfated KS between 
E12 and E15.28
The current investigation was designed to test the hypoth­
esis that sulfation of KS provides an environment of hydration 
conducive to the deposition of collagen fibrils and the estab­
lishment of a highly ordered stromal matrix in the developing 
chick. To this end, experiments were conducted to quantify
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c o l la g e n  b io s y n th e s i s ,  K S s u l f a t i o n  s t a t u s ,  c o l l a g e n  f ib r i l  s p a c ­
in g , a n d  c o lla g e n -K S  P G  a s s o c i a t i o n s  d u r i n g  t h e  l a t t e r  s t a g e s  o f  
c h ic k  c o r n e a l  m o r p h o g e n e s i s .
M e t h o d s
Specimens
For x-ray d iffraction  a n d  b io c h e m ica l s tu d ie s , a  s e r ie s  o f  6 9  em b ry o n ic  
ch ick  co rn eas  w as o b ta in e d  th a t  c o m p r is e d  da ily  in c re m e n ta l s tages  
from  E l2 to  E l8. C o rn eas  w e re  e x c ise d  b y  a n  in c is io n  a ro u n d  th e  
lim bus in eyes  o f  em b ry o n ic  c h ic k s  o b ta in e d  fro m  H am burger-H am il- 
to n  (H H >staged, fe rtilized  eggs  c o lle c te d  fro m  a c o m m e rc ia l h a tc h e ry  
(Hy-Line UK, W arw ick sh ire , UK) a p p ro x im a te ly  2 h o u rs  e ar lie r, w h e re  
E l2 =  HH38, E l3 =  H H 39, E l l  =  H H 40, E15 =  H H 41, E l6  =  H H 42, 
E17 =  HH43 and E18 = H H 44. Im m ed ia te ly  o n  e x c is io n , th e  c o rn e a s  
w ere  san d w ich ed  b e tw e e n  layers  o f  c ling film  to  m in im ize  d e h y d ra tio n  
and  w e re  p laced  on  d ry  ice. F ro zen  c o rn e a s  w e re  t ra n s fe r re d  to  —80°C  
sto rage  until th e  s y n c h ro tro n  x-ray  d iff ra c tio n  e x p e r im e n ts  c o u ld  b e  
co n d u c ted . For e le c tro n  m ic ro sc o p y , a sm a lle r  g ro u p  o f  fe rtilized  eggs 
(H enry  S tew art & Co. Ltd., L ou th , L in co ln sh ire , U K ) w a s  in c u b a te d  at 
37°C until stag ing  an d  e x c is io n . All w o rk  w a s  c o n d u c te d  in  a c c o rd a n c e  
w ith  th e  ARVO S ta tem en t fo r th e  U se o f  A n im als in  O p h th a lm ic  an d  
Vision R esearch, as w ell as w ith  loca l e th ic s  g u id e lin e s .
Synchrotron X-Ray Diffraction
Individual co rn eas  (w =  69), still s e c u re d  in  c lin g  film , w e re  p o s it io n e d  
in a sealed sp ec im en  h o ld e r  b e tw e e n  s h e e ts  o f  x -ray -tran sp a re n t m ylar 
w h e re  they  w e re  a llo w ed  to  th a w . In  tu rn , e a c h  c o rn e a  in  = 8 -1 1  
daily from  E12 to  E18) w as th e n  p la c e d  in to  th e  p a th  o f  a fo c u s e d  (1 X 
1 m m ) m o n o ch ro m a tic  (A =  0 .1 5 4  n m ) x-ray  b e a m  o n  b e am lin e  2.1 o f  
th e  S ynchro tron  R ad iation  S ource , D a re sb u ry  L ab o ra to ry  (C h esh ire , 
UK). All co rn eas  w e re  e x p o s e d  fo r  2 m in u te s  e a c h , a n d  th e  re su ltin g  
fiber d iffraction  p a tte rn s  w e re  r e c o rd e d  o n  a  m u ltiw ire , gas p ro p o r ­
tional area d e te c to r  p la te  p o s it io n e d  8 .2 5  m  b e h in d  th e  c o rn e a . Im m e­
diately  a fte r x-ray e x p o su re , th e  c o rn e a s  w e re  re f ro z e n  a n d  tra n s p o r te d  
to  th e  h o m e lab o ra to rie s  fo r b io c h e m ic a l a n d  im m u n o c h e m ic a l analy ­
ses (d escrib ed  in th e  fo llo w in g  sec tio n s ) . D iffrac tio n  p a t te rn s  (5 1 2  X 
512 p ixe ls) w e re  analyzed  w ith  p u rp o s e -w r i t te n  s o ftw a re  (U nix-based ; 
Sun M icrosystem s, M o u n tain  V iew , CA) a n d  g ra p h ic s  a n d  s ta tis tic s  
packages (U nix; O p tim as, B othell, WA; S ta tis tica ; StatSoft, T ulsa , OK, 
Excel; M icrosoft, R ed m o n d , W A), as d e s c r ib e d  p re v io u s ly .51 T h e  p o s i­
tio n  o f  th e  first-order e q u a to ria l ( i.e ., in te rf ib r illa r)  re f le c tio n , c a lib ra ted  
to  th e  67-nm  axial D -period ic  r e p e a t  o f  c o lla g e n  in  w e t  ra t tail te n d o n , 
w as used  to  p ro v id e  a m e a su re  o f  th e  m e a n  c e n te r - to -c e n te r  co llag en  
fibril Bragg sp ac in g  as an  av erag e  th ro u g h o u t  th e  w h o le  th ic k n e ss  o f  
th e  cen tra l co rn ea . S tatistical s ig n ific a n ce  w a s  a sc e r ta in e d  by  u sing  
statistical te sts  for large d a ta  g ro u p s : o n e -w a y  ANOVA w ith  p o s t-h o c  
T ukev  HSD.
After x-ray analysis, th e  c o rn e a s  w e re  re f ro z e n  fo r  tra n s p o r ta tio n  to  
th e  ho m e  laboratory ' a n d  d ig e s ted  fo r  17 h o u rs  a t 6 0 °C  w ith  1 m g/m L  
papain  (Sigma-Aldrich, P oo le , U K ) in  0 .0 5  M so d iu m  a c e ta te  b u ffe r (pH  
5.6), co n ta in in g  0 .025  M EDTA a n d  5 mM  c y s te in e  HC1. T h e  en zy m e  
w as inactivated  at 100°C, a n d  th e  d ig e s ts  s to re d  a t — 20°C  u n til  fu r th e r  
analysis.
Hydroxyproline Assay
Papain d igests from  ind iv idua l c o rn e a s  w e re  h y d ro ly z e d  b y  u s in g  equal 
vo lum es o f  11.7 N c o n c e n tr a tio n  HC1 to  s u p e rn a ta n t a t 110°C  o v e r­
night. S pec im ens w e re  th e n  ly o p h iliz ed . D rie d  h y d ro ly z a te s  w e re  re ­
c o n stitu ted  in th e ir  s ta r tin g  v o lu m e  o f  d is tilled  w a te r  a n d  c en trifu g e d  
to  rem ove p a rticu la te  m a te ria l. H y d ro x y p ro lin e  re s id u es  w e re  assayed  
in trip lica te  as p rev io u s ly  d e s c r ib e d ,52 ag a in st k n o w n  s tan d a rd s  an d  
read a t 540 nm  a fte r 10 to  20  m in u te s  in c u b a tio n  a t 70°C . Statistical 
significance w as a sc e r ta in e d  by' u s in g  s ta tis tic a l te s ts  fo r  large data 
g roups: one-w ay ANOVA w ith  p o s t-h o c  T u k ey  HSD.
KS Quantification by Competitive ELISA
O p tim ized , c o m p e titiv e  ELISAs w e re  d ev e lo p ed  to  quantify  pen tasu l- 
fa ted  hex asacch a rid e s  an d  te tra su lfa ted  h e x asacch arid es  as th e  sm allest 
lin ea r s tru c tu re s  in  KS chains, as reco g n ized  by  th e  m onoclonal an ti­
b o d ie s  5D4 an d  1B4, re sp ec tiv e ly .55' 55 N inety-six-w ell EIA m ic ro tite r 
p la te s  (M P B iom edicals, C am bridge, UK) w e re  c o a ted  by  passive ad­
so rp tio n  w ith  a  250  ng /m L  ch o n d ro itin a se  ABC-digested bov ine  a rtic ­
u la r cartilage  ag g recan  (BAC ABC c o re )  a n tig en  in  a 20-mM sod ium  
c a rb o n a te  c o a tin g  b u ffer (pH  9 .6 ), fo r 14 h o u rs  a t 37°C. Native agg re­
c an  c o re  p ro te in  is su b s titu ted  w ith  b o th  c h o n d ro itin  su lfate (CS) a n d  
KS chains, a n d  CS w as selectively  re m o v e d  b y  ch o n d ro itin a se  d igestion  
to  leave a KS-linked c o a tin g  p ro te in . T h e  p la tes  w e re  w ash ed  w ith  Tris 
saline  azide (TSA) an d  th e  u n re a c te d  sites  b lo ck e d  w ith  th e  add ition  o f 
1% (w t/v o l)  b o v in e  seru m  a lbum in  (BSA) in  TSA. All in cuba tions  w e re  
p e rfo rm ed  fo r 1 h o u r  a t 37°C.
P apa in  d igests  from  single c o rn e a s  w e re  serially  d ilu ted  an d  al­
lo w e d  to  b in d  w ith  an  equal v o lu m e  o f  5D4 (1 :8000  d ilu tion  in  1% 
BSA/TSA) and  in c u b a ted  to  c o m p e te  against th e  BAC ABC co re . A 
s tan d a rd  cu rv e  w as g e n era ted  from  serial d ilu tio n s  o f  BAC ABC c o re /  
5D 4. T h e  p la te s  w e re  th e n  w a sh e d  w ith  TSA b e fo re  incuba tion  w ith  
a lka line  p h o s p h a ta s e -c o n ju g a te d  g o a t an ti-m ouse  an tibody  (1 :5 0 0 0  
d ilu tion ; P rom ega, M adison, W I). T h e  p la te s  w e re  again w ash ed  b e fo re  
a lka line  p h o sp h a ta se  su b stra te  (p -n itro p h en y l p h o sp h a te , 1 m g/m L ) 
w a s  a p p lie d  in  DEA b u ffe r (0 .1 2 6  mM  M gCl2, 1 M d ie th an o lam in e , pH  
c o rre c te d  to  9-8). C o lo r d ev e lo p m en t w as  q u an tified  o n  a p la te  re a d e r  
(M ultiskan  MS; Labsystem s, H elsinki, F in land) a t 405 nm , to  d e te rm in e  
th e  in h ib itio n  o f  b ind ing .
T h e  sam e s to ck  co rn ea l e x tra c ts  w e re  th e n  assayed fo r le sse r 
su lfa ted  KS by using  th e  l-B-4 m o n o c lo n a l an tibody . O p tim iza tion  o f  
co n d itio n s  e s ta b lish ed  th a t m ic ro tite r  p la te s  w e re  c o a ted  w ith  125 
n g /m L  BAC ABC co re  a n d  ELISAs p e rfo rm e d  as d e sc rib e d  above, w ith  
a 1 :4000 l-B-4 d ilu tion . S tatistical s ign ificance w as  a sce rta in ed  w ith  
sta tis tica l te s ts  fo r large da ta  g ro u p s: one-w ay  ANOVA w ith  p ost-hoc  
T u k ey  HSD.
Electron Microscopy
O n  e x cisio n , c o rn e as  from  E12 to  E18 ch ic k s  (n  =  21) w e re  p re p a re d  
fo r  e le c tro n  m ic ro sco p y , as d e sc rib e d  p rev io u s ly .21,56 A series  o f  E12 to  
E l8  c o rn e a s  w as fixed  in  2.5% g lu ta ra ld eh y d e  in  25 mM sod ium  a ce ta te  
b u ffe r  w ith  0.05%  cu p ro lin ic  b lu e  (0.1 M M gCl2; pH  5.7), to  s ta in  th e  
su lfa ted  PGs. A n o th e r series  w a s  fix ed  fo r 10 m in u tes  in  4% p ara fo r­
m a ld eh y d e  (pH  7.2). T h ese  c o rn e a s  w e re  th e n  w ash e d  tw ice  in  c h o n ­
d ro itin ase  b u ffer (50  mM  Tris, [pH  8], 60  mM  sod ium  ace ta te , an d  
0.02%  BSA) a n d  q u a rte re d . C o m e a l p ie c e s  w e re  in c u b a ted  fo r 4 h o u rs  
a t 37°C  in  ch o n d ro itin a se  b u ffer co n ta in in g  2 .5  U /m L c h o n d ro itin a se  
ABC (fro m  Proteus vulgaris; Sigm a-Aldrich) to  rem o v e  th e  c h o n ­
d ro itin - a n d  d erm atan -su lfa te  GAG ch ain s  from  th e  tissue. C o m m er­
cially  p re p a re d  p ro te a se  in h ib ito r  co ck tail fo r general u se  (Sigma- 
A ld rich ) w as  a lso ad d ed  to  1% to ta l v o lu m e  to  in h ib it en d o g en o u s  
PG -degradative  activ ity . T h e  c o n tro l c o rn e as  w e re  sim ilarly p ro c e ss e d  
in b u ffer m in u s  enzym e. T h e  sam p les  w e re  w a sh e d  in c h o n d ro itin a se  
b u ffe r (m in u s  en zy m e) b e fo re  fixa tion  a n d  s ta in ing  o vern igh t, as b e ­
fo re. All c o rn e a s  w e re  th e n  c o n tra s t e n h a n c e d  w ith  sod ium  tu n g s ta te  
a n d  d e h y d ra te d  an d  e m b e d d e d  in  A rald ite , a cco rd in g  to  s ta n d a rd  
p ro to c o ls .56 U ltra th in  sec tio n s  (~ 9 0 -n m  th ic k )  w e re  c u t o n  glass 
knives, c o lle c te d  o n  c o p p e r  grids, a n d  s ta in ed  w ith  1% aq u eo u s  phos- 
p h o tu n g s tic  acid  a n d  sa tu ra ted  aq u eo u s  u rany l ace ta te  be fo re  ex am i­
n a tio n  by  tran sm issio n  e le c tro n  m ic ro sco p y  GEM-1010; JEOL, Tokyo, 
Jap a n )  e q u ip p e d  w ith  an  11-m egapixel CCD cam era  (O rius SC1000 
CCD cam era; G atan  Ltd., UK, C am bridge, UK).
Results
Mesenchymally derived presumptive keratocytes that populate 
the developing chick cornea are responsible for establishing 
the secondary stroma by synthesizing and depositing hybrid 
collagen type I/V fibrils.1,2 Quantification of collagen as hy-
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T a b le  1. A verage A m o u n t o f  H y d ro x y p ro lin e  a n d  A v erage  C o llag en  In te rf ib rilla r  S pacing in  E m bryon ic  C hick  C orneas
E12 
(n =  8)
E13 
(n =  10)
E14 
(n =  11)
E15 
(n =  10)
E16
(ft =  11)
E17 
(w = 10)
E18
(» = 9)
H ydroxypro line, p g /m L  
C ollagen fibril
Bragg spacing, nm
4 .3 8  ±  0 .1 8  
6 0 .8  ±  0 .6 0
8 .0 6  ±  1.07 
6 3 1  ±  1.01
7 .4 3  ±  0 .4 8  
6 3 .9  ±  0 .99
17 .48  ±  1.46 
6 1 .9  ±  1.22
17.23  ±  0 .74  
59  8  ±  1.53
34 .52  ±  4.11 
57 .0  ±  0 .87
34.69 ± 1.64 
53-7 ±  0.94
Em bryonic days E12 to  E18 a re  e q u iv a le n t to  H am b u rg e r-H a m ilto n  stag es  38  to  44 o f  d e v e lo p m en t. H y d ro x y p ro lin e  m easu rem en ts  are  also 
rep resen ta tiv e  o f  to ta l co lla g en  c o n te n t  p e r  c o rn e a . D ata  a re  e x p re s s e d  as th e  m e a n  ±  SE.
droxyproline (Table 1) indicated two significant increases in 
hydroxyproline content, found betw een E l4 and E l5 (P <  
0.005) and El6 and E17 (P = 0.001). At E16 Coleman et al.37 
measured 20.7 p.g hydroxyproline per cornea and Conrad,3” 
19 5 pg. Our value of 17.23 pg/com ea at this developmental 
stage is consistent with these published values.
X-ray diffraction patterns generated by corneas at E l2 gave 
rise to collagen interfibrillar reflections that w ere consistent 
with a rather loose, hydrated network of formative lamellae 
that constitutes the tissue at this time. With development, 
interfibrillar reflections became more intense, presumably as a 
consequence of growth and the added deposition of collagen 
as fibrils, consistent with the results of the hydroxyproline 
analysis shown in Table 1. Analysis of all 69 x-ray diffraction 
patterns showed that the average center-to-center collagen 
fibril spacing from E l4 to E18 decreased as the cornea thinned 
and became more transparent (Table 1).
These collagen spacing data were highly representative of 
the comeal stroma as a whole, w ith all fibrils in the path of the 
x-ray beam (which measured approximately 1 X 1  mm) pass­
ing through the whole thickness of the cornea contributing to 
the x-ray pattern and thus the calculated values. X-ray analysis, 
however, could not identify how  the stromal matrix was 
changing at the suprafibrillar level. Electron micrographs con­
firmed the overall nature of the stromal com paction and indi­
cated, not a homogeneous coming together of widely and 
uniformly spaced fibrils with time, but rather a progressive 
coalescence of bundles of collagen fibrils in w hich the fibrils 
were already fairly well organized and packed laterally (Fig. 1). 
Based on the fundamental principles of x-ray fiber diffraction, 
the collagen-free spaces between fibril bundles, which were 
quite prevalent before E l5, did not contribute to collagen 
interfibrillar reflection. Thus, the values displayed in Table 1 
derive from collagen fibrils that are regularly spaced, whether 
they exist in bundles, as in the earlier stages that w e investi­
gated, or in stacked lamellae, as seen later in development. Our 
observations (Fig. 1), together w ith those of other investiga­
tors3,6 showed that stromal com paction during development 
entailed collagen fibril bundles coming together to form lamel­
lae, whereas x-ray data indicated that fibrils w ithin the bundles 
and lamellae are moving closer together from E14 onward.
As synchrotron x-ray diffraction is a noninvasive technique, 
the 69 corneas from which ultrastructural collagen fibril data 
were acquired (Table 1) were available for subsequent immu­
nochemical quantification of KS epitope. Data were normal­
ized to hydroxyproline content to reflect changes in lesser-
sulfated (lB4-immunoreactive) and highly sulfated (5D4- 
immunoreactive) KS epitope, relative to matrix deposition 
(Table 2). It is important to remember that these values repre­
sent relative epitope labeling between samples and that the 
nature of the antibodies used potentially allows multiple bind­
ing sites within the same GAG chain. KS values are relative to 
BAC-ABC core protein labeling equivalents.
Levels of highly sulfated KS as a proportion of hydroxypro­
line throughout the E12-to-E18 interval were consistently 
higher than corresponding amounts of the low-sulfated 
epitope. The amount of lesser-sulfated KS fluctuated between 
E12 and E18, but did not change appreciably, whereas levels of 
highly sulfated KS increased markedly. As can be seen in Table 
2, highly sulfated KS levels remained fairly steady between E13 
and E l5, after which a sharp rise occurred ([P = 0.001), such 
that by El6 the average amount had more than doubled from 
levels at E l5. Although there was a reduction subsequently, it 
is not statistically significant (P = 0.528). Examination by 
electron microscopy of corneas in the E12-to-E18 timeframe in 
which chondroitin/dermatan sulfate GAG chains had been en­
zymatically removed from the tissue revealed cuprolinic blue- 
contrasted sulfated KS PGs as small collagen fibril-associated 
filaments that increased in abundance with time.
Discrete fibril bundles coalescing into a continuous matrix 
have been observed by other investigators3 and are apparent in 
Figures 1, 2. Measurements of (1) hydroxyproline, (2) highly 
and lesser sulfated KS, and (3) collagen fibril spacing were 
performed for each of the 69 corneas examined (Tables 1, 2). 
Consequently, we can seek correlations independent of devel­
opmental day. In doing so, it is evident that a positive correla­
tion exists between hydroxyproline content and highly sul­
fated KS, as assessed by 5D4 binding (R2 = 0.682), and 
between hydroxyproline content and lesser-sulfated KS, as 
measured by 1B4 binding (R2 = 0.395), as shown in Figure 3. 
These parallel changes presumably reflect embryonic growth 
and continued matrix deposition. However, no appreciable 
correlation was found between the ratio of KS to hydroxypro­
line and collagen fibril spacing, when data from all 69 corneas 
were analyzed independent of developmental stage (Fig. 4).
D iscussion
The changing sulfation patterns of KS in the developing chick 
cornea raise several questions regarding the likely functional 
role of this molecule with respect to its sulfation status. Sulfa-
T a b le  2. T he  A verage A m o u n ts  o f  1 B4- a n d  5D 4-L abeled  KS E p ito p e  R elative to  BAC-ABC C ore  a fte r N orm aliza tion  to  H yd ro x y p ro lin e  C o n ten t 
in Em bryonic C hick  C o rn eas
E12 (if =  8) E13 (n = 10) E14 (n =  11) E15 (« =  10) E l6  (ft =  11) E17 (n = 10) E18 (n =  9)
Lesser sulfated KS (1B4-Iabeled 0 .1 2 5  ±  0 .0 4 3  0 .1 2 8  ±  0 .0 3 2  0 .1 5 3  ±  0 .0 4 6  0 .129  ±  0 .024  0 .109  ±  0 .0 1 6  0 .114  ±  0 .022  0 .118  ±  0.024
ep itope/liydroxypro li ne)
Highly sulfated KS (5D 4-labeled 0 .7 7 5  ±  0 .2 6 1  0 .9 5 8  ±  0 .1 5 2  0 .865  ±  0 .160  0 .840  ±  0.111 1 .879 ±  0 .1 6 7  1.449 ±  0 .143  1.874 ±  0 .206
ep itop e /h y d ro x y p ro lin e)
Data are  th e  m ean  ±  SE. E m b ry o n ic  days  E12 to  E18 o f  d e v e lo p m en t a re  eq u iv a len t to  H am burger-H am ilton  stages  38  to  44.
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F ig u r e  1. T ransm ission  e le c tro n  m ic ro g ra p h s  o f  d e v e lo p in g  c h ic k  c o rn e a l s trom a. T issue  c o m p a c tio n  p ro g re sse d  from  loose  b u n d les  o f  collagen 
fibrils at E12 to  a m a tu re  lam e lla r fo rm  a t E18. Scale  b a r, 1 ftm .
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F i g u r e  2 . T ransm ission  e le c tro n  m ic ro g ra p h s  o f  c h o n d ro itin a s e  d ig e sted  dev elo p in g  ch ick  c o m ea l s trom a. In c rea sed  d ep o sitio n  o f cupro lin ic  
b lu e -s ta in ed  su lfa ted  KS PG  filam en ts  o c c u r s  in  th e  E 12-E 18  tim efram e. Scale bar, 1 /xm.
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R = 0.3952 R2 = 0.6824_ 100
10 20 30  4 0  5 0  60
pm g/m l Hydroxyproline
0 10 20 30 40 50 60
pg/ml Hydroxyproline
F i g u r e  3. Correlation  o f  antibody la­
beling  in  re la tion  to  BAC-ABC core  
against hydroxypro line  con ten t (w ith­
o u t norm alization  to  hydroxyproline, 
raw  data n o t sh o w n ) for lesser {left, 
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tion of individual comeal KS chains is not homogeneous, and 
unsulfated disaccharides, which are predom inant nearer the 
linkage region, become increasingly sulfated toward the non­
reducing terminal.39 Moreover, KS chains undergo sequential 
elongation and sulfation during synthesis.40 The absence of 
sulfotransferase enzyme in human corneas with macular cor­
neal dystrophy, as in mutant corneas of C£s/5-knockout mice, 
results in an immature, truncated GAG and an atypical comeal 
phenotype.18 21 Thus, KS chain length and sulfation are dic­
tated by tissue-specific factors such as the presence of process­
ing enzymes. During chick development, galactose-transferase 
activity increases with KS biosynthesis and is maintained at an 
unusually high level in adult cells.29 The sequential mechanism 
of GAG subunit sulfation becomes apparent in the absence of 
the sulfotransferase enzyme, when neither GlcNAc nor Gal 
residues are sulfated.41 The negative charge provided by sulfa­
tion could serve to prevent KS GAG chain collapse during 
elongation and perhaps offer an explanation of the differential 
sulfation between shorter and longer KS chains. The presence 
of increasing amounts of highly sulfated KS during embryonic 
development is possibly linked to the appearance of the sulfate 
donor, 3'-phosphoadenosine-5'-phosphosulfate (PAPS).42 The 
measured elevation of 5D4 labeling at the time of increased 
fibrillogenesis and matrix compaction could be a result of PAPS 
availability facilitating increases in KS chain length and greater 
sulfation. The combination of these events could enhance 
organized stroma formation through the binding of core pro­
teins and the hydrophilic influence of sulfate groups.
A major purpose of the present study was to investigate the 
structural remodeling of the stroma in relation to changing 
sulfation patterns of constitutive KS epitope during chick cor­
neal morphogenesis. The results confirm previous synchrotron 
x-ray diffraction studies that docum ented the progressive com­
paction of comeal collagen fibrils w ith embryonic growth in 
the chick.43 '4 In the dataset examined herein, compaction 
occurred after E l4 (Table 1), w ith electron microscopy indi­
cating that the compaction happened within bundles of colla­
gen fibrils in which fibrils are already fairly well organized 
spatially (Fig. 1). The x-ray diffraction and electron microscopy
findings, when considered together, imply that collagen bun­
dles are coalescing into lamellae, whereas, at the same time, 
fibrils within bundles are becoming more closely spaced. Be­
tween El 5 and E l6, the stroma experiences a significant in­
crease in highly sulfated KS epitope that is disproportionate to 
the measured increase in hydroxyproline (Table 2). This ob­
servation is illustrative of an accelerated deposition of highly 
sulfated KS post-El5 which exceeds the anticipated in ovo 
comeal growth rate, as implied by hydroxyproline deposition. 
Thus, as the chick cornea develops and becomes transparent 
and compacted, the nature of KS antigenicity changes, with the 
highly sulfated KS fraction accumulating preferentially over 
that of the lesser-sulfated isoform and from a higher starting 
point. It seems counterintuitive to reason that negatively 
charged, highly sulfated KS GAG would accumulate as the 
stroma condenses and act as a biological driving force for tissue 
dehydration. Quite the opposite: The water-retentive proper­
ties of this hydrophilic macromolecule would be expected to 
swell the comeal matrix, rather than to aid in its compaction. 
Indeed, the current data show that the stroma was already 
undergoing compaction when the cornea, at E l5, experienced 
the first sizable increase in highly sulfated KS epitope.
This result suggests that the emergence of more highly 
sulfated KS GAG in the chick cornea as it matures in ovo is not 
a driving force correlating with the homogeneous compaction 
of collagen fibrils in the coalescing collagen bundles and de­
veloping stromal lamellae and perhaps points to the influence 
of other modulating factors that help drive the structural re­
modeling of the developing comeal stroma in the week before 
hatching.
Activity of the bicarbonate pump in the comeal endothe­
lium is critical for controlling comeal hydration and thickness 
and thus for maintaining transparency in the adult eye.45-47 It 
is also likely to be important in stromal water regulation and 
compaction in the developing cornea. However, the precise 
stage at which the endothelial pump mechanism becomes 
active is unknown. Histologic investigations have shown that 
an intact endothelial monolayer is established by E5 to E6.5 
Stromal fluid at this time is mostly immobilized by hyaluronic
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acid; later, small leucine-rich PGs, particularly KS PGs most 
likely influence the water-binding characteristics of the stroma. 
Conrad et al.,<H studying gene expression associated with 
chick comeal development, including those genes involved in 
endothelial transport, found 5- to 10-fold increases in sodium- 
potassium ATPase transporter, sodium bicarbonate trans­
porter, and carbonic anhydrase II (CA2), alongside increases in 
KS gene expression from E9 to E16. CA2 in particular, through 
increased transport of N a ' /H C 03_ and Cl-  would be ex­
pected to drive thinning of the cornea. Perhaps the accumula­
tion of oversulfated KS during this time serves to maintain local 
collagen hydration, as gross dehydration and compaction 
progress through the action of the nascent endothelial pump.
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AB STR ACT
Purpose: C o l l a g e n  f i b r i l s  i n  t h e  c o r n e a l  s t r o m a  i n  m a c u l a r  c o r n e a l  d y s t r o p h y ,  o n  a v e r a g e ,  a r e  m o r e  
c l o s e l y  s p a c e d  t h a n  i n  t h e  n o r m a l  c o r n e a .  T h i s  s t u d y  w a s  c o n d u c t e d  t o  i n v e s t i g a t e  i f  t h i s  o c c u r s  
u n i f o r m l y  a c r o s s  t h e  s t r o m a  o r  i s  m o r e  p r e v a l e n t  a t  c e r t a i n  s t r o m a l  d e p t h s .
Methods: M i c r o b e a m  s y n c h r o t r o n  X - r a y  f i b e r  d i f f r a c t i o n  p a t t e r n s  w e r e  o b t a i n e d  i n  2 5  p m  s t e p s  
a c r o s s  t h e  w h o l e  t h i c k n e s s  o f  a  t h i n  s t r i p  o f  a  m a c u l a r  c o m e a l  d y s t r o p h y  c o r n e a  o b t a i n e d  a t  k e r ­
a t o p l a s t y .  D a t a  w e r e  a n a l y z e d  f o r  m e a n  c o l l a g e n  i n t e r f i b r i l l a r  s p a c i n g  a t  a l l  p o s i t i o n s .  S e r u m  w a s  
a n a l y z e d  i m m u n o c h e m i c a l l y  t o  d e t e r m i n e  i m m u n o p h e n o t y p e ,  a n d  t r a n s m i s s i o n  e l e c t r o n  m i c r o s ­
c o p y  w a s  c a r r i e d  o u t  t o  v i s u a l i z e  s t r o m a l  u l t r a s t r u c t u r e .
Results: K e r a t a n  s u l p h a t e  w a s  n o t  d e t e c t a b l e  i n  b l o o d  s e r u m ,  c l a s s i f y i n g  t h e  d i s e a s e  a s  m a c u l a r  
c o r n e a l  d y s t r o p h y  t y p e  I .  C o l l a g e n  i n t e r f i b r i l l a r  s p a c i n g  d r o p p e d  l i n e a r l y  w i t h  s t r o m a l  d e p t h  f r o m  
t h e  a n t e r i o r  t o  p o s t e r i o r  c o r n e a ,  m e a s u r i n g  5 - 1 0 %  l e s s  i n  t h e  p o s t e r i o r  1 0 0  p m  o f  t h e  M C D  s t r o m a  
c o m p a r e d  t o  t h e  a n t e r i o r  1 0 0  p m  (p < 0 . 0 0 1 ) .  I s o l a t e d  p o c k e t s  o f  c o l l a g e n  f i b r i l s  w i t h  u n u s u a l l y  l a r g e  
d i a m e t e r s  w e r e  i d e n t i f i e d  i n  t h e  d e e p  s t r o m a .
Conclusions: C o l l a g e n  f i b r i l  s p a c i n g  i s  r e d u c e d  a n d  l a r g e - d i a m e t e r  c o l l a g e n  f i b r i l s  a r e  s e e n  i n  m a c u l a r  
c o m e a l  d y s t r o p h y  t y p e  I ,  w i t h  t h e  d e e p  s t r o m a  a f f e c t e d  m o r e .  W e  s p e c u l a t e  t h a t  t h e  u l t r a s t r u c t u r a l  
a b n o r m a l i t i e s  a r e  m o r e  p r e v a l e n t  i n  t h e  p o s t e r i o r  s t r o m a  b e c a u s e  t h e  s t r u c t u r a l  i n f l u e n c e  o f  s u l p h a t e d  
k e r a t a n  s u l p h a t e  g l y c o s a m i n o g l y c a n s / p r o t e o g l y c a n s  i s  h i g h  i n  t h i s  r e g i o n  o f  t h e  c o r n e a .
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INTRODUCTION
M a c u l a r  c o m e a l  d y s t r o p h y  ( M C D ;  M e n d e l i a n  I n h e r i ­
t a n c e  i n  M a n  ( M I M )  2 1 7 8 0 0 ) ,  a n  a u t o s o m a l  r e c e s s i v e
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d i s e a s e  c h a r a c t e r i z e d  b y  p r o g r e s s i v e  c o r n e a l  c l o u d i ­
n e s s  a n d  f o c a l  o p a c i t i e s ,  i s  c a u s e d  b y  a n  a n o m a l y  i n  
t h e  p r o d u c t i o n  o f  k e r a t a n  s u l p h a t e  ( K S )  g l y c o s a m i n o ­
g l y c a n  ( G A G ) . 1-7 T h e  c o n d i t i o n  h a s  b e e n  c a t e g o r i z e d  
i n t o  t h r e e  m a i n  i m m u n o p h e n o t y p e s  ( t y p e  I ,  t y p e  I A ,  
a n d  t y p e  I I )  b a s e d  o n  t h e  r e a c t i v i t y  o f  c o r n e a l  t i s s u e  
a n d / o r  s e r u m  t o  a  m o n o c l o n a l  a n t i b o d y  ( 5 D 4 ) ,  w h i c h  
r e c o g n i z e s  h i g h - s u l p h a t e d  K S . 8'9 S u l p h a t e d  K S ,  w h i c h  
i s  p r e s e n t  i n  t h e  c o r n e a  a n d  s e r u m  o f  n o n - a f f e c t e d
580 R I O H T I  L I N K
C ollagen  Structure in Macular Corneal Dystrophy 581
i n d i v i d u a l s ,  i s  a b s e n t  f r o m  s e r u m  a n d  c o r n e a  i n  t h e  
m a j o r i t y  o f  M C D  p a t i e n t s ,  a n d  t h e s e  a r e  c a t e g o r i z e d  a s  
M C D  t y p e  I . 10,11 A  s m a l l e r  s u b s e t  o f  p a t i e n t s  a r e  d e s i g ­
n a t e d  M C D  t y p e  I I  b e c a u s e  o f  i m m u n o d e t e c t a b l e  K S  i n  
t h e i r  s e r u m  a n d  c o r n e a . 1213 F u r t h e r  s t u d i e s  h a v e  i d e n t i ­
f i e d  M C D  t y p e  I A ,  i n  w h i c h  t h e r e  i s  n o  d e t e c t a b l e  K S  
i n  s e r a  o f  a f f e c t e d  i n d i v i d u a l s ,  b u t  5 D 4 - p o s i t i v e  s i g n a l  
i n  k e r a t o c y t e s . 14
K S  i n  c o r n e a  i s  a n  i m p o r t a n t  m a t r i x  m o l e c u l e , 15 
w h i c h  i s  b o u n d  t o  o n e  o f  t h r e e  c o r e  p r o t e i n s ,  l u m i c a n ,  
k e r a t o c a n ,  o r  m i m e c a n  a n d ,  t h u s ,  e x i s t s  a s  a  p r o t e o ­
g l y c a n  ( P G ) . 16-18 K S - P G s  b i n d  t o  c o l l a g e n  f i b r i l s  v i a  
t h e i r  c o r e  p r o t e i n s  a t  d e f i n e d  l o c a t i o n s  a l o n g  t h e  f i b r i l  
a x i s , 19-20 w i t h  t h e  h y d r o p h i l i c ,  s u l p h a t e d  G A G  c h a i n s  
o c c u p y i n g  t h e  e x t r a f i b r i l l a r  s p a c e  w h e r e  t h e y  h e l p  
d e f i n e  t h e  s w e l l i n g  p r o p e r t i e s  o f  t h e  s t r o m a  a n d  t h e  
s t r u c t u r a l  a r r a n g e m e n t  o f  t h e  c o l l a g e n  f i b r i l s . 21-24 T h e  
c o r n e a  i n  M C D  i s  t h i n n e r  t h a n  n o r m a l , 25-26 a n d  u n l i k e  i n  
o t h e r  c o n d i t i o n s ,  s u c h  a s  k e r a t o c o n u s  w h e r e  a  s l i p p a g e  
o f  l a m e l l a e  i s  s u s p e c t e d  o f  b e i n g  r e s p o n s i b l e  f o r  t h e  
r e d u c t i o n  i n  c e n t r a l  c o r n e a l  t h i c k n e s s , 27-28 t h e  c o l l a g e n  
f i b r i l s  i n  M C D  a r e  m o r e  c l o s e l y  s p a c e d  t h a n  n o r m a l . 29-30 
S y n c h r o t r o n  X - r a y  d i f f r a c t i o n  m e a s u r e m e n t s  o f  f i b r i l  
s p a c i n g  i n  M C D  c o r n e a s  r e p r e s e n t  a n  a v e r a g e  v a l u e  
t h r o u g h o u t  t h e  w h o l e  t h i c k n e s s  o f  t h e  s t r o m a . 29-30 K S ,  
h o w e v e r ,  i s  n o t  e v e n l y  d i s t r i b u t e d  t h r o u g h o u t  t h e  
c o r n e a , 31-32 s o  t o  i n v e s t i g a t e  w h e t h e r  o r  n o t  t h e  P G  
a l t e r a t i o n s  m a n i f e s t e d  i n  M C D  a r e  a s s o c i a t e d  w i t h  
l o c a t i o n - s p e c i f i c  c h a n g e s  i n  s t r o m a l  e x t r a c e l l u l a r  m a t r i x  
a r c h i t e c t u r e ,  w e  c o n d u c t e d  a  s e r i e s  o f  m i c r o b e a m  
s y n c h r o t r o n  X - r a y  d i f f r a c t i o n  e x p e r i m e n t s  a t  a  s p a t i a l  
r e s o l u t i o n  o f  2 5  ( i m  t o  a s c e r t a i n  t h e  d e p t h - d e p e n d e n t  
n a t u r e  o f  c o l l a g e n  f i b r i l  s p a c i n g  M C D .
MATERIALS AND M ETH O D S
T h e  p a t i e n t  w a s  a  5 0 - y r - o l d  f e m a l e  w i t h  b i l a t e r a l  
M C D ,  w h o  1 1  y e a r s  e a r l i e r  h a d  u n d e r g o n e  p e n e t r a t i n g  
k e r a t o p l a s t y  i n  h e r  r i g h t  e y e .  A s  w i t h  t h e  r i g h t  c o r n e a ,  
t h e  l e f t  c o r n e a  w a s  a f f e c t e d  b y  a  d i f f u s e  g r o u n d - g l a s s ­
l i k e  s t r o m a l  o p a c i t y ,  a n d  n u m e r o u s  i r r e g u l a r l y - s h a p e d  
w h i t e  p a t c h e s  t h a t  w e r e  c o n f i n e d  m a i n l y  t o  t h e  d e e p  
p a r t  o f  t h e  s t r o m a  ( F i g u r e  1 ) .  T h e  e d g e s  o f  t h e  o p a c i t i e s  
w e r e  d u l l  a n d  i n d i s t i n c t .  A  p e n e t r a t i n g  k e r a t o p l a s t y  
w a s  p e r f o r m e d  a f t e r  w h i c h  t h e  e x c i s e d  b u t t o n  ( 7  m m  
d i a m e t e r )  w a s  i m m e d i a t e l y  w r a p p e d  i n  C l i n g f i l m  t o  
p r e v e n t  d e h y d r a t i o n ,  a n d  s t o r e d  a t  - 8 0 ° C  f o r  s e v e n  
d a y s  p r i o r  t o  t r a n s p o r t a t i o n  o n  d r y  i c e  t o  t h e  S P r i n g - 8  
s y n c h r o t r o n  f a c i l i t y  w h e r e  s m a l l - a n g l e  X - r a y  s c a t t e r ­
i n g  w a s  u s e d  t o  i n v e s t i g a t e  t h e  i n t e r n a l  f i n e  s t r u c t u r e  
o f  t h e  c o r n e a l  s t r o m a  i n  i t s  t h a w e d ,  h y d r a t e d  s t a t e . 33 
A  h u m a n  e y e - b a n k  c o r n e a  d e e m e d  u n s u i t a b l e  f o r  
g r a f t i n g  b e c a u s e  a  l o w  e n d o t h e l i a l  c e l l  c o u n t  w a s  
s i m i l a r l y  e x a m i n e d .  U n d e r  a  b i n o c u l a r  m i c r o s c o p e ,
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FIGURE 1 Slit-lamp examination of the MCD cornea showing 
diffuse ground-glass-like stromal opacification and focal 
deposits.
t w o  t h i n  s t r i p s  w e r e  c u t  a c r o s s  t h e  c e n t e r s  o f  t h e  
M C D  a n d  e y e  b a n k  c o r n e a s  u s i n g  a  s u r g i c a l  b l a d e ,  
w i t h  t h e  e d g e  o f  a  g l a s s  m i c r o s c o p e  s l i d e  s e r v i n g  a s  a  
g u i d e  f o r  t h e  d i s s e c t i o n .  T h i s  w a s  d o n e  w i t h  t h e  e p i ­
t h e l i a l  s i d e  u p ,  a n d  t h e  c u t  s t r i p s  w e r e  e s t i m a t e d  t o  
b e  i n  t h e  r e g i o n  o f  4 0 0  p m  t h i c k .  O n e  s t r i p  f r o m  e a c h  
c o r n e a  w a s  a n a l y z e d  w i t h  t h e  X - r a y  b e a m  d i r e c t e d  
t h r o u g h  t h e  t i s s u e  f r o m  f r o n t  t o  b a c k ,  w h i l e  t h e  o t h e r  
s t r i p s  w e r e  o r i e n t e d  s o  t h a t  t h e  b e a m  p a s s e d  t h r o u g h  
t h e m  e d g e w a y s .  X - r a y  p a t t e r n s  w e r e  c o l l e c t e d  f r o m  
r e g i o n s  o f  t h e  c o r n e a s  c o r r e s p o n d i n g  t o  t h e  c e n t r a l  
p r e - p u p i l l a r y  z o n e ;  t h e  M C D  c o r n e a  w a s  a l s o  e x a m ­
i n e d  i n  t h e  m i d - p e r i p h e r y ,  a p p r o x i m a t e l y  3  m m  f r o m  
t h e  c o r n e a l  c e n t e r .  A s  d e s c r i b e d  p r e v i o u s l y ,  a  s e r i e s  o f  
s m a l l - a n g l e  X - r a y  d i f f r a c t i o n  p a t t e r n s  w a s  o b t a i n e d  o n  
t h e  h i g h  f l u x  b e a m l i n e ,  4 0 X U ,  u s i n g  a  2 5  p m  m i c r o ­
b e a m  i n  2 5  p m  s t e p s  a n d  w i t h  s u b - s e c o n d  e x p o s u r e  
t i m e s . 34 P a t t e r n s  w e r e  a n a l y z e d  t o  p r o v i d e  v a l u e s  f o r  
t h e  m e a n  c o l l a g e n  i n t e r f i b r i l l a r  s p a c i n g  c a l i b r a t e d  t o  
t h e  m e r i d i o n a l  r e f l e c t i o n  a r i s i n g  f r o m  t h e  6 7 n m  a x i a l  
r e p e a t  o f  c o l l a g e n  i n  r a t  t a i l  t e n d o n ,  a n d  a d j u s t e d  b y  
a  1 . 1 2  c a l i b r a t i o n  f a c t o r  t o  t a k e  i n t o  a c c o u n t  t h e  m o d e  
o f  p a c k i n g  o f  c o l l a g e n  f i b r i l s  i n  c o r n e a 35 a s  w a s  d o n e  
i n  p r e v i o u s  s t u d i e s  o f  M C D . 29-30
A f t e r  X - r a y  e x p o s u r e ,  s m a l l  f u l l - t h i c k n e s s  p i e c e s  o f  
M C D  c o r n e a  w e r e  p r e p a r e d  b y  c o n v e n t i o n a l  f i x a t i o n  i n  
2 . 5 %  b u f f e r e d  g l u t a r a l d e h y d e ,  f o l l o w e d  b y  p o s t - f i x a t i o n  
f o r  1  h r  e a c h  i n  1 %  a q u e o u s  o s m i u m  t e t r o x i d e  a n d  0 . 5 %  
a q u e o u s  u r a n y l  a c e t a t e .  T i s s u e  w a s  t h e n  d e h y d r a t e d  
t h r o u g h  a n  a s c e n d i n g  s e r i e s  o f  e t h a n o l ,  i m m e r s e d  i n  
p r o p y l e n e  o x i d e ,  a n d  e m b e d d e d  i n  A r a l d i t e  C Y 2 1 2  
e p o x y  r e s i n  ( A g a r  S c i e n t i f i c ,  S t a n s t e d ,  U K ) .  U l t r a  t h i n  
s e c t i o n s  w e r e  c u t  w i t h  a  d i a m o n d  k n i f e  o n  a  L e i c a  U C 6  
u l t r a m i c r o t o m e  ( L e i c a ,  V i e n n a ,  A u s t r i a ) ,  p i c k e d  u p  o n  
u n c o a t e d  c o p p e r  g r i d s ,  c o n t r a s t e d  w i t h  s a t u r a t e d  u r a ­
n y l  a c e t a t e  a n d  R e y n o l d ' s  l e a d  c i t r a t e ,  a n d  i m a g e d  o n  a  
P h i l i p s  ( P h i l i p s ,  E i n d h o v e n ,  T h e  N e t h e r l a n d s ) / E M 2 0 8  
e l e c t r o n  m i c r o s c o p e .
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T h e  p a t i e n t ' s  s e r u m  K S  l e v e l  w a s  m e a s u r e d  b y  i n h i ­
b i t i o n  E L I S A  a n a l y s i s  u s i n g  5 D 4  a n t i - K S  m o n o c l o n a l  
a n t i b o d y . 10 I n  b r i e f ,  a  s e r u m  s a m p l e  o r  b o v i n e  c a r t i l a g e  
K S  s t a n d a r d  ( K S - 2 e q ,  k i n d l y  p r o v i d e d  b y  P r o f .  E u g e n e  
J . - M .  A .  T h o n a r ,  R u s h  P r e s b y t e r i a n - S t .  L u k e ' s  M e d i c a l  
C e n t e r ,  C h i c a g o ,  I l l i n o i s ,  U S A )  w a s  m i x e d  w i t h  5 D 4  
a n t i b o d y  ( S e i k a g a k u  C o . ,  T o k y o ,  J a p a n )  a n d  i n c u b a t e d  
a t  4 ° C  o v e r n i g h t .  T h e  m i x t u r e  w a s  t h e n  t r a n s f e r r e d  t o  
a  9 6 - w e l l  E L I S A  p l a t e  t h a t  w a s  c o a t e d  w i t h  b o v i n e  
n a s a l  s e p t u m  D 1  f r a c t i o n ,  w h i c h  c o n t a i n e d  K S  a n t i ­
g e n .  T h i s  w a s  i n c u b a t e d  a t  4 ° C  f o r  l h r ,  a f t e r  w h i c h  
t h e  p l a t e  w a s  e m p t i e d  a n d  w a s h e d  t h r e e  t i m e s  w i t h  
P B S  p H  5 . 3  c o n t a i n i n g  0 . 0 5 %  T w e e n - 2 0  ( P B S T 5 . 3 ) .  
H o r s e r a d i s h  p e r o x i d a s e - c o n j u g a t e d  g o a t  a n t i - m o u s e  
I g G  a n t i b o d y  ( T h e r m o  S c i e n t i f i c ,  R o c k f o r d ,  I l l i n o i s ,  
U S A )  w a s  d i l u t e d  i n t o  1 %  B S A  i n  P B S T 5 . 3  a n d  a d d e d  
t o  t h e  E L I S A  p l a t e ,  f o l l o w e d  b y  a  l h r  i n c u b a t i o n  a t  
r o o m  t e m p e r a t u r e .  T h e  p l a t e  w a s  e m p t i e d  a n d  w a s h e d  
w i t h  P B S T 5 . 3  t h r e e  t i m e s  a n d  d e v e l o p e d  w i t h  D u o S e t  
E L I S A  d e v e l o p m e n t  r e a g e n t  ( R & D  S y s t e m s ,  M i n n e a p o ­
l i s ,  M i n n e s o t a ,  U S A )  a c c o r d i n g  t o  t h e  m a n u f a c t u r e r ' s  
i n s t r u c t i o n s .  T h e  p a t i e n t ' s  s e r u m  K S  c o n c e n t r a t i o n  w a s  
c a l c u l a t e d  i n  r e f e r e n c e  t o  a b s o r b a n c e  v a l u e s  o f  t h e  K S  
s t a n d a r d .
T h e  r e s e a r c h  d e s c r i b e d  i n  t h i s  a r t i c l e  w a s  a p p r o v e d  
b y  t h e  C o m m i t t e e  f o r  E t h i c a l  I s s u e s  o n  H u m a n  
R e s e a r c h  o f  K y o t o  P r e f e c t u r a l  U n i v e r s i t y  o f  M e d i c i n e  
a n d  f o l l o w e d  t h e  t e n e t s  o f  t h e  D e c l a r a t i o n  o f  H e l s i n k i .  
I n f o r m e d  c o n s e n t  w a s  o b t a i n e d  f r o m  t h e  M C D  p a t i e n t  
a f t e r  s h e  h a d  r e c e i v e d  a  d e t a i l e d  e x p l a n a t i o n  o f  t h e  
p r o c e d u r e s .
RESULTS
K S  i n  t h e  s e r u m  o f  t h e  M C D  p a t i e n t  w a s  q u a n t i f i e d  b y  
E L I S A  w i t h  t h e  5 D 4  a n t i b o d y  a t  l e s s  t h a n  l O n g / m l ,  
i n d i c a t i n g  t h e  i m m u n o p h e n o t y p e  t o  b e  M C D  t y p e  I .  
T h i s  i s  c o n s i s t e n t  w i t h  t h e  g e n e t i c  s t a t u s ,  i n  w h i c h  t h e  
p a t i e n t  p r e s e n t e d  t h e  m u t a t i o n  C  ( c . 6 3 1 )  t o  T  i n  e x o n  1  
o f  t h e  CHST6  g e n e .
C o l l a g e n  i n t e r f i b r i l l a r  s p a c i n g ,  m e a s u r e d  a t  2 7  
p o s i t i o n s ,  2 5  p m  a p a r t ,  i n  t h e  c e n t r a l  r e g i o n  o f  t h e  
e y e  b a n k  c o r n e a  a n d  t h e  M C D  c o r n e a  w i t h  t h e  b e a m  
d i r e c t e d  a t  r i g h t  a n g l e s  t o  t h e  c o r n e a l  s u r f a c e  a n d  
p a s s e d  t h r o u g h  t h e  w h o l e  t h i c k n e s s  o f  t h e  t i s s u e  g a v e  
m e a n  v a l u e s  o f  5 2 . 0 n m  ( S D  ±  0 . 3  n m )  a n d  4 0 . 7 n m  
( S D  ±  0 . 7 n m ) ,  r e s p e c t i v e l y .  P r e v i o u s  m e a s u r e m e n t s  
b y  s y n c h r o t r o n  X - r a y  d i f f r a c t i o n  o f  c o l l a g e n  f i b r i l  
s p a c i n g  i n  M C D  i n d i c a t e d  a  r e d u c t i o n  o f  2 2 %  c o m ­
p a r e d  t o  t h e  f i b r i l  s p a c i n g  i n  a  p o s t - m o r t e m  h u m a n  
c o r n e a ,  w i t h  t h e  v a l u e s  r e p r e s e n t i n g  a n  a v e r a g e  
t h r o u g h o u t  t h e  w h o l e  t h i c k n e s s  o f  t h e  s t r o m a . 30 A  
s i m i l a r  p r o p o r t i o n a l  r e d u c t i o n  i s  s e e n  i n  t h e  c u r r e n t  
a n a l y s i s .  W h a t  i s  n o t  k n o w n ,  h o w e v e r ,  i s  w h e t h e r
o r  n o t  t h i s  r e d u c e d  f i b r i l  s p a c i n g  i n  M C D  v a r i e s  
w i t h  s t r o m a l  d e p t h .  T o  r e c t i f y  t h i s ,  m e a s u r e m e n t s  
o f  c o l l a g e n  i n t e r f i b r i l l a r  s p a c i n g  w e r e  o b t a i n e d  i n  
s e q u e n t i a l  s t e p s  o f  2 5  p m  a c r o s s  M C D  a n d  e y e  b a n k  
c o r n e a s  f r o m  f r o n t  t o  b a c k .  E y e  b a n k  d a t a  c o n f i r m e d  
p r e v i o u s  d e p t h - p r o f i l e d  X - r a y  d i f f r a c t i o n  s t u d i e s , 34 
a n d  s h o w e d  t h a t  c o l l a g e n  f i b r i l s  w e r e  m o r e  w i d e l y  
s p a c e d  i n  t h e  p o s t e r i o r  s t r o m a  ( b y  a p p r o x i m a t e l y  
2 5 % )  a s  c o m p a r e d  t o  t h e  m i d - d e p t h  o r  a n t e r i o r  
s t r o m a  ( F i g u r e  2 ) .  T h e  o p p o s i t e  w a s  t r u e ,  h o w e v e r ,  
f o r  t h e  M C D  c o r n e a ,  w i t h  c o l l a g e n  f i b r i l  s p a c i n g  
c l e a r l y  l o w e r  i n  t h e  p o s t e r i o r  s t r o m a  ( F i g u r e  2 ) .  
T h i s  p a t t e r n  w a s  s e e n  i n  t h e  c o r n e a l  m i d - p e r i p h e r y  
i n  M C D  t o o ,  a l t h o u g h  t h e  c o l l a g e n  s p a c i n g  v a l u e s  
a r e  h i g h e r  o v e r a l l  t h a n  t h o s e  i n  t h e  c o r n e a l  c e n t e r  a s  
t e n d s  t o  b e  t h e  c a s e  i n  h u m a n  c o r n e a s . 36 I n  t h e  c e n ­
t r a l  r e g i o n  o f  t h e  M C D  c o r n e a ,  c o l l a g e n  s p a c i n g  i s  
5 . 4 %  l e s s  i n  t h e  p o s t e r i o r  1 0 0  p m  o f  s t r o m a  c o m p a r e d  
t o  t h e  a n t e r i o r  1 0 0  p m  ( p < 0 . 0 1 ) ,  w h i l e  i n  t h e  m i d ­
p e r i p h e r y ,  t h e  p o s t e r i o r  1 0 0  p m  o f  t h e  M C D  s t r o m a  
s h o w s  a  c o l l a g e n  s p a c i n g  t h a t  i s  1 0 . 0 %  l e s s  t h a n  t h a t  
i n  t h e  a n t e r i o r  1 0 0  p m  ( p < 0 . 0 1 ) .  T h u s ,  t h e  p r o f i l e  
o f  c o l l a g e n  f i b r i l  s p a c i n g  a s  a  f u n c t i o n  o f  s t r o m a l  
d e p t h  i n  M C D — i . e . ,  l o w e r  f i b r i l  s p a c i n g  i n  t h e  d e e p
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FIGURE 2 Center-to-center collagen fibril spacing measured 
in 25 pm  steps across an eye bank cornea (top) and MCD cor­
nea (bottom). In the eye bank, cornea fibril spacing is lower in 
the anterior stroma, while in the central and mid-peripheral 
regions of the MCD cornea, a clear decrease in collagen fibril 
spacing is evident in the deeper stroma.
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C o l l a g e n  S t r u c t u r e  i n  M a c u l a r  C o r n e a l  D y s t r o p h y  5 8 3
s t r o m a — i s  u n l i k e  t h a t  f o r  a  h u m a n  c o r n e a  f r o m  t h e  
e y e  b a n k ,  w h i c h  d i s p l a y s  a  l o w e r  f i b r i l  s p a c i n g  i n  
t h e  a n t e r i o r  s t r o m a .
C o n f i r m a t i o n  o f  m o r e  p r e v a l e n t  s t r o m a l  a l t e r a t i o n s  
i n  t h e  p o s t e r i o r  c o r n e a  i n  M C D  c a m e  f r o m  a n  e l e c t r o n  
m i c r o s c o p i c  e x a m i n a t i o n  o f  t h e  c o r n e a .  T h i s  d i s c l o s e d  
t h a t  t h e  c o l l a g e n  f i b r i l s  a p p e a r  s t r u c t u r a l l y  n o r m a l  i n  
t h e  a n t e r i o r  c o r n e a ,  b u t  t h a t  t h e  d e e p  s t r o m a  p o s s e s s e s  
f o c a l  p o c k e t s  o f  a b n o r m a l l y  l a r g e  d i a m e t e r  c o l l a g e n  
f i b r i l s  ( F i g u r e  3 ) .  F i b r i l s  ( n  =  8 0 2 )  i n  t h e  e y e  b a n k  c o r n e a  
e x a m i n e d  h e r e  d i s p l a y e d  a  n o r m a l  d i s t r i b u t i o n  o f  f i b r i l  
d i a m e t e r s  t h a t  r a n g e d  f r o m  2 0 . 0 - 3 5 . 6  n m  ( F i g u r e  4 ) ,  
a n d  w a s  c e n t e r e d  o n  2 6 . 4 n m  ( S D  ±  2 . 6  n m ) ,  s i m i l a r  
t o  p u b l i s h e d  v a l u e s . 37 M e a s u r e m e n t  o f  8 0 0  f i b r i l s  i n
300nm
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FIGURE 3 Transverse-section electron microscopic images 
of collagen fibrils in the anterior (A) and posterior (B) stroma 
in MCD. Focal pockets of collagen fibrils of abnormally large 
diameter are present in the posterior stroma. Magnification 
32k.
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a r e a s  o f  t h e  p o s t e r i o r  M C D  c o r n e a ,  w h i c h  c o n t a i n e d  
c o n g r e g a t i o n s  o f  l a r g e - d i a m e t e r  f i b r i l s ,  o n  t h e  o t h e r  
h a n d ,  i n d i c a t e d  a  l a r g e r  s p r e a d  o f  d i a m e t e r s  1 9 . 6  n m  
t o  6 3 . 1  n m ,  w i t h  a  d i s t r i b u t i o n  t h a t  w a s  n o t  n o r m a l  
( o n e - s a m p l e  K o l m o g o r o v - S m i m o v  t e s t  p < 0 . 0 0 1 ) ,  b u t  
w a s  s k e w e d  b y  t h e  e x i s t e n c e  o f  f i b r i l s  w i t h  l a r g e r - t h a n -  
n o r m a l  d i a m e t e r s  ( F i g u r e  4 ) .  L a r g e - d i a m e t e r  c o l l a g e n  
f i b r i l s  h a v e  b e e n  d o c u m e n t e d  p r e v i o u s l y  i n  M C D  
w h e r e  t h e y  w e r e  r e p o r t e d  t o  r a n g e  i n  s i z e  f r o m  2 0  n m  
t o  6 0  n m . 38/39 H o w e v e r ,  i t  w a s  n o t  i n d i c a t e d  a t  w h a t  
s t r o m a l  d e p t h  t h e y  e x i s t e d .  I n  t h e  M C D  c o r n e a  s t u d i e d  
h e r e ,  a b n o r m a l l y  l a r g e  c o l l a g e n  f i b r i l s  w e r e  r e s t r i c t e d  
t o  t h e  d e e p  s t r o m a .
DISCUSSION
A n  a b n o r m a l i t y  i n  t h e  b i o s y n t h e t i c  p a t h w a y  o f  K S  
o c c u r s  i n  M C D  a n d  c a u s a t i v e  m u t a t i o n s  h a v e  b e e n  
f o u n d  i n  a  g e n e ,  CHST6, w h i c h  e n c o d e s  t h e  s u l f o ­
t r a n s f e r a s e  e n z y m e  N - a c e t y l g l u c o s a m i n e  6 - 0  s u l f o ­
t r a n s f e r a s e  ( C G n 6 S T ) . 40 K S  i s  a  l i n e a r  c a r b o h y d r a t e  
c h a i n  c o m p r i s e d  o f  a  r e p e a t i n g  s e r i e s  o f  d i s a c c h a r i d e s ,  
i n  w h i c h  e a c h  i s  c o m p o s e d  o f  g a l a c t o s e  ( G a l )  a n d  
N - a c e t y l g l u c o s a m i n e  ( G l c N A c ) .  C G n 6 S T  a n d  g a l a c ­
t o s e  6 - 0  s u l f o t r a n s f e r a s e  ( G 6 S T )  t r a n s f e r  s u l p h a t e  
o n t o  t h e  6 - 0  p o s i t i o n s  o f  G l c N A c  a n d  G a l , 41,42 t h u s  a  
m u t a t i o n  i n  CHST6  a d v e r s e l y  a f f e c t s  t h e  p r o d u c t i o n  o f  
a  m a t u r e ,  s u l p h a t e d  K S .  S i n c e  t h e  i n i t i a l  d i s c o v e r y  o f  
t h e  c a u s a t i v e  g e n e  f o r  M C D ,  m o l e c u l a r  g e n e t i c  s t u d i e s  
h a v e  r e p o r t e d  m u t a t i o n s  i n  C H S T 6  i n  M C D  p a t i e n t s  
w o r l d w i d e . 43-57
K S - P G s  a r e  b e l i e v e d  t o  i n f l u e n c e  t h e  u l t r a s t r u c -  
t u r a l  a r r a n g e m e n t  o f  c o l l a g e n  f i b r i l s  i n  t h e  c o r n e a ,  
a n d  r e c e n t  t h r e e - d i m e n s i o n a l  d a t a  f r o m  e l e c t r o n  
t o m o g r a p h y  h a v e  s u g g e s t e d  t h a t  t h e y  d o  s o  b y  f o r m ­
i n g  m a c r o m o l e c u l a r  s t r u c t u r e s  m o r e  c o m p l e x  t h a n  
p r e v i o u s l y  b e l i e v e d . 58,59 F i b r i l  d i a m e t e r  i n  t h e  c o r -
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FIGURE 4 Histograms showing the range of collagen fibrils 
diameters in deep regions of the MCD stroma, which contain 
abnormally large diameter fibrils (A), and in the eye bank 
cornea (B).
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n e a  i s  c o n t r o l l e d ,  i n  p a r t ,  b y  t h e  p r o p o r t i o n  o f  t y p e  
V  c o l l a g e n  m o l e c u l e s  i n  t h e  h y b r i d  t y p e  I / V  f i b r i l ,  
w i t h  h i g h e r  p r o p o r t i o n s  o f  c o l l a g e n  t y p e  V  l e a d i n g  
t o  n a r r o w e r  f i b r i l s . 60 E v i d e n c e  e x i s t s ,  t o o ,  f o r  a  r o l e  
f o r  K S - P G s  i n  t h e  r e g u l a t i o n  o f  f i b r i l  d i a m e t e r  a n d  in 
vitro  b o t h  l u m i c a n  a n d  d e c o r i n  ( a  c o m e a l  P G  w i t h  a  
h y b r i d  c h o n d r o i t i n  s u l p h a t e / d e r m a t a n  s u l p h a t e  [ C S /  
D S ]  G A G )  r e g u l a t e  c o l l a g e n  f i b r i l l o g e n e s i s ,  a l t h o u g h ,  
i n t e r e s t i n g l y ,  t h e y  d o  s o  w i t h ,  a s  w e l l  a s  w i t h o u t ,  t h e  
G A G  s i d e  c h a i n . 61 T h i s  s u g g e s t s  t h a t  t h e  r e g u l a t o r y  
a b i l i t y  m i g h t  l i e  w i t h  t h e  c o r e  p r o t e i n ,  a n d  s t u d i e s  o f  
t h e  c o r n e a s  o f  l u m i c a n - n u l l  m i c e  s h o w  t h a t  c o l l a g e n  
f i b r i l s  a r e  s o m e t i m e s  a b n o r m a l l y  l a r g e ,  p r e s u m a b l y  
b e c a u s e  o f  t h e  r e d u c t i o n  o f  t h i s  K S - P G  i n  t h e  s t r o m a . 62 
T h e  p r e s e n c e  o f  u n u s u a l l y  l a r g e  c o l l a g e n  f i b r i l s  i n  t h e  
c o r n e a s  o f  M C D  p a t i e n t s  i s  s u g g e s t i v e  o f  a  r o l e  f o r  
t h e  G A G  s i d e  c h a i n  o f  K S  i n  t h e  r e g u l a t i o n  o f  f i b r i l  
d i a m e t e r .  C o l l a g e n  i n t e r m o l e c u l a r  s p a c i n g  a p p e a r s  t o  
b e  u n c h a n g e d  w i t h i n  f i b r i l s  i n  M C D  c o r n e a s . 63 W e  c a n ,  
t h e r e f o r e ,  p r o b a b l y  a s s i g n  t h e  l a r g e r  f i b r i l  d i a m e t e r s  
t o  t h e  a g g r e g a t i o n  o f  m o r e  m o l e c u l e s  i n t o  f i b r i l s ,  a n d  
e v e n  p e r h a p s  t h e  m e r g i n g  o f  e x i s t i n g  f i b r i l s ,  r a t h e r  
t h a n  t h e  e x i s t e n c e  o f  m o r e  w i d e l y  s p a c e d  c o l l a g e n  
m o l e c u l e s  w i t h i n  f i b r i l s .  S t u d i e s  o n  t h e  c o r n e a s  o f  
g e n e - t a r g e t e d  m i c e  w i t h  a  m u t a t i o n  o f  Chst5, a  m u r i n e  
e q u i v a l e n t  o f  CHST6  i n  h u m a n s ,  h a v e  r e p o r t e d  a  t h i n  
s t r o m a  a n d  c l o s e r - t h a n - n o r m a l  c o l l a g e n  f i b r i l  s p a c i n g ,  
b u t  n o t  p o c k e t s  o f  a b n o r m a l l y  l a r g e  c o l l a g e n  f i b r i l s  
i n  t h e  c o r n e a l  s t r o m a . 64 T h e  m o u s e  c o r n e a ,  h o w e v e r ,  
c o n t a i n s  K S  G A G  c h a i n s  t h a t  a r e  l e s s  s u l p h a t e d  t h a n  
t h o s e  i n  t h e  h u m a n  c o r n e a , 32-65 s o  p e r h a p s  t h e  l a c k  o f  
K S  s u l f o t r a n s f e r a s e  a c t i v i t y  i n  t h e  C hst5-nul\  m o u s e  
h a s  l e s s  o f  a n  i m p a c t  o n  c o l l a g e n  f i b r i l  d i a m e t e r  
b e c a u s e  o f  t h e  l i m i t e d  n e e d  f o r  s u l p h a t e d  K S  i n  t h e  
c o r n e a  o f  t h i s  s p e c i e s .
T h e  l o w  l e v e l s  o f  s u l p h a t e d  K S  i n  t h e  m o u s e  c o r ­
n e a  h a v e  b e e n  a t t r i b u t e d  t o  t h e  t h i n n e s s  o f  t h e  c o r n e a ,  
i n t o  w h i c h  o x y g e n  r e a d i l y  d i f f u s e s  t o  a l l  l a y e r s  o f  t h e  
s t r o m a . 32 I t  w a s  p o s t u l a t e d  b y  S c o t t  t h a t  p r o p o r t i o n ­
a l l y  h i g h e r  l e v e l s  o f  s u l p h a t e d  K S  f o u n d  i n  t h e  d e e p e r  
l a y e r s  o f  t h e  t h i c k e r  c o r n e a s  o f  l a r g e r  a n i m a l s  i s  a  
d i r e c t  c o n s e q u e n c e  o f  t h e  r e s t r i c t e d  o x y g e n  s u p p l y ,  
a n d  t h a t  K S  a c t s  a s  a  " s t a n d - i n "  f o r  C S / D S  i n  c o n d i ­
t i o n s  o f  l a c k i n g  o x y g e n . 66-68 T h i s  c o n c e p t  h a s  s u p p o r t  
i n  o t h e r  t i s s u e s ,  s u c h  a s  a r t i c u l a r  c a r t i l a g e ,  i n  w h i c h  a  
s i m i l a r l y  i n c r e a s e d  i n c i d e n c e  o f  K S  i s  s e e n  i n  t h i c k e r  
c a r t i l a g e s ,  a c c o m p a n i e d  b y  a  g r e a t e r  a b u n d a n c e  i n  
d e e p e r  l a y e r s . 69-70 K S  i s  n o t  f o u n d  i n  s u l p h a t e d  f o r m  
i n  t h e  s t r o m a  i n  M C D  I , 10-14 b u t  r a t h e r  i s  p r e s e n t  i n  
u n s u l p h a t e d  o r  l o w - s u l p h a t e d  f o r m . 71-73 T h e  c u r r e n t  
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Cornea
D ecorin A ccum ulation Contributes to the Stromal 
Opacities Found in  C ongenital Stromal 
C om eal D ystrophy
Cecilie B redrup , 1,2,3 Espen S tang ,4 O ve B ru la n d ,5 B arbara  P. P a lka ,5 R obert D. Young,5 
Ja n  H aavik,6 Per M. K n appskog , 13 a n d  E yv in d  R od a h l1,2
P u r p o s e . Congenital stromal corneal dystrophy (CSCD) is char­
acterized by stromal opacities that morphologically are seen as 
interlamellar layers of amorphous substance with small fila­
ments, the nature of which has hitherto been unknown. CSCD 
is associated with truncating mutations in the decorin gene 
(DCN). To understand the molecular basis for the comeal 
opacities we analyzed the expression of decorin in this disease, 
both at the morphologic and the molecular level.
M e t h o d s . Comeal specimens were examined after contrast 
enhancement with cuprolinic blue and by immunoelectron 
microscopy. Decorin protein from com eal tissue and kerato- 
cyte culture was studied by immunoblot analysis before and 
after O- and N-deglycosylation. The relative level of DCN mRNA 
expression was examined using Q-RT-PCR, and cDNA was 
sequenced. Recombinant wild-type and truncated decorin tran­
siently expressed in HEK293 cells w ere analyzed by gel filtra­
tion and immunoblotting.
R e su l t s . The areas of interlamellar filaments were stained by 
cuprolinic blue. Immunoelectron microscopy using decorin 
antibodies revealed intense labeling of these areas. Both wild- 
type and truncated decorin protein was expressed in comeal 
tissue and keratocytes of affected persons. When decorin ex­
pressed in HEK293 cells was examined by gel filtration, the 
truncated decorin eluted as high molecular weight aggregates.
C o n c l u s io n s . Accumulation of decorin was found in the interla­
mellar areas of amorphous substance. The truncated decorin is 
present in CSCD corneas, and there is evidence it may aggregate 
in vitro. Thus, decorin accumulation appears to contribute to the 
stromal opacities that are characteristic of CSCD. (Invest Ophthal­
mol Vis Sci. 2010;51:5578-5582) DOI:10.1l67/iovs.09-4933
Congenital stromal corneal dystrophy (CSCD; Online Men- delian Inheritance in Man 610048) is a rare autosomal 
dominant disorder characterized by small opacities found
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throughout the stroma. These small flakes and spots are 
present shortly after birth and are thought to be slowly pro­
gressive. Most patients will need bilateral corneal transplanta­
tions as young adults. By transmission electron microscopy, the 
opacities can be visualized as layers of thin filaments embedded 
in an amorphous material that separates apparently normal 
stromal lamellae. The nature of these opacities has hitherto 
been unknown. Genetic analysis in two CSCD families has 
revealed frameshift mutations in the C-terminal part of the 
decorin gene in affected persons.1,2 Both mutations (c.967delT 
and c.94ldelC) are predicted to introduce the same premature 
stop codon, causing the deletion of 33 amino acids in the 
C-terminal end of the decorin protein.1-2
Decorin is a small leucine-rich proteoglycan (SLRP) involved 
in several important biological processes, including collagen 
fibrillogenesis and matrix assembly.3,1 Decorin-deficient mice 
have abnormal collagen morphology in skin and tendons but 
have clear corneas.5 This indicates that decorin is not essential 
for comeal transparency. To improve our understanding of 
why heterozygous truncating mutations in the decorin gene 
cause comeal clouding, we analyzed decorin expression in 
CSCD corneas morphologically and at a molecular level.
M a t e r ia l s  a n d  M e t h o d s
P a tien ts  w ith  CSCD an d  u n a ffec ted  p e rso n s  w e re  inv ited  to  pa rtic ipa te  
in  th e  study. In fo rm ed  w ritte n  c o n se n t w as  o b ta in e d  from  all partic i­
p an ts . T h e  s tu d y  w as  a p p ro v e d  by  th e  R egional C o m m ittee  fo r M edical 
an d  R esearch  E thics, W es te rn  N orw ay  ORB 0 0 0 0 1 8 7 2 ) an d  ad h ered  to  
th e  te n e ts  o f  th e  D ecla ra tion  o f  H elsinki.
Tissue Samples
Skin b io p sy  sam p les  w e re  o b ta in e d  from  th e  fo rea rm  skin o f affected  
p e rs o n s  carry ing  th e  c .9 6 7 d e lT  m u ta tio n  a n d  from  h ealthy  family 
m em b ers . A CSCD c o m e a l b u tto n  w as  available a fte r th e ra p eu tic  co r­
neal grafting . T h e  c lin ical find ings o f  th e  p a tie n t have p rev iously  b een  
d e sc rib e d  (V-6 in B red ru p  e t a l .1). A n u n a ffec te d  c o rn ea  w as ob ta ined  
from  an  u n re la te d  p e rs o n  w h o  h a d  an  ey e  rem o v ed  becau se  o f  malig­
n a n t ch o ro id a l m elanom a.
Cuprolinic Blue Staining
CSCD a n d  h e a lth y  c o m e a l sam p les  w e re  p lu n g e  frozen  a n d  s to red  in 
liqu id  n itro g en . T h a w ed  sam ples  w e re  fix ed  o v e rn ig h t in 2.5% glutar- 
a ld eh y d e  in  25 mM so d iu m  ace ta te  buffer, pH  5.7, con ta in ing  0.1 M 
m agnesium  ch lo rid e  a n d  0.05%  cu p ro lin ic  b lu e  (BioSciences, W ar­
ring ton , PA). T h e  sam ples  w e re  w a sh e d  in  25 mM sod ium  ace ta te  
buffer, th e n  tra n sfe rre d  to  aq u eo u s  0.5% sod ium  tu n g sta te  fo r 15 
m inu tes , fo llow ed  by  50% e th an o lic  0.5% sod ium  tu n g sta te  for 15 
m inu tes. S pec im ens w e re  d e h y d ra ted  in  an  a scen d in g  e thano l series, 
fo llow ed  by  p ro p y le n e  o x ide , an d  w e re  in filtra ted  w ith  Araldite resin. 
T h ey  w e re  e m b e d d ed  in  m o u ld s  w ith  fresh  resin  an d  w e re  cu re d  fo r 24
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h o u rs  a t 60°C . U ltra th in  sec tio n s  w e re  c u t  w ith  a  d ia m o n d  knife, 
c o lle c te d  o n  u n c o a te d  c o p p e r  g rid s, s ta in e d  w ith  1% p h o s p h o tu n g s tic  
ac id  a n d  s a tu ra te d  u rany l a c e ta te  so lu tio n s , a n d  e x a m in e d  in  a  tra n s ­
m issio n  e le c tro n  m ic ro s c o p e  (EM 208; P h ilip s, E in d h o v en , T h e  N e th ­
erlan d s) .
Im m unoelectron M icroscopy
C o m e a l s p e c im e n s  w e re  fix ed  u s in g  4% p a ra fo rm a ld e h y d e  a n d  0.1%  
g lu ta ra ld e h y d e  in 0.1 M p h o s p h a te  b u ffe r  fo r 2 h o u rs  a n d  p ro c e s s e d  fo r 
c rv o s e c tio n in g  a n d  im m u n o lab e lin g  esse n tia lly  as p re v io u s ly  d e ­
s c r ib e d .6 Som e s ec tio n s  w e re  in c u b a te d  w ith  0 .4  IJ/m L  c h o n d ro itin a s e  
ABC in 0.1 M Tris a ce ta te , pH  6 .8 , fo r  1 h o u r  a t ro o m  te m p e ra tu re  an d  
w a sh e d  in  PBS b e fo re  b lo c k in g  a n d  im m u n o la b e lin g . B o u n d  a n tib o d ie s  
w e re  v isu a lized  u s ing  p ro te in  A g o ld  (G . P o s th u m a , U tre c h t, T h e  
N e th e r la n d s) . T h e  sec tio n s  w e re  e x a m in e d  u s in g  a n  e le c tro n  m ic ro ­
s c o p e  (CM  120; P h ilip s).7
T h re e  d eco r in  an tib o d ie s  w e re  u s e d — g o a t a n t i - h u m a n  d e c o r in  
a n tib o d y  AF143 (R& I) System s, M in neapo lis , M N) a n d  tw o  rab b it 
an tise ra , I.F-136 an d  LF-122, g e n e ro u s ly  p ro v id e d  by  Larry F ish e r (D ep t, 
o f  H e alth  a n d  H um an  Services, NIH, B eth esd a , M D). T h e  ta rg e t fo r
I.F-136 is an  N -term inal p e p tid e ,8 a n d  th a t  fo r  LF-1229 a n d  AF143 is 
re c o m b in a n t h u m an  d eco rin . W h e n  lab e lin g  w ith  th e  g o a t an ti-d ec o rin  
an tib o d y , a rabb it an ti-goat IgG a n tib o d y  (C a p p e l; ICN B io ch em ica ls  
C osta  M esa, CA) w as u sed  as sec o n d a ry  a n tib o d y  b e fo re  in c u b a tio n  
w ith  p ro te in  A gold.
Extraction o f Decorin from  Corneal Tissue
U n tre a te d  c o m e a l sam p les  th a t h ad  b e e n  s to re d  in  liq u id  n itro g e n  w e re  
a d d e d  to  200 /xL lysis b u ffer (5  mM  EDTA, 150 m M  NaCl, 0 .0 0 2  M 
p h cn y lm e th y lsu lfo n y l fluoride, 50  mM  Tris-HCI, p H  7 .5 )  c o n ta in in g  1 
/xL p ro te a s e  in h ib ito r co ck tail (P 8340 ; Sigm a-A ldrich, St. Louis, M O). 
The sa m p le  w as h o m o g e n iz ed  (T issueL yser II; Q iag en , H ilden , G e r­
m any) fo r  200 sec o n d s  b e fo re  th e  a d d itio n  o f  1 p L  N o n id e t P-40, 1 pL  
T w e e n  20 , and  1 pL  20% so d iu m  d o d e c y l s u lp h a te  (SDS) an d  w as 
in c u b a te d  a t 37°C fo r 30 m in u te s . T h e  sam p le  w a s  c e n tr ifu g e d  a t 
l6 0 0 0 g  fo r  10 m inu tes, a n d  th e  s u p e rn a ta n t w a s  c o lle c te d .
Keratocyte and Fibroblast Cultures
Skin b io p sy  sp ec im e n s  an d  p a r t  o f  th e  c o m e a l  b u t to n s  w e re  c u t  in to  
sm all p ie c e s . K era to cy tes  a n d  f ib ro b la s ts  w e re  c u ltiv a te d  (A m nio- 
c h ro m e  II w ith  A m n io ch ro m e  II S u p p le m e n t m o d if ied ; Lonza, Ver- 
v ic rs . B elg ium ) at 37°C  w ith  5% C 0 2. W h e n  fu lly  c o n flu e n t, th e  cells  
w e re  tra n s fe rre d  (A m n io c h ro m e  II w ith o u t  S u p p le m e n t; L onza), a n d  
th e  m e d iu m  w as h a rv e ste d  a f te r  6  h o u rs . C ells  w e re  ly sed  u s in g  50 mM 
Tris-HCI, pH  7.5, c o n ta in in g  20 0  mM  N aCl, 5 m M  EDTA, 1% Igepal, 1 
p g /m L  a p ro tin in , 1 mM p h e n y lm e th y lsu lfo n y l flu o rid e , c o m p le te  p ro - 
te a se  in h ib ito r  co ck tail (R o ch e  D iag n o stic s  G m bH , M an n h e im , G er­
m any), 0.5%  T w een , a n d  0.1%  SDS.
RNA Analyses
Total RNA w as p u rif ied  from  th e  c o rn e a l s p e c im e n  a n d  H EK 293 cells 
(T issueL yzer and  RN easy kits; Q iag en ). T h e  q u a lity  o f  th e  p u rif ie d  RNA 
w as an a ly zed  (E x p erio n  system ; Bio-Rad, H e rc u le s , CA), a n d  cDNA 
sy n th e s is  w a s  p e rfo rm e d  (T aqM an R ev e rse  T ra n s c r ip tio n  kit; ABI, Fos­
te r  C ity, CA). DCN RNA e x p re ss io n  w as d e te rm in e d  u s in g  q u a n tita tiv e  
re v e rse  transcrip tase-P C R  (Q-RT-PCR) u s in g  ABI p r im e rs  a n d  p ro b e s  
(A ssay o n  D em and ; H S 00266491) a n d  w a s  a n a ly ze d  (7 9 0 0  in s tru m en t; 
ABI). E x p ress io n  o f  j3-actin w as  u s e d  as a n  e n d o g e n o u s  n o rm a liza tio n  
c o n tro l.
PCR am p lifica tio n  o f  DCN from  cD N A  o f  c u ltu re d  c o rn e a l cells  w as 
p e rfo rm e d  w ith  fo rw a rd  p r im e r  (5'-GAGGGAGCTTCACTTGGA- 
CAACA-3 ) and  rev e rse  p r im e r  (5 '-G A ATGGCAGAGCGCACGTAG-3'). 
a n d  th e  PCR p ro d u c t w as s e q u e n c e d .
Construction o f  Plasmids
B oth  w ild -ty p e  a n d  m u ta n t DCN f ro m  a h e te ro z y g o u s  sam p le  w e re  
c lo n e d  b y  PCR am plifica tion  o f  cD N A  u s in g  fo rw a rd  p r im e r  (5 '-cgcg-
gatccGCAAATTCCCGGATTAAA-3')  a n d  reve rse  p rim er (5 '-ctagtcta- 
gaTGCATAATAAGTCATGTGGGTAA-3'), w ith  seq u en c es  in co rp o ra t­
ing  re s tric tio n  sites  facilita ting  c lo n in g  ad d ed  at th e  5 '-end  (low er 
caps). PCR p ro d u c ts  w e re  d ig e sted  a n d  liga ted  in to  th e  pC D N A 3.1(+) 
v e c to r  (Inv itrogen , C arlsbad, CA) using  th e  BamHl and  Xba\ restric­
tio n  enzym es (NEB; Ip sw ich , MA). All p lasm ids w e re  verified  by  DNA 
seq u en c in g .
Transient Transfection o f  Cells
H um an  em b ry o n ic  k idney  cells  (H E K 293) w e re  g ro w n  in  D u lb ecco ’s 
m od ified  Eagle m ed iu m  (DMEM; G ibco , A uckland, N ew  Zealand) sup­
p le m e n te d  w ith  10% feta l c a lf  serum . Six m illion  cells w e re  p la ted  o n to  
10-cm d ish es  th e  day  be fo re  tran sfe c tio n  to  o b ta in  90% to  95% conflu­
e n c e  at tran sfec tio n . T h e  tra n sfec tio n  m ix tu re  c o n ta in ed  60  /xL reagen t 
(L ipo fec tam ine  2000; In v itro g en ), 24  /xg e x p re ss io n  v ec to r (w ild-type 
an d  m u ta te d  d eco rin ), o r  e m p ty  v e c to r  as a negative  co n tro l. T rans­
fe c tio n  w as p e rfo rm ed  a cco rd in g  to  th e  m a n u fa c tu re r’s reco m m en d a­
tio n s . A GFP e x p re ss io n  v e c to r  (pS iren  R etroQ , 2.5 /xg; C lon tech  
L abora to ries, M ountain  V iew , CA) w as a d d ed  as an  in te rna l c o n tro l o f 
tra n s fe c tio n  efficacy. T h e  m e d iu m  w as c h an g e d  daily. At 48  h o u rs  after 
tra n sfec tio n , th e  cells w e re  tra n s fe rre d  to  serum -free  DMEM for 6  
h o u rs , a n d  th e  m ed iu m  w as  th e n  harv ested .
N- and O-Deglycosylation Using Chondroitinase 
ABC and N-Glycosidase F
H o m o g e n ized  c o m e a l tissu e  o r  cell c u ltu re  m ed iu m  (50  /xL) w ith  1 /xL 
p ro te a se  in h ib ito r  c o ck tail P 8340  an d  10 /xL c h o n d ro itin a se  ABC (Sig­
m a-A ldrich; 0 .01 U/p.L in 50 mM Tris-HCI buffer, pH  8.0, co n ta in ing  60 
mM  sod ium  a ce ta te  a n d  0.02%  b o v in e  seru m  album in  [BSA]) w as 
in c u b a te d  a t 37°C  fo r 6  h o u rs . A fter a ce to n e  p re c ip ita tio n , th e  p e lle t 
w as  d isso lved  in  e ith e r  20 jxL sam p le  b u ffer (In v itro g en ) for im m uno- 
b lo ttin g  o r  in  25 /xL o f  20  mM  sod ium  p h o s p h a te  buffer, pH  7.2, 
c o n ta in in g  1% SDS fo r fu r th e r  N -deglycosidase  F d igestion .
F o r N -deg lycosy lation  a lone , a sam p le  w ith  ace to n e-p rec ip ita ted  
cell c u ltu re  m ed iu m  (5 0  /xL) d isso lv ed  in  25 /xL o f  20  mM sodium  
p h o s p h a te  buffer, pH  7 .2 , c o n ta in in g  1% SDS w as p re p a re d . Both th is  
a n d  th e  sam ple  th a t h ad  p rev io u sly  u n d e rg o n e  O -deglycosylation w e re  
d e n a tu ra te d  by  h e a tin g  to  100°C  fo r  2 m in u tes . T h e  reac tio n  m ix tu res 
w e re  th e n  ad ju sted  to  c o n ta in  10 mM EDTA, 0.5%  N o n id e t P-40, 0.1% 
SDS, a n d  1% 2 -m ercap to e tan o i in  20  mM  sod ium  p h o s p h a te  buffer, pH  
7 .2 , in  a to ta l v o lu m e  o f  150 /xL. O n e  u n it  o f  N -glycosidase F (R oche 
D iagnostics  G m bH ) w as  a d d ed , a n d  th e  sam p les  w e re  in cu b a ted  fo r 1 
h o u r  a t 37°C . O n e  add itiona l u n it o f  N -glycosidase F w as th e n  added, 
a n d  th e  in cu b a tio n s  c o n tin u e d  fo r a n o th e r  h o u r.
W estern Blot Analysis
P ro te in s  w e re  sep a ra te d  w ith  a h ig h -reso lu tio n  gel system  (12% Nu- 
PAGE N ovex  Bis-Tris Gel; In v itro g en ) a cc o rd in g  to  th e  m an u fac tu re r’s 
in s tru c tio n s  an d  w e re  e lec tro p h o re tic a lly  tran sfe rre d  to  n itrocellu lose  
m e m b ran es  (Bio-Rad, H ercu les, CA). A fter b lo ck in g  w ith  5% nonfa t dry 
m ilk  (Bio-Rad), 1% g lycine, a n d  1% BSA in  PBS-T b u ffer (PBS con ta in ing  
0.05%  T w e e n  20), th e  m e m b ran e s  w e re  in c u b a ted  o vern igh t a t 4°C 
w ith  goa t a n ti-  h u m a n  d e co r in  a n tib o d y  (R&D System s) a t a d ilu tion  o f
0 .05  /xg/mL. M em branes w e re  w a sh e d  w ith  PBS co n ta in ing  0.05% 
T w e e n  20  a n d  in c u b a te d  w ith  h o rse rad ish  p e ro x id a se -c o n ju g a te d  
a n t i -g o a t  IgG (S anta C ruz B io technology , Santa C ruz, CA) a t a d ilu tion  
o f  0 .2  /xg/mL fo r 2 h o u rs  a t ro o m  te m p e ra tu re . P ro te in s  w e re  visualized 
(S u p er Signal W est P ico  system ; P ierce , R ockford , IL), and  p ro te in  
s tan d a rd  (M agicM ark; In v itro g en ) w as  u sed  as a m o lecu lar w e igh t 
m arker.
Gel Filtration o f Decorin
M edium  from  tra n sfec ted  HEK293 cells w as c o n c e n tra te d  ap p ro x i­
m ately  50 tim es w ith  a cen trifuga l filter (A m icon Ultra, 10K NMWL; 
M illipore, Billerica, MA) a n d  d ilu ted  in 10 mM HEPES buffer, pH  7.4,
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co n ta in in g  150 m M  N aCl, 3 .4  m M  EDTA, a n d  0 .005%  (v o l/v o l) su rfac­
ta n t P20.
S am ples (5 0 0  g.L) w e re  ru n  o n  a  c o lu m n  (S u p e rd e x  2 0 0  HR 10 /30 ; 
A m ersham  B io sc ien ces , P isca taw ay , N J) c o n n e c te d  to  a  c h ro m a to g ra ­
p h y  system  (B ioLogic HR; B io-R ad) w ith  a b so rb a n c e  d e te c tio n  a t 280  
n m  a n d  a  flow  ra te  o f  0 .2  m L /m in  a t 4°C . T h e  c o lu m n  w as  e q u ilib ra te d  
in  10 mM HEPES b u ffer , p H  7 .4 , c o n ta in in g  150 mM  NaCl, 3 .4  mM  
EDTA, an d  0.005%  (v o l/v o l)  s u rfa c ta n t P20. T h e  c o lu m n  w a s  c a lib ra ted  
u s in g  th e  fo llo w in g  p ro te in s  as  s tan d a rd s : ca ta la se  (M W t. 250  kD a), 
BSA (M W t, 6 6  kD a), a n d  ly so zy m e  (M W t, 14.3 kD a). F rac tio n s  (5 0 0  gL ) 
w e re  c o lle c ted  a n d  s u b je c te d  to  im m u n o b lo t analysis  u s in g  affinity- 
p u rified  an tib o d ie s  ag a in s t r e c o m b in a n t h u m a n  d e co r in .
Results
Cuprolinic Blue Staining
The healthy comeal sample had a normal ultrastructure. Some 
fracture lines, interpreted as freeze-thaw artifacts, were found 
(Fig. 1A). In contrast, the CSCD cornea was severely disorga­
nized. Areas of am orphous substance with small filaments 
disrupted layers of apparently normal collagen fibrils. These 
areas were often located in the immediate vicinity of kerato- 
cytes. In some places, the lamellar structure of collagen fibrils 
appeared to disintegrate (Fig. IB). The abnormal filaments seen 
in the CSCD cornea stained with cuprolinic blue, indicating the 
presence of sulfated glycosaminoglycans (GAGs; Fig. 1D). Cu­
prolinic blue staining was also found along the collagen fibrils 
in CSCD and in healthy corneas (Fig. 1).
Immunoelectron M icroscopy
When examining normal and CSCD corneas by immunoelec­
tron microscopy, decorin immunolabeling was located along 
collagen fibrils. This was particularly prominent when using 
the R&D System goat anti-decorin antibody (Fig. 2). A similar 
pattern was seen with antibody LF-136, whereas LF-122 did not
F ig u r e  1 . E lec tro n  m ic ro g ra p h s  o f  c o rn e a l s tro m a  a f te r  c u p ro lin ic  
b lu e  stain ing . (A ) O v e rv ie w  o f  h e a l th y  c o rn e a  s h o w in g  n o rm al s trom al 
a rc h ite c tu re  w ith  s o m e  fre e z e - th a w  b re a k s  (arrow). (B ) CSCD c o rn e a  
w ith  a reas o f sm all f ilam e n ts  s e p a ra tin g  w h a t a p p e a r  to  b e  no rm al 
lam ellae. ( Q  D etail o f  a fre e z e - th a w  b re a k  in  h ea lth y  c o rn e a  sh o w in g  
m inim al s ta in in g  w ith  c u p ro lin ic  b lu e . (D ) D etail o f  an  a rea  w ith  
ab n o rm al filam en ts  s h o w in g  s tro n g  s ta in in g  w ith  c u p ro lin ic  b lue . As­
terisk: in  so m e  p la c e s  th e  filam en ts  s e e m  to  fo rm  lo n g e r s tru c tu re s .
*•' 500
F ig u r e  2 . E lec tron  m ic ro g rap h s  o f  c o m e a l s trom a  after labeling w ith  
an  a n ti-  d e co rin  an tibody . (A) S ec tion  o f  h ea lth y  co rn ea  trea ted  w ith  
c h o n d ro itin a se  ABC be fo re  labeling . L abeling is diffusely d istribu ted  
a long  co llagen  fibrils. (B -E ) Sec tions o f  CSCD co rn e a  w ith o u t (B, C) o r 
w ith  (D , E ) c h o n d ro itin a se  ABC tre a tm e n t b e fo re  labeling. Labeling is 
loca lized  to  sm all filam ents in  th e  a m o rp h o u s  area  n ear keratocy tes 
(K; B, D ), a n d  in a reas w ith  ab n o rm al filam ents (C, E).
label the collagen fibrils (data not shown). In addition, strong 
decorin immunolabeling was found in the abnormal areas of 
CSCD cornea, particularly in the areas with abnormal filaments. 
This finding was similar for all three decorin antibodies. 
Decorin immunolabeling of keratocytes was not above back­
ground. Chondroitinase ABC treatment strongly increased 
decorin immunolabeling (Fig. 2), particularly for antibody LF- 
122 (data not shown).
Decorin Expression in Patient Samples
Primary keratocyte cultures from a person heterozygous for 
the c.967delT mutation (hetDCN) and from an unaffected 
person (normDCN) were established. No major differences 
regarding the morphology of the cells could be observed. Both 
cell types had to be fully confluent for high levels of decorin to 
be secreted into the medium. Sequencing of cDNA from cul­
tured hetDCN corneal cells revealed that both wild-type tran­
scripts and transcripts with the deletion were present (data not 
shown).
Supernatant from homogenized cornea and medium from 
cultured keratocytes were examined by immunoblot analysis 
before and after treatment with chondroitinase ABC and N- 
glycosidase F. In both hetDCN and normDCN samples, decorin 
was detected as a diffuse band with molecular weights of 
approximately 80 kDa and 90 kDa in the medium from kerato­
cyte culture and homogenized cornea, respectively. The wild- 
type decorin expressed in hetDCN samples, particularly from 
comeal tissue, appeared to migrate slightly faster than that 
expressed in the normDCN samples. No difference in glycosyl- 
ation was observed, as assessed by chondroitinase ABC or 
N-glycosidase F treatment between hetDCN and normDCN 
samples (Fig. 3).
After treatment with chondroitinase ABC and N-glycosidase 
F, a single band of approximately 41 kDa, as determined by 
molecular weight markers (MagicMark; Invitrogen) was ob­
served in the normDCN samples, whereas two clearly distin­
guishable bands (41 and 37 kDa) were seen in the hetDCN 
samples (Fig. 3). The same pattern was seen in cultured fibro­
blasts (data not shown). Decorin was not detected by immu­
noblot analysis of normDCN and hetDCN keratocyte lysates 
(data not shown).
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K era to cy te s C orneal tissu e HEK293 cells
norm D C N  hetD CN  norm DCN hetDCN WT MUT
M (kDa) 1 2 3 4  1 2 3 4  1 2 3 4  1 2 3 4  1 2 3 4  1 2  3 4
♦ •  m
120
80  »  III
60
50  •
4 0  -
30  -
20 -
= 1 •  • mm
F ig u re  3. W e s te rn  b lo t  a n a ly s is  o f  d e c o r in .  S h o w n  a re  u n tr e a te d  sa m p le s  (1 ) , s am p le s  tre a te d  w ith  
c h o n d ro i t in a s e  ABC (2 ) , N -g ly c o s id ase  F (3 ) , a n d  sa m p le s  tre a te d  w ith  b o th  c h o n d ro it in a s e  ABC an d  
N -g lycosidase  F (4 )  fro m  k e ra to c y te s ,  c o rn e a l  tis su e , a n d  H EK 293 ce lls . K e ra to c y te s  a n d  c o rn e a l  tis su e  
w e re  o b ta in e d  fro m  e i th e r  a h e a l th y  c o rn e a  (n o rm D C N ) o r  a CSCD c o rn e a  h e te ro z y g o u s  fo r th e  
c .9 6 7 d e lT  m u ta t io n  (h e tD C N ). T h e  H E K 293 c e lls  h a d  b e e n  tra n s fe c te d  w ith  e i th e r  W T o r  M UT DCN 
cD NA . S e p a ra te  g e ls  w e r e  u s e d  fo r  s a m p le s  fro m  k e ra to c y te s ,  c o m e a l tis su e , a n d  HEK 293  ce lls . 
D iffe ren t m ig ra tio n  b e tw e e n  g e ls  is  a t t r ib u te d  to  v a ria tio n  in  e le c tro p h o re s is  tim e . M, m o le c u la r  
w e ig h t m a rk e r .
Transient Transfection o f  Cells
HEK293 cells were transfected with plasmids containing wild- 
type decorin (WT) or DCN cDNA with the c.967delT mutation 
(MUT). Low endogenous expression of decorin was found in 
HEK293 cells by Q-RT-PCR, with a cycle threshold of approxi­
mately 35. Decorin could not be identified by immunoblot anal­
ysis of cells transfected with GFP expression vector alone (data 
not shown). On immunoblot analysis, decorin was detected as 
four bands (80, 65, 48, and 45 kDa; Fig. 3). After complete N- and 
O-deglycosylation, a single band of 39 kDa mid 35 kDa in the WT 
and MUT samples, respectively, was left. All bands in the MUT 
sample had slightly lower molecular weight corresponding to the 
expression of a truncated protein (Fig. 3).
Gel Filtration
Medium from WT- and MUT-transfected HEK293 cells were 
subjected to size exclusion chromatography using a liigh-reso- 
lution gel filtration column (Superdex 200 HR 10/30; Amer- 
sham Biosciences; Freiburg, Germany). The fractionation range 
for globular proteins on this column is betw een 10 and 600 
kDa. The UV absorption profile was similar for WT and MUT 
media. Fractions were subjected to immunoblot analysis; in the 
WT medium, decorin was detected across 12 fractions in a broad 
molecular weight range. Medium from MUT-transfected cells 
showed a different pattern. Here decorin was found in only five 
fractions starting in the void volume of the column, correspond­
ing to the presence of decorin as aggregates (Fig. 4).
Immunoblot analyses of early WT fractions showed decorin as 
a diffuse band with an estimated molecular weight around 80 
kDa. The molecular weight was gradually reduced in later frac­
tions, suggesting varying degrees of glycosylation of decorin. In all 
MIT’ fractions, decorin was detected as a major band with an 
estimated molecular weight of 40 kDa. Higher molecular weight 
bands were also observed (Fig. 4).
D i s c u s s i o n
CSCD is characterized by stromal layers of abnormal filaments, 
randomly arranged and loosely embedded in an amorphous 
substance.110' 12 In the present study a CSCD cornea, exhibit­
ing these typical findings, was available for cuprolinic blue 
staining and immunoelectron microscopy. The abnormal fila­
ments were found to stain with cuprolinic blue, indicating the
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presence of sulfated GAGs. Immunoelectron microscopy re­
vealed staining with decorin antibodies in these areas and 
w here disorganized lamellae were found. Staining was stronger 
after treatm ent w ith chondroitinase ABC, most likely because 
the GAG chain of decorin disturbs antibody recognition.13 
Deposition of various substances in the keratocytes or extra­
cellular matrix has been found in several other stromal dystro­
phies. Examples include the transforming growth factor-j3- 
induced gene ( TGFBT) corneal dystrophies, lattice comeal 
dystrophy type II, Schnyder comeal dystrophy, and macular 
corneal dystrophy.M15
T he two decorin mutations found associated w ith CSCD, 
c.967delT and c.94ldelC, are predicted to produce a truncated 
pro tein  because of the deletion of 33 C-terminal amino acids. 
Analyses of mRNA in a person carrying the c.967delT mutation 
show ed that both the wild-type and the mutated allele are 
transcribed. By Western blot analysis, the presence of both WT 
and truncated decorin protein could be observed in comeal 
tissue and in keratocyte and fibroblast cell cultures. Decorin 
contains a single chondroitin/dermatan sulfate GAG chain at­
tached  to a serine residue near the N term inus16 and three 
N-linked oligosaccharides.1' These would theoretically not be 
affected by the C-terminal decorin truncation found in CSCD.
Decorin is a class I SLRP with a core of 12 leucine-rich- 
repeats (LRR) flanked by cysteine-rich capping domains impor­
tant for the stability of the protein.1” The LRR domain forms a 
curved solenoid fold, with the second-to-last LRR (the ear 
repeat) spanning away from the main solenoid and coming 
back at the last LRR. The truncation is likely to disrupt the 
disulfide bond between Cys283 and Cys3l6 in the mature 
pro tein  (corresponding to amino acids 313-346 in the unproc­
essed gene product) that connects the last LRR to the top of 
the  ear repeat. It is thought that this disulfide bond is important 
for folding the ear repeat back to complete the solenoid and thus 
to maintain the structure of the protein.17,IH The decorin muta­
tions found associated with CSCD are, therefore, likely to result in 
an altered protein structure with other properties than WT.
W hen concentrated medium from WT HEK293 cells was 
subjected to size exclusion chromatography, decorin eluted 
over a broad molecular weight range. In contrast, w hen me­
dium  from MUT HEK293 cells was examined, decorin eluted in 
the  void volume of the column. The finding of decorin from 
the  MUT sample as high molecular weight complexes sug­
gested  that the truncated decorin was more likely than the WT 
decorin  to aggregate in vitro. Decorin is known to form 
d im ers19 and probably also larger protein complexes, and it 
in teracts with a number of other proteins. The precise nature 
of th e  high molecular weight complexes observed in the MUT 
sam ple is unknown. Varying degrees of glycosylation were 
observed in the WT sample, a feature of HEK293 cells previ­
ously described by others.20 The same pattern was not ob­
served in the MUT sample, possibly because the presence of 
truncated  decorin in aggregates prevented the separation of 
pro teins with varying degrees of glycosylation.
In conclusion, we provide evidence that decorin accumu­
lates in the amorphous areas w ith small filaments that cause the 
strom al opacities in CSCD. Truncated decorin is expressed in 
patien ts with CSCD and is more likely than WT to form high- 
m olecular weight complexes. These altered molecular features 
could  be important for the accumulation of decorin in CSCD.
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